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Introduction 11
In the past two decades, epidemiological studies have demonstrated associations of low 
birth weight with cardiovascular disease and its risk factors. The fetal origins hypoth-
esis proposes that an adverse fetal environment leads to developmental adaptations 
that permanently program the fetus’ structure, physiology and metabolism [1]. This 
programming is in favor of short-term survival and leads to fetal growth retardation 
and low birth weight. Long-term eff ects of this programming would be detrimental and 
lead to several health problems in adulthood including cardiovascular disease. Based on 
this hypothesis, the search for the origins of cardiovascular disease has recently been 
extended from epidemiological studies in adults and children to new studies focused 
on fetal and early postnatal life. 
The fetal origins hypothesis was the main point of departure for studies presented 
in this thesis. Unravelling the mechanisms underlying the associations of low birth 
weight with cardiovascular disease may eventually lead to new strategies for identifi ca-
tion of groups at risk and prevention. The general aim of the studies presented in this 
thesis was to identify pathways leading from adverse fetal exposures to suboptimal fetal 
growth patterns and subsequently to risk factors for cardiovascular disease in later life. 
The adverse fetal exposure of main interest was maternal smoking in pregnancy, which 
is the single most important determinant of low birth weight in Western countries.
In chapter 2, a descriptive review is presented focused on epidemiological studies 
testing the various hypotheses proposed to explain the associations of low birth weight 
with cardiovascular disease in later life. In chapter 3 the Generation R Study is presented. 
This is a recently started cohort study designed to study growth, development and 
health from fetal life until young adulthood. Data from the Generation R Study were 
used for studies presented in chapter 4. Studies in this chapter deal with the eff ect of 
maternal smoking and alcohol consumption in pregnancy on fetal growth. Studies in 
chapter 5 deal with the postnatal cardiovascular consequences of fetal growth retarda-
tion and maternal smoking in pregnancy. The long-term eff ect of maternal smoking was 
studied in the Epidemiological Prevention Organization Zoetermeer (EPOZ) Study, which 
comprises children initially aged 5 to 19 years and currently followed for 27 years. Finally, 
in chapter 6, the results described in this thesis are placed in a broader context, some 
methodological aspects are discussed and suggestions for further research regarding 
this topic are presented. 
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Abstract
Epidemiological studies have demonstrated associations of low birth weight with car-
diovascular disease, type 2 diabetes and their risk factors in adult life. These fi ndings 
led to sharp debates in the literature concerning potential methodological study fl aws 
and the eff ect size and causality of the associations. More recent studies seem to have 
overcome most methodological fl aws and suggest a small eff ect size of low birth weight 
on adult diseases for the individual. However, the eff ect size may still be important on 
a population level. Various causal pathways have been hypothesized as mechanisms 
underlying these associations. These hypotheses have proposed central roles for 1) fetal 
undernutrition; 2) increased cortisol exposure; 3) genetic susceptibility; and 4) acceler-
ated postnatal growth. These hypotheses have been studied in various epidemiological 
study designs. Thus far, it is still not known which mechanisms underlie the associations 
between low birth weight and diseases in adult life. The causal pathways seem to be 
complex and may include combined environmental and genetic mechanisms in vari-
ous periods of life. Well-designed epidemiological studies are necessary to estimate the 
population eff ect size and to identify the underlying mechanisms. This knowledge is 
needed to develop strategies for identifying groups at risk and prevention focused on 
early life.
Hypotheses on the fetal origins of adult diseases 15
In the past 15 years, many studies demonstrated associations between low birth weight 
and cardiovascular disease, type 2 diabetes and their risk factors in adult life. These fi nd-
ings led to sharp debates concerning possible explanations. Researchers seem to be 
divided into almost religious camps of non-believers and believers [1]. Non-believers 
consider methodological study fl aws as explanations for the associations. Believers con-
sider the associations as causal and discuss possible biological underlying mechanisms 
(Table 1). This review is focused on published epidemiological studies designed to iden-
tify the mechanisms underlying the associations between low birth weight and adult 
diseases. 
Table 1.  Subjects most debated
Inconsistencies
Incomplete statistical analysis
(Residual) confounding
Selection bias
Causality
Strength and public health impact
Underlying mechanisms
Methodological fl aws 
The fi rst studies demonstrating associations between low birth weight and diseases in 
later life led to methodological concerns including confounding, inconsistent results 
and selection bias [2, 3]. These studies were based on retrospective data from birth-
cohorts and not able to adjust for potential confounders. More recent studies were 
able to take socio-economic status, life style factors and family history of cardiovascu-
lar disease into account in large cohorts and still demonstrated the associations [4-6]. 
Residual confounding could still be the case due to insuffi  ciently measured variables 
including parental or current off spring socio-economic status, parental smoking habits 
and cardiovascular disease and gestational age. Exploration and careful interpretation 
of the types and extent of confounding in the associations is needed. Even when the 
confounding eff ects of these variables will be quantifi ed, it could be diffi  cult to interpret 
how they aff ect physiological mechanisms underlying the epidemiological associa-
tions. For example, in case of a true causal pathway from a suboptimal maternal diet 
to an impaired fetal growth and diseases in later life, taking socio-economic status into 
account might lead to disappearance of the association if socio-economic status is relat-
ed to maternal diet. Biological knowledge and pre-specifi ed hypotheses are necessary 
for careful interpretation of these complex associations. 
Other objectives from non-believers are the inconsistencies in growth characteris-
tics in early life used in the various studies. Because birth weight is only a proxy for fetal 
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growth and development, major eff orts have been made to fi nd historical data sets with 
more detailed growth characteristics at birth. This has led to many studies showing asso-
ciations of weight, head circumference, abdominal circumference and ponderal index 
(kg/m3) at birth, placental weight and weight at 1 year with cardiovascular disease, type 
2 diabetes and their risk factors in adult life [7, 8]. Although specifi c explanations have 
been proposed for almost all of these separate measures at birth and their associations 
with diseases in later life, the results have rarely been replicated. Weight is the only birth 
characteristic consistently associated with cardiovascular disease and type 2 diabetes 
in adult life [9, 10]. Length, head circumference and abdominal circumference are more 
diffi  cult to measure at birth than weight. The number of studies with these specifi c mea-
surements is smaller and random error may be larger. Therefore, of all anthropometric 
measures at birth, weight may be most likely to demonstrate signifi cant associations 
with any outcomes in adult life. 
Not only the use of diff erent growth characteristics at birth but also the eff ect of 
weight in later life on the associations is subject of debate. Most studies examining the 
associations of birth weight with adult diseases simply adjust for current weight in their 
statistical models. However, in this case, the eff ect estimates of low birth weight on for 
example blood pressure in adult life, depend on the separate associations between birth 
weight and blood pressure, between birth weight and current weight and between cur-
rent weight and blood pressure [11]. If the associations between birth weight and adult 
diseases are absent or weak, adjusting for current weight frequently reveals stronger 
and negative associations. The interpretation of this eff ect could be that if subjects grow 
to the same weight in adulthood, the ones with lower birth weight have an increased 
blood pressure. Lucas et al. proposed that in this case, not birth weight itself, but post-
natal change from birth weight to current weight may be associated with an increased 
blood pressure [12]. They proposed four regression models to analyze separate eff ects 
of birth weight, postnatal weight change and current weight. 
Criticisms frequently have pointed to the enormous loss at follow-up in the historical 
cohort studies. In the initial studies, results were based on only 5 to10% of the original 
birth-cohorts [2]. Although selection bias would only arise if the associations between 
low birth weight and diseases in later life are diff erent between those studied and those 
lost to follow-up, distortion of the observed associations is more likely to occur in case of 
massive loss to follow-up. More recent studies had follow-up rates of more than 90% and 
still demonstrated associations between birth weight and diseases in later life [4-6].
Much of the current skepticism is not focused on the methodological fl aws any-
more, but on the strength, public health impact and causality of the associations [13]. A 
meta-analysis of studies reporting associations between birth weight and blood pres-
sure in later life demonstrated an increase of systolic blood pressure of 0.4 mmHg per 
kilogram decrease in birth weight [9]. This is much lower than previously suggested esti-
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mates (increase of 2 to 4 mmHg per kilogram decrease in birth weight).  A similar small 
eff ect was demonstrated in a meta-analysis of studies reporting associations between 
low birth weight and cholesterol in adult life [14]. Publication bias and inappropriate 
adjustment for potential confounders were suggested as explanations for the earlier 
suggested stronger estimates [15]. Although the real eff ect sizes may be small for the 
individual, they could still be causal and important on a population level. Evidence for 
the causality of the associations comes from experimental animal studies that have 
been reviewed previously [16]. Causality is also suggested by presence of the associa-
tions between low birth weight and diseases in adult life in epidemiological studies with 
minimal loss to follow-up and appropriate adjustment for potential confounders in early 
and adult life [4-6]. 
Thus far, not all of the mentioned methodological issues have been clarifi ed yet. 
However, the concept that children born with a low birth weight have an increased risk 
of developing cardiovascular disease and type 2 diabetes has gradually been recognized 
as potentially scientifi cally plausible. 
Underlying causal mechanisms
Various causal pathways underlying the associations between low birth weight and adult 
diseases have been hypothesized. These hypotheses proposed central roles for respec-
tively 1) fetal undernutrition; 2) increased cortisol exposure; 3) genetic susceptibility; 
and 4) accelerated postnatal growth [17-20] (Table 2). These hypotheses are supported 
Table 2.  Hypotheses on the fetal origins of adult diseases 
Fetal undernutrition [17, 21]
Suboptimal fetal nutrition leads to developmental adaptations that permanently program the fetus’ structure, physiology 
and metabolism. This programming is in favor of short-term survival and leads to low birth weight. Long-term eff ects of 
this programming are detrimental and lead to cardiovascular disease and type 2 diabetes. This hypothesis has gradually 
modifi ed into a more general developmental plasticity model in which various fetal and postnatal factors could lead to 
programming responses.
Steroids exposure and the hypothalamic-pituitary-adrenal axis [18]
Increased exposure to cortisol leads to both low birth weight and diseases in later life. Impaired placental 11-beta-
hydroxysteroid dehydrogenase enzyme activity, which converts cortisol into inactive cortisone, leads to increased fetal 
exposure to cortisol, low birth weight and developmental adaptations in cardiovascular and metabolic systems. These 
adaptations subsequently predispose the individual to cardiovascular disease and type 2 diabetes.
Genetic susceptibility [19]
Genetic variations related to insulin resistance, impaired insulin secretion or cardiovascular development lead prenatally to 
impaired fetal growth and postnatally to type 2 diabetes and cardiovascular disease. 
Accelerated postnatal growth [20]
Rapid postnatal growth instead of birth weight per se leads to diseases in later life. Rapid childhood growth occurs in most 
children with low birth weight and could lead to metabolic and vascular changes and subsequently to diseases in later life. 
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by small studies in humans and studies in animals. Since fi ndings from these studies 
cannot easily be extrapolated to the general population, we reviewed epidemiological 
studies focused on these hypotheses. 
Fetal undernutrition
The fi rst hypothesis explaining the associations between birth weight and diseases in 
later life was formulated by Barker and his colleagues from Southampton and is focused 
on fetal undernutrition and programming [17, 21]. Suboptimal fetal nutrition would lead 
to developmental adaptations that permanently program the fetus’ structure, physiol-
ogy and metabolism. This programming would be in favor of short-term survival and 
lead to low birth weight. Long-term eff ects of this programming would be detrimental 
and lead to cardiovascular disease and type 2 diabetes. Based on more recent animal 
and human studies, this hypothesis has gradually been modifi ed into a general devel-
opmental plasticity model in which various fetal and postnatal environmental factors 
lead to programming responses [22]. Low birth weight is in this hypothesis a proxy for 
suboptimal fetal growth and development and not the causal factor per se. Measures 
of an adverse fetal nutrition may be stronger risk factors for adult diseases than birth 
weight. The fetal nutrition supply line includes maternal anthropometrics and diet, pla-
centa function and the fetus’ own metabolism to use nutrients. This hypothesis has been 
tested in epidemiological studies by relating various determinants of an adverse fetal 
nutrition to diseases and their risk factors in adult life.
Studies that examined the direct eff ect of maternal anthropometrics on diseases 
in the off spring demonstrate confl icting results [23-30] (Table 3). Low maternal body 
mass index in early and late pregnancy was not associated with high blood pressure but 
was associated with early measures of insulin resistance in the off spring [24-29]. These 
results were adjusted for birth weight. The eff ect of maternal weight gain in pregnancy 
on development of cardiovascular disease and type 2 diabetes in the off spring is not 
known. Maternal triceps skin fold thickness in pregnancy was inversely associated with 
blood pressure in the off spring [27, 29, 30]. From all maternal anthropometric measures, 
maternal skin fold thickness seems to be the most consistent independent determinant 
of blood pressure in the off spring. It has been suggested that skin fold thickness may be 
a more stable measure of maternal nutritional status than body mass index in early or 
late pregnancy [27]. 
The eff ect of maternal diet on the development of risk factors for cardiovascular 
disease and type 2 diabetes in the off spring has been studied in retrospective cohort 
studies focused on total energy and macronutrient and micronutrient intake. Follow-up 
studies in subjects who have been exposed prenatally to the famine during World War 
II have been conducted in cohorts in Amsterdam in the Netherlands and in Leningrad 
in Russia. These historical disasters provided the opportunity to study long-term eff ects 
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of extreme maternal undernutrition in pregnancy. Studies in the Amsterdam cohort 
demonstrated that prenatal exposure to the famine is associated with coronary heart 
disease and impaired glucose tolerance in adult life [31, 32]. These associations have 
been replicated only partly in the Leningrad cohort [33, 34]. More detailed information 
about the eff ect of macronutrient and micronutrient intake has come from follow-up 
Table 3.  Determinants of fetal nutrition studied in association with risk factors for cardiovascular disease and type 
2 diabetes
First author (year) Main fi nding
Maternal anthropometrics: weight and body mass index
Forsen (1997) [23] Obesity in short stature mothers is associated with death from coronary heart 
disease in the off spring. 
Shiell (2000), Mi (2000) [24, 25] Low maternal body mass in early and late pregnancy is associated with early 
measures of insulin resistance, but not with blood pressure in the adult off spring. 
The eff ect is independent of their off spring birth and current weight.
Margetts (1991), Godfrey (1994), 
Laor (1997), Clark (1998) [26-29]
Maternal weight in pregnancy is not associated with their off spring’s blood 
pressure in childhood and adolescence. 
Maternal anthropometrics: triceps skinfold thickness
Godfrey (1994), Clark (1998), Adair 
(2001) [27, 29, 30]
Maternal triceps skin fold thickness in pregnancy is inversely associated with 
blood pressure in childhood in their off spring in childhood.
Maternal diet: energy intake
Roseboom (2000), Ravelli (1998), 
Stanner (1997), Sparen (2004) 
[31-34]
Maternal exposure to the Dutch famine during pregnancy is associated with 
impaired glucose tolerance and coronary heart disease in the adult off spring. 
These fi ndings could not fully be replicated in the Leningrad siege study.
Maternal diet: macronutrients
Campbell (1996), Shiell (2001) 
[35, 36] 
Maternal protein and carbohydrate intake are associated with high blood 
pressure in the off spring.
Shiell (2000) [24] Increased maternal intake of fat and protein is associated with reduced 
insulin secretion in the adult off spring suggesting pancreatic dysfunction. No 
associations were found with measures of insulin resistance.
Maternal diet: micronutrients
Belizan (1997), Hatton (2003), 
Gillman (2004), Morley (2004) 
[38-41]
Maternal calcium intake during pregnancy is associated with lower blood 
pressure in the infant off spring. Findings in these studies were independent from 
birth weight.
Placenta: weight
Godfrey (2000) [42] Placenta weight is not consistently associated with risk factors for cardiovascular 
disease and type 2 diabetes in adulthood.
Placenta: haemodynamic function
Smith (2001) [43] Placenta dysfunction, like pre-eclampsia, is associated with low birth weight and 
high blood pressure in the off spring.
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studies in off spring whose mothers have participated in nutritional studies during preg-
nancy. Observational studies demonstrated complex interactions between maternal 
protein and carbohydrate intake as determinants of blood pressure and insulin secre-
tion in adults but not in the infant off spring [24, 35-37]. These fi ndings have not been 
replicated in other studies. The only micronutrient intake during pregnancy studied in 
relation to risk factors for cardiovascular disease in the off spring is calcium intake. Since 
calcium supplementation in pregnancy might reduce pregnancy-induced hyperten-
sion and pre-eclampsia, various studies of calcium supplementation in pregnancy have 
been conducted. These studies provided the opportunity to study the eff ect of maternal 
calcium supplementation on the off spring’s blood pressure. Four prospective studies 
including two randomized controlled trials, demonstrated that maternal calcium intake 
during pregnancy is associated with lower blood pressure in infant off spring [38-41]. 
These fi ndings were independent from birth weight. 
Placenta function is probably the most important determinant of fetal nutrition in 
Western countries. Proxies of placental function studied in relation to adult diseases in 
the off spring in epidemiological studies include placental weight and haemodynamic 
function. The associations between placental weight or placental/birth weight ratio and 
cardiovascular disease and type 2 diabetes have been reviewed previously [42]. No con-
sistent associations were found. Pre-eclampsia, a more severe form of haemodynamic 
placental dysfunction, is associated with both later cardiovascular disease in the mother 
and high blood pressure in the off spring [43]. The less severe form of placental dysfunc-
tion, measured as sub-clinical blood fl ow alterations in the uterine artery, is associated 
with low birth weight but the association of this form of placental dysfunction with car-
diovascular disease and type 2 diabetes in the off spring has not been studied yet. 
The last step in the fetal supply line, the fetus’ own metabolism to use nutrients, 
is not easy to study in epidemiological studies. The fetal undernutrition hypothesis 
suggests fetal programming in various organs. Programming eff ects that have been 
proposed include an impaired nephron number and increased arterial stiff ness [44, 45]. 
Impaired nephron number or increased arterial stiff ness could be intermediates in the 
associations of fetal nutrition or low birth weight with hypertension in adult life. Autop-
sy studies demonstrated that the nephron number is positively associated with birth 
weight and inversely associated with blood pressure [46, 47]. Renal volume measured 
by ultrasound has been suggested to be a proxy for nephron number suitable for use 
in epidemiological studies and is positively associated with birth weight and negatively 
associated with blood pressure [48, 49]. The intermediate role of nephron number or 
renal volume in the association between low birth weight and hypertension in adult life 
has not yet been studied directly. Arterial stiff ness, a strong determinant of blood pres-
sure, seems to be negatively associated with birth weight in children and adults [50, 51]. 
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It is not known whether increased arterial stiff ness is an intermediate in the association 
between low birth weight and hypertension in later life. 
Thus far, the fetal undernutrition hypothesis is not strongly supported by epide-
miological studies. Results of epidemiological studies using measures of fetal nutrition 
are inconsistent and can not explain the associations between low birth weight and 
cardiovascular disease or type 2 diabetes in adult life. The most robust fi nding in these 
studies seems to be the association between maternal calcium supplementation and 
lower blood pressure in the off spring. The intermediate role of proposed programming 
mechanisms including impaired nephron number or increased arterial stiff ness cannot 
directly be concluded from current epidemiological studies. 
Steroids exposure and the hypothalamic-pituitary-adrenal axis
Edwards et al. hypothesized that an increased cortisol exposure leads to both low birth 
weight and diseases in later life [18]. Placental 11-beta-hydroxysteroid dehydrogenase 
enzyme (11-βHSD) converts maternal cortisol into inactive cortisone. They suggested 
that impaired activity of the placental 11-βHSD would lead to increased fetal exposure 
to cortisol and subsequently to fetal growth retardation and developmental adaptations 
in cardiovascular and metabolic systems. These adaptations would subsequently predis-
pose the individual to cardiovascular disease and type 2 diabetes in later life. Increased 
fetal exposure to cortisol may be the result of both absolute and relative impaired 
11-βHSD due to increased maternal cortisol levels. This hypothesis is supported by 
experimental studies in animals, which have been reviewed in detail previously [52]. 
Environmentally or genetically determined common variations in 11-βHSD activity may 
explain the inverse association between birth weight and hypertension in the general 
population. However, no such variations have been reported yet. Epidemiological stud-
ies in humans are scarce mainly because of the diffi  culty of measuring 11-βHSD activity. 
Small studies have demonstrated that placental 11-βHSD gene expression is impaired 
in pre-eclampsia [53]. The enzyme activity is not associated with birth weight but seems 
to be associated with essential hypertension [54, 55]. The direct eff ect of placental 11-
βHSD activity on adult blood pressure has not been studied in humans.
Increased cortisol levels may not only be the result of absolute or relative impaired 
11-βHSD activity but also of other developmental changes in the hypothalamic-pituitary-
adrenal axis [56]. These developmental changes may be the result of various environ-
mental or genetic causes. Several measures of increased hypothalamic-pituitary-adrenal 
axis activity are associated with low birth weight [57, 58]. Instead of causing both low 
birth weight and cardiovascular disease and type 2 diabetes in later life, increased cor-
tisol levels may also be an intermediate in the causal pathway linking low birth weight 
with diseases in later life. From current epidemiological studies, it is not clear whether 
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increased cortisol exposure is just one of the results of developmental changes in early 
life or an intermediate in the causal pathway. 
Genetic susceptibility
Hattersley and Tooke proposed the fetal insulin hypothesis [19]. They hypothesized 
that genetic variations related to insulin resistance lead prenatally to impaired insulin 
mediated growth and postnatally to type 2 diabetes and cardiovascular disease. This 
hypothesis is primarily based on studies demonstrating rare monogenetic variants lead-
ing to both low birth weight and impaired insulin secretion or insulin sensitivity. More 
common genetic variants related to insulin metabolism or cardiovascular development 
may be an explanation for the association between low birth weight and diseases in 
later life in the general population. Epidemiological study designs used to examine this 
hypothesis include follow-up studies of parents from children with low birth weight, 
twin studies and genetic association studies.
Mothers with pregnancies complicated by preterm delivery, fetal growth restric-
tion or pre-eclampsia have an increased risk of developing ischemic heart disease, 
cerebrovascular accidents and insulin resistance many decades later [43, 59, 60]. The 
associations of low birth weight in the off spring with later disease in the mothers them-
selves are stronger than the associations of low birth weight with diseases in adult life 
in the off spring. Pre-eclampsia and cardiovascular disease in women may have the same 
genetic and environmental determinants. Similar follow-up studies have been con-
ducted in fathers from children with low birth weight. Low birth weight in the off spring 
is associated with development of type 2 diabetes in fathers in Western populations 
[61-65]. These fi ndings suggest that genetic variants lead to both low birth weight and 
type 2 diabetes. 
Twin studies seem to provide an optimal model to distinguish between environ-
mental and genetic variants as underlying mechanisms. Diff erences in birth weights 
within monozygotic twin pairs are more likely to be the result of unequal nutrients 
supply. Because of their similar genetic background, associations of low birth weight 
with diseases in later life within only monozygotic twin pairs suggest environmental 
instead of genetic underlying mechanisms. Previous studies demonstrated associations 
in both monozygotic and dizygotic twin pairs, only in dizygotic twin pairs, and in neither 
monozygotic nor dizygotic twin pairs [66-77]. Thus although promising, twin studies 
have been inconclusive and failed to give insight in the mechanisms underlying the 
associations between low birth weight and diseases in adult life [78]. 
Genetic association studies could reveal common genetic variants explaining the 
associations between low birth weight and diseases in later life. Recent studies sug-
gested that various common genetic variants previously linked to type 2 diabetes or 
cardiovascular disease are associated with low birth weight. Genetic variants studied 
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most frequently in diff erent cohorts include the insulin variable number tandem repeat 
(INS VNTR) gene variant, various variants in the insulin like growth factor-1 (IGF-1) gene 
and variants in the peroxisome proliferator-activated receptor gamma 2 (PPAR-γ2) gene 
[79-92] (Table 4). The biological roles of these gene variants were demonstrated in stud-
ies relating them with the gene expression of insulin and insulin like growth factor-2 
(IGF-2), with IGF-1 serum levels and with insulin metabolism, respectively [86, 93-95]. 
To date, these gene variants seem to explain part of the associations between low birth 
weight and diseases in later life. However, as frequently seen in genetic association stud-
ies, current studies did demonstrate confl icting results [96]. 
Table 4.  Common genetic variants studied to explain the associations between low birth weight and diseases in 
later life
 First author (year) Main fi nding
Insulin gene variable number of tandem repeat (INS VNTR)
Dunger (1999) [80]
III/III genotype is associated with increased head circumference, length and weight at 
birth. 
Ong (1999) [81] 
III/III genotype is associated with increased risk of developing type 2 diabetes in adults 
without postnatal growth realignment but not with birth weight.
Bazaes (2003) [82] III/III genotype is associated with increased fasting insulin and insulin secretion in infants. 
Ong (2004) [83]
III/III genotype is associated with larger head circumference at birth. Genotype interacts 
with early postnatal weight gain in determining childhood body mass index, weight and 
waist circumference.
Benett (2004), Mitchell 
(2004) [84, 85]
III/III genotype is not associated with size at birth in children with and without postnatal 
growth realignment.
Insulin like growth factor-1 gene (IGF-1)
Vaessen (2001) [86]
Absence of 192-bp allele is associated with impaired height, increased risk of type 2 
diabetes and myocardial infarction and lower IGF-1 levels.
Vaessen (2002) [87] Absence of 192-bp allele is associated with low birth weight and postnatal weight gain.
Frayling (2002) [88]
Absence of 192-bp allele is weakly associated with increased risk of type 2 diabetes and 
higher IGF-1 levels.
Arends (2002) [89]
Carrying the 191 allele is associated with persistent smaller head circumference and 
lower IGF-1 levels.
Peroxisome proliferator-activated receptor gamma2 gene (PPAR-γ2)
Deeb (1998) [95]
Pro12Pro genotype is associated with higher body mass index, impaired insulin 
sensitivity and type 2 diabetes.
Eriksson (2002) [91]
Pro12Pro genotype modifi es the association between low birth weight and insulin 
resistance.
Yliharsila (2004) [92] Pro12Pro genotype modifi es the association between low birth weight and hypertension.
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Accelerated postnatal growth 
Singhal and Lucas proposed the growth acceleration hypothesis suggesting that pri-
marily rapid postnatal growth instead of low birth weight per se leads to diseases in 
later life [20]. Rapid postnatal growth rate occurs in most children with low birth weight 
who demonstrate a catch-up growth in infancy in the fi rst 6 to 24 months [97]. The 
associations between low birth weight and diseases in later life may be based on this 
compensatory accelerated postnatal growth. Studying this hypothesis and the separate 
infl uences of birth weight and postnatal growth on development of diseases in later 
life requires detailed growth data with a long-term follow-up. The association between 
low birth weight and cardiovascular disease and type 2 diabetes is amplifi ed by a high 
body mass index in childhood and adult life [4, 98, 99]. Even small body mass index 
percentile changes without marked childhood obesity in low birth weight children leads 
to an increased risk of impaired insulin resistance in adult life [100]. Prospective stud-
ies demonstrated that weight gain in the fi rst two years and early adiposity rebound 
are, independent of birth weight, associated with development of childhood obesity 
[101, 102]. Increased early postnatal weight gain induced by nutrient enriched formula 
feeding is associated with increased blood pressure, adverse lipid profi le and insulin 
resistance in later life [103, 104]. These studies support the growth acceleration hypoth-
esis. The diffi  culty of studying this hypothesis is that fetal and postnatal growth are not 
independent and complex models are required to analyze separate eff ects of diff erent 
growth periods [12]. The association between early weight gain and diseases in later life 
may not be causal per se and could be explained by both environmental and genetic 
mechanisms. 
New epidemiological studies
Recent epidemiological studies examining the associations of low birth weight with 
cardiovascular disease and type 2 diabetes in adult life have overcome some but not 
all methodological issues. Further exploration of the role of potential confounders and 
of the population eff ect size is necessary. Although animal and epidemiological studies 
support the proposed hypotheses, none of these current hypotheses fully explain the 
associations. The causal pathways linking low birth weight to cardiovascular disease and 
type 2 diabetes in later life may be complex and probably include combined several 
environmental and genetic mechanisms in various periods of life. Parts of these causal 
pathways can only be studied in experimental animal or small studies in humans. New 
well-designed epidemiological studies are necessary to overcome the existing meth-
odological issues, to quantify the population eff ect size and to identify the combined 
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causal pathways underlying the associations. These studies should combine the follow-
ing approaches:
1) An optimal epidemiological approach to overcome earlier methodological fl aws 
and biases and to establish the population eff ect size;
2) A life course approach to identify fetal and postnatal growth and developmental 
patterns and their determinants associated with cardiovascular disease or type 2 
diabetes in adult life;
3) A combined approach into possible environmental and genetic variations underly-
ing the associations.
The epidemiological study design that seems most suitable for these approaches is a 
population-based prospective cohort study beginning in pregnant or even pre-preg-
nant women and their partners in which the off spring is followed from fetal life into 
adulthood (Figure 1). This design is ideal for data quality, taking account of potential 
confounders and identifying growth patterns at risk. Studies with this design have been 
started worldwide recently and will soon start to publish results [105, 106]. Although 
surrogate outcomes in childhood are available since risk factors for cardiovascular dis-
ease and type 2 diabetes track to some extent from childhood to adulthood, the major 
limitation of this design is the long period needed for the adult diseases to develop. This 
limitation can be overcome by using existing retrospective follow-up studies or register-
based studies with longitudinal data on at least childhood growth and development of 
risk factors of cardiovascular disease and type 2 diabetes. The main advantage of this 
design is the earlier availability of outcomes directly related to cardiovascular disease 
and type 2 diabetes. This design may not be able to take account of all possible con-
founders and is not suitable to study the eff ect of fetal or early postnatal infl uences. 
Studies with these approaches should be able to overcome the methodological 
issues and identify mechanisms in the causal pathways that underlie the associations. 
Maybe more importantly, they should lead to a rational debate and discussion between 
the non-believers and believers and close the gap between them. After more than 15 
years of studies into the fetal origins of adult diseases, it is time to clarify the importance, 
eff ect size and causality of the associations and, if indeed causal, to develop strategies 
for identifying groups at risk and prevention focused on the earliest phase of life.
26
C
ha
p
te
r 2
Fi
gu
re
 1
.  
M
od
el
s f
or
 st
ud
yi
ng
 th
e 
hy
po
th
es
es
 o
n 
fe
ta
l o
rig
in
s o
f a
du
lt 
di
se
as
es
 in
 e
pi
de
m
io
lo
gi
ca
l s
tu
di
es
C
h
ild
M
o
th
er
F
at
h
er
 
F
et
al
 a
n
d
 p
la
ce
n
ta
l g
ro
w
th
 
B
ir
th
 w
ei
g
h
t
C
h
ild
h
o
o
d
 g
ro
w
th
 
R
is
k 
fa
ct
o
rs
 f
o
r 
ad
u
lt
 
d
is
ea
se
 in
 c
h
ild
re
n
 
In
cl
ud
in
g:
B
lo
od
 p
re
ss
ur
e 
Li
pi
ds
A
rt
er
ia
l s
tif
fn
es
s 
A
th
er
os
cl
er
os
is
C
or
on
a
ry
 h
ea
rt
 d
is
ea
se
 
In
su
lin
 r
es
is
ta
nc
e 
In
su
lin
 s
ec
re
tio
n
B
od
y 
co
m
po
si
tio
n
M
o
th
er
A
nt
hr
op
om
et
ric
s 
an
d 
di
et
 b
ef
or
e 
a
nd
 d
ur
in
g 
p
re
gn
a
nc
y,
 
m
ed
ic
al
 h
is
to
ry
 (
in
cl
ud
in
g 
bi
rt
h 
w
e
ig
ht
),
 m
ed
ic
al
 fa
m
ily
 
hi
st
or
y;
 s
oc
io
-e
co
no
m
ic
 s
ta
tu
s;
 li
fe
 s
ty
le
 h
ab
its
R
is
k 
fa
ct
o
rs
 f
o
r 
ad
u
lt
 d
is
ea
se
 in
 m
o
th
er
 
C
h
ild
h
o
o
d
 d
ie
t 
F
at
h
er
 
A
nt
hr
op
om
et
ric
s,
 m
ed
ic
al
 h
is
to
ry
 (
in
cl
ud
in
g 
bi
rt
h 
w
ei
gh
t)
, 
m
ed
ic
al
 fa
m
ily
 h
is
to
ry
; s
oc
io
-e
co
n
om
ic
 s
ta
tu
s;
 li
fe
 s
ty
le
 
ha
bi
ts
R
is
k 
fa
ct
o
rs
 f
o
r 
ad
u
lt
 d
is
ea
se
 in
 f
at
h
er
 
D
ev
el
o
p
m
en
ta
l c
h
an
g
es
 in
 c
ar
d
io
va
sc
u
la
r 
an
d
 m
et
ab
o
lic
 s
ys
te
m
s 
Th
is
 m
od
el
 d
em
on
st
ra
te
s c
or
e 
as
so
ci
at
io
ns
 th
at
 h
av
e 
to
 b
e 
st
ud
ie
d 
to
 c
la
rif
y 
th
e 
m
ec
ha
ni
sm
s u
nd
er
ly
in
g 
th
e 
as
so
ci
at
io
ns
 b
et
w
ee
n 
lo
w
 b
irt
h 
w
ei
gh
t a
nd
 d
is
ea
se
s i
n 
la
te
r l
ife
. T
he
 
m
id
-a
re
a 
de
m
on
st
ra
te
s a
ss
oc
ia
tio
ns
 in
 c
hi
ld
re
n 
th
at
 h
av
e 
to
 id
en
tif
y 
gr
ow
th
 p
at
te
rn
s a
nd
 d
ev
el
op
m
en
ta
l c
ha
ng
es
 in
 fe
ta
l l
ife
 a
nd
 e
ar
ly
 c
hi
ld
ho
od
 th
at
 le
ad
 to
 ri
sk
 fa
ct
or
s o
f d
is
ea
se
s 
in
 a
du
lth
oo
d.
 T
he
 u
pp
er
 a
nd
 lo
w
er
 a
re
as
 d
em
on
st
ra
te
 a
ss
oc
ia
tio
ns
 in
 m
ot
he
r a
nd
 fa
th
er
, r
es
pe
ct
iv
el
y,
 th
at
 c
ou
ld
 g
iv
e 
in
si
gh
t i
n 
bo
th
 d
et
er
m
in
an
ts
 o
f p
re
na
ta
l a
nd
 p
os
tn
at
al
 g
ro
w
th
 
pa
tt
er
ns
 a
nd
 in
 th
e 
un
de
rly
in
g 
en
vi
ro
nm
en
ta
l a
nd
 g
en
et
ic
 m
ec
ha
ni
sm
s.
Hypotheses on the fetal origins of adult diseases 27
References
1. Poulter NR. Birthweights, maternal cardiovascular events, and Barker hypothesis. Lancet 
2001;357:1990-1.
2. Kramer MS, Joseph KS. Enigma of fetal/infant-origins hypothesis. Lancet 1996;348:1254-5.
3. Paneth N, Susser M. Early origin of coronary heart disease (the “Barker hypothesis”). BMJ 
1995;310:411-2.
4. Frankel S, Elwood P, Sweetnam P, Yarnell J, Smith GD. Birthweight, body-mass index in middle age, 
and incident coronary heart disease. Lancet 1996;348:1478-80.
5. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL, Stampfer MJ. Birth weight and adult 
hypertension, diabetes mellitus, and obesity in US men. Circulation 1996;94:3246-50.
6. Rich-Edwards JW, Colditz GA, Stampfer MJ, Willett WC, Gillman MW, Hennekens CH, et al. Birthweight 
and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med 1999;130:278-84.
7. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from isch-
aemic heart disease. Lancet 1989;2:577-80.
8. Barker DJ, Godfrey KM, Osmond C, Bull A. The relation of fetal length, ponderal index and head cir-
cumference to blood pressure and the risk of hypertension in adult life. Paediatr Perinat Epidemiol 
1992;6:35-44.
9. Huxley R, Neil A, Collins R. Unravelling the fetal origins hypothesis: is there really an inverse associa-
tion between birthweight and subsequent blood pressure? Lancet 2002;360:659-65.
10. Newsome CA, Shiell AW, Fall CH, Phillips DI, Shier R, Law CM. Is birth weight related to later glucose 
and insulin metabolism?: A systematic review. Diabet Med 2003;20:339-48.
11. Tu YK, West R, Ellison GT, Gilthorpe MS. Why evidence for the fetal origins of adult disease might be 
a statistical artifact: The “reversal paradox” for the relation between birth weight and blood pressure 
in later life. Am J Epidemiol 2005;161:27-32.
12. Lucas A, Fewtrell MS, Cole TJ. Fetal origins of adult disease-the hypothesis revisited. BMJ 
1999;319:245-9.
13. Kramer MS. Invited commentary: association between restricted fetal growth and adult chronic 
disease: is it causal? Is it important? Am J Epidemiol 2000;152:605-8.
14. Huxley R, Owen CG, Whincup PH, Cook DG, Colman S, Collins R. Birth weight and subsequent cho-
lesterol levels: exploration of the “fetal origins” hypothesis. JAMA 2004;292:2755-64.
15. Schluchter MD. Publication bias and heterogeneity in the relationship between systolic blood pres-
sure, birth weight, and catch-up growth: a meta analysis. J Hypertens 2003;21:273-9.
16. Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. 
Science 2004;305:1733-6.
17. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardio-
vascular disease in adult life. Lancet 1993;341:938-41.
18. Edwards CR, Benediktsson R, Lindsay RS, Seckl JR. Dysfunction of placental glucocorticoid barrier: 
link between fetal environment and adult hypertension? Lancet 1993;341:355-7.
19. Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of 
low birthweight with diabetes and vascular disease. Lancet 1999;353:1789-92.
20. Singhal A, Lucas A. Early origins of cardiovascular disease: is there a unifying hypothesis? Lancet 
2004;363:1642-5.
21. Barker DJ. Fetal origins of coronary heart disease. BMJ 1995;311:171-4.
22. Bateson P, Barker D, Clutton-Brock T, Deb D, D’Udine B, Foley RA, et al. Developmental plasticity and 
human health. Nature 2004;430:419-21.
23. Forsen T, Eriksson JG, Tuomilehto J, Teramo K, Osmond C, Barker DJ. Mother’s weight in pregnancy 
and coronary heart disease in a cohort of Finnish men: follow up study. BMJ 1997;315:837-40.
24. Shiell AW, Campbell DM, Hall MH, Barker DJ. Diet in late pregnancy and glucose-insulin metabolism 
of the off spring 40 years later. BJOG 2000;107:890-5.
28
C
ha
p
te
r 2
25. Mi J, Law C, Zhang KL, Osmond C, Stein C, Barker D. Eff ects of infant birthweight and maternal body 
mass index in pregnancy on components of the insulin resistance syndrome in China. Ann Intern 
Med 2000;132:253-60.
26. Margetts BM, Rowland MG, Foord FA, Cruddas AM, Cole TJ, Barker DJ. The relation of maternal weight 
to the blood pressures of Gambian children. Int J Epidemiol 1991;20:938-43.
27. Godfrey KM, Forrester T, Barker DJ, Jackson AA, Landman JP, Hall JS, et al. Maternal nutritional status 
in pregnancy and blood pressure in childhood. BJOG 1994;101:398-403.
28. Laor A, Stevenson DK, Shemer J, Gale R, Seidman DS. Size at birth, maternal nutritional status in 
pregnancy, and blood pressure at age 17: population based analysis. BMJ 1997;315:449-53.
29. Clark PM, Atton C, Law CM, Shiell A, Godfrey K, Barker DJ. Weight gain in pregnancy, triceps skinfold 
thickness, and blood pressure in off spring. Obstet Gynecol 1998;91:103-7.
30. Adair LS, Kuzawa CW, Borja J. Maternal energy stores and diet composition during pregnancy pro-
gram adolescent blood pressure. Circulation 2001;104:1034-9.
31. Roseboom TJ, van der Meulen JH, Osmond C, Barker DJ, Ravelli AC, Schroeder-Tanka JM, et al. Coro-
nary heart disease after prenatal exposure to the Dutch famine, 1944-45. Heart 2000;84:595-8.
32. Ravelli AC, van der Meulen JH, Michels RP, Osmond C, Barker DJ, Hales CN et al. Glucose tolerance in 
adults after prenatal exposure to famine. Lancet 1998;351:173-7.
33. Stanner SA, Bulmer K, Andres C, Lantseva OE, Borodina V, Poteen VV, et al. Does malnutrition in utero 
determine diabetes and coronary heart disease in adulthood? Results from the Leningrad siege 
study, a cross sectional study. BMJ 1997;315:1342-8.
34. Sparen P, Vagero D, Shestov DB, Plavinskaja S, Parfenova N, Hoptiar V, et al. Long term mortality after 
severe starvation during the siege of Leningrad: prospective cohort study. BMJ 2004;328:11.
35. Campbell DM, Hall MH, Barker DJ, Cross J, Shiell AW, Godfrey KM. Diet in pregnancy and the off -
spring’s blood pressure 40 years later. BJOG 1996;103:273-80.
36. Shiell AW, Campbell-Brown M, Haselden S, Robinson S, Godfrey KM, Barker DJ. High-meat, low-
carbohydrate diet in pregnancy: relation to adult blood pressure in the off spring. Hypertension 
2001;38:1282-8.
37. Huh SY, Rifas-Shiman SL, Kleinman KP, Rich-Edwards JW, Lipshultz SE, Gillman MW. Maternal protein 
intake is not associated with infant blood pressure. Int J Epidemiol 2004; 34:378-84.
38. Belizan JM, Villar J, Bergel E, del Pino A, Di Fulvio S, Galliano SV, et al. Long-term eff ect of calcium 
supplementation during pregnancy on the blood pressure of off spring: follow up of a randomised 
controlled trial. BMJ 1997;315:281-5.
39. Hatton DC, Harrison-Hohner J, Coste S, Reller M, McCarron D. Gestational calcium supplementation 
and blood pressure in the off spring. Am J Hypertens 2003;16:801-5.
40. Gillman MW, Rifas-Shiman SL, Kleinman KP, Rich-Edwards JW, Lipshultz SE. Maternal calcium intake 
and off spring blood pressure. Circulation 2004;110:1990-5.
41. Morley R, Carlin JB, Dwyer T. Maternal calcium supplementation and cardiovascular risk factors in 
twin off spring. Int J Epidemiol 2004;33:1304-9.
42. Godfrey KM, Barker DJ. Fetal nutrition and adult disease. Am J Clin Nutr 2000;71:1344S-52S.
43. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a 
retrospective cohort study of 129,290 births. Lancet 2001;357:2002-6.
44. Mackenzie HS, Brenner BM. Fewer nephrons at birth: a missing link in the etiology of essential 
hypertension? Am J Kidney Dis 1995;26:91-8.
45. Martyn CN, Greenwald SE. Impaired synthesis of elastin in walls of aorta and large conduit arteries 
during early development as an initiating event in pathogenesis of systemic hypertension. Lancet 
1997;350:953-5.
46. Hinchliff e SA, Lynch MR, Sargent PH, Howard CV, van Velzen D. The eff ect of intrauterine growth 
retardation on the development of renal nephrons. BJOG 1992;99:296-301.
47. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. 
N Engl J Med 2003;348:101-8.
Hypotheses on the fetal origins of adult diseases 29
48. Spencer J, Wang Z, Hoy W. Low birth weight and reduced renal volume in Aboriginal children. Am J 
Kidney Dis 2001;37:915-20.
49. Singh GR, Hoy WE. Kidney volume, blood pressure, and albuminuria: fi ndings in an Australian 
aboriginal community. Am J Kidney Dis 2004;43:254-9.
50. Cheung YF, Wong KY, Lam BC, Tsoi NS. Relation of arterial stiff ness with gestational age and birth 
weight. Arch Dis Child 2004;89:217-21.
51. Martyn CN, Barker DJ, Jespersen S, Greenwald S, Osmond C, Berry C. Growth in utero, adult blood 
pressure, and arterial compliance. Br Heart J 1995;73:116-21.
52. Seckl JR. Prenatal glucocorticoids and long-term programming. Eur J Endocrinol 2004;151: U49-62.
53. Schoof E, Girstl M, Frobenius W, Kirschbaum M, Dorr HG, Rascher W, et al. Decreased gene expression 
of 11-beta-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase in 
human placenta of patients with preeclampsia. J Clin Endocrinol Metab 2001;86:1313-7.
54. Rogerson FM, Kayes KM, White PC. Variation in placental type 2 11beta-hydroxysteroid dehydroge-
nase activity is not related to birth weight or placental weight. Mol Cell Endocrinol 1997;128:103-9.
55. Bocchi B, Kenouch S, Lamarre-Cliche M, Muff at-Joly M, Capron MH, Fiet J, et al. Impaired 11-beta 
hydroxysteroid dehydrogenase type 2 activity in sweat gland ducts in human essential hyperten-
sion. Hypertension 2004;43:803-8.
56. Clark PM. Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult 
disease hypothesis. Eur J Pediatr 1998;157:S7-10.
57. Phillips DI, Walker BR, Reynolds RM, Flanagan DE, Wood PJ, Osmond C, et al. Low birth weight predicts 
elevated plasma cortisol concentrations in adults from 3 populations. Hypertension 2000;35:1301-
6.
58. Ward AM, Syddall HE, Wood PJ, Chrousos GP, Phillips DI. Fetal programming of the hypothalamic-
pituitary-adrenal (HPA) axis: low birth weight and central HPA regulation. J Clin Endocrinol Metab 
2004;89:1227-33.
59. Pell JP, Smith GC, Walsh D. Pregnancy complications and subsequent maternal cerebrovascular 
events: a retrospective cohort study of 119,668 births. Am J Epidemiol 2004;159:336-42.
60. Lawlor DA, Davey Smith G, Ebrahim S. Birth weight of off spring and insulin resistance in late adult-
hood: cross sectional survey. BMJ 2002;325:359-62.
61. Lindsay RS, Dabelea D, Roumain J, Hanson RL, Bennett PH, Knowler WC. Type 2 diabetes and low 
birth weight: the role of paternal inheritance in the association of low birth weight and diabetes. 
Diabetes 2000;49:445-9.
62. Yajnik CS, Coyaji KJ, Joglekar CV, Kellingray S, Fall C. Paternal insulin resistance and fetal growth: 
problem for the ‘fetal insulin’ and the ‘fetal origins’ hypotheses. Diabetologia 2001;44:1197-8.
63. Hypponen E, Smith GD, Power C. Parental diabetes and birth weight of off spring: intergenerational 
cohort study. BMJ 2003;326:19-20.
64. Yajnik CS, Joglekar CV, Pandit AN, Bavdekar AR, Bapat SA, Bhave SA, et al. Higher off spring birth 
weight predicts the metabolic syndrome in mothers but not fathers 8 years after delivery: the Pune 
Children’s Study. Diabetes 2003;52:2090-6.
65. Wannamethee SG, Lawlor DA, Whincup PH, Walker M, Ebrahim S, Davey-Smith G. Birthweight of 
off spring and paternal insulin resistance and paternal diabetes in late adulthood: cross sectional 
survey. Diabetologia 2004;47:12-8.
66. Poulsen P, Vaag AA, Kyvik KO, Moller Jensen D, Beck-Nielsen H. Low birth weight is associated with 
NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia 1997;40:439-46.
67. Poulter NR, Chang CL, MacGregor AJ, Snieder H, Spector TD. Association between birth weight and 
adult blood pressure in twins: historical cohort study. BMJ 1999;319:1330-3.
68. Dwyer T, Blizzard L, Morley R, Ponsonby AL. Within pair association between birth weight and blood 
pressure at age 8 in twins from a cohort study. BMJ 1999;319:1325-9.
69. Loos RJ, Fagard R, Beunen G, Derom C, Vlietinck R. Birth weight and blood pressure in young adults: 
a prospective twin study. Circulation 2001;104:1633-8.
30
C
ha
p
te
r 2
70. Iliadou A, Cnattingius S, Lichtenstein P. Low birthweight and Type 2 diabetes: a study on 11,162 
Swedish twins. Int J Epidemiol 2004;33:948-53. 
71. RG IJ, Stehouwer CD, Boomsma DI. Evidence for genetic factors explaining the birth weight-blood 
pressure relation. Analysis in twins. Hypertension 2000;36:1008-12.
72. Christensen K, Stovring H, McGue M. Do genetic factors contribute to the association between birth 
weight and blood pressure? J Epidemiol Community Health 2001;55:583-7.
73. Johansson-Kark M, Rasmussen F, De Stavola B, Leon DA. Fetal growth and systolic blood pressure in 
young adulthood: the Swedish Young Male Twins Study. Paediatr Perinat Epidemiol 2002;16:200-9.
74. Hubinette A, Cnattingius S, Ekbom A, de Faire U, Kramer M, Lichtenstein P. Birthweight, early 
environment, and genetics: a study of twins discordant for acute myocardial infarction. Lancet 
2001;357:1997-2001.
75. Vagero D, Leon D. Ischaemic heart disease and low birth weight: a test of the fetal-origins hypoth-
esis from the Swedish Twin Registry. Lancet 1994;343:260-3.
76. Zhang J, Brenner RA, Klebanoff  MA. Diff erences in birth weight and blood pressure at age 7 years 
among twins. Am J Epidemiol 2001;153:779-82.
77. Baird J, Osmond C, MacGregor A, Snieder H, Hales CN, Phillips DI. Testing the fetal origins hypothesis 
in twins: the Birmingham twin study. Diabetologia 2001;44:33-9.
78. Leon DA. The foetal origins of adult disease: interpreting the evidence from twin studies. Twin Res 
2001;4:321-6.
79. Casteels K, Ong K, Phillips D, Bendall H, Pembrey M. Mitochondrial 16189 variant, thinness at birth, 
and type-2 diabetes. ALSPAC study team. Avon Longitudinal Study of Pregnancy and Childhood. 
Lancet 1999;353:1499-500.
80. Dunger DB, Ong KK, Huxtable SJ, Sherriff  A, Woods KA, Ahmed ML, et al. Association of the INS VNTR 
with size at birth. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Nat 
Genet 1998;19:98-100.
81. Ong KK, Phillips DI, Fall C, Poulton J, Bennett ST, Golding J, et al. The insulin gene VNTR, type 2 
diabetes and birth weight. Nat Genet 1999;21:262-3.
82. Bazaes RA, Petry CJ, Ong KK, Avila A, Dunger DB, Mericq MV. Insulin gene VNTR genotype is associ-
ated with insulin sensitivity and secretion in infancy. Clin Endocrinol 2003;59:599-603.
83. Ong KK, Petry CJ, Barratt BJ, Ring S, Cordell HJ, Wingate DL, et al. Maternal-fetal interactions and 
birth order infl uence insulin variable number of tandem repeats allele class associations with head 
size at birth and childhood weight gain. Diabetes 2004;53:1128-33.
84. Bennett AJ, Sovio U, Ruokonen A, Martikainen H, Pouta A, Taponen S, et al. Variation at the insulin 
gene VNTR (variable number tandem repeat) polymorphism and early growth: studies in a large 
Finnish birth cohort. Diabetes 2004;53:2126-31.
85. Mitchell SM, Hattersley AT, Knight B, Turner T, Metcalf BS, Voss LD, et al. Lack of support for a role of 
the insulin gene variable number of tandem repeats minisatellite (INS-VNTR) locus in fetal growth or 
type 2 diabetes-related intermediate traits in United Kingdom populations. J Clin Endocrinol Metab 
2004;89:310-7.
86. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, et al. A polymorphism in the 
gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 
2001;50:637-42.
87. Vaessen N, Janssen JA, Heutink P, Hofman A, Lamberts SW, Oostra BA, et al. Association between 
genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 
2002;359:1036-7.
88. Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL, et al. A putative functional 
polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose 
tolerance, and fetal growth in U.K. populations. Diabetes 2002;51:2313-6.
Hypotheses on the fetal origins of adult diseases 31
89. Arends N, Johnston L, Hokken-Koelega A, van Duijn C, de Ridder M, Savage M, et al. Polymorphism 
in the IGF-I gene: clinical relevance for short children born small for gestational age. J Clin Endocri-
nol Metab 2002;87:2720-24.
90. Johnston LB, Dahlgren J, Leger J, Gelander L, Savage MO, Czernichow P, et al. Association between 
insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre- and postnatal growth 
in two European small for gestational age populations. J Clin Endocrinol Metab 2003;88:4805-10.
91. Eriksson JG, Lindi V, Uusitupa M, Forsen TJ, Laakso M, Osmond C, et al. The eff ects of the Pro12Ala 
polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitiv-
ity and insulin metabolism interact with size at birth. Diabetes 2002;51:2321-4.
92. Yliharsila H, Eriksson JG, Forsen T, Laakso M, Uusitupa M, Osmond C, et al. Interactions between per-
oxisome proliferator-activated receptor-gamma 2 gene polymorphisms and size at birth on blood 
pressure and the use of antihypertensive medication. J Hypertens 2004;22:1283-7.
93. Kennedy GC, German MS, Rutter WJ. The minisatellite in the diabetes susceptibility locus IDDM2 
regulates insulin transcription. Nat Genet 1995;9:293-8.
94. Paquette J, Giannoukakis N, Polychronakos C, Vafi adis P, Deal C. The INS 5’ variable number of tan-
dem repeats is associated with IGF2 expression in humans. J Biol Chem 1998;273:14158-64.
95. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, et al. A Pro12Ala substitution in 
PPARgamma2 associated with decreased receptor activity, lower body mass index and improved 
insulin sensitivity. Nat Genet 1998;20:284-7.
96. Frayling TM, Hattersley AT, Smith GD, Ben-Shlomo Y. Confl icting results on variation in the IGFI gene 
highlight methodological considerations in the design of genetic association studies. Diabetologia 
2002;45:1605-6.
97. Hokken-Koelega AC, De Ridder MA, Lemmen RJ, Den Hartog H, De Muinck Keizer-Schrama SM, Drop 
SL. Children born small for gestational age: do they catch up? Pediatr Res 1995;38:267-71.
98. Forsen T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker D. The fetal and childhood growth 
of persons who develop type 2 diabetes. Ann Intern Med 2000;133:176-82.
99. Eriksson JG, Forsen T, Tuomilehto J, Osmond C, Barker DJ. Early growth and coronary heart disease 
in later life: longitudinal study. BMJ 2001;322:949-53.
100. Bhargava SK, Sachdev HS, Fall CH, Osmond C, Lakshmy R, Barker DJ, et al. Relation of serial changes 
in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 
2004;350:865-75.
101. Ong KK, Ahmed ML, Emmett PM, Preece MA, Dunger DB. Association between postnatal catch-up 
growth and obesity in childhood: prospective cohort study. BMJ 2000;320:967-71.
102. Stettler N, Zemel BS, Kumanyika S, Stallings VA. Infant weight gain and childhood overweight status 
in a multicenter, cohort study. Pediatrics 2002;109:194-9.
103. Singhal A, Cole TJ, Lucas A. Early nutrition in preterm infants and later blood pressure: two cohorts 
after randomised trials. Lancet 2001;357:413-9.
104. Singhal A, Fewtrell M, Cole TJ, Lucas A. Low nutrient intake and early growth for later insulin resis-
tance in adolescents born preterm. Lancet 2003;361:1089-97.
105. Hofman A, Jaddoe VW, Mackenbach JP, Moll HA, Snijders RF, Steegers EA, et al. Growth, develop-
ment and health from early fetal life until young adulthood: the Generation R Study. Paediatr Perinat 
Epidemiol 2004;18:61-72.
106. Inskip HM, Godfrey KM, Robinson SM, Law CM, Barker DJ, Cooper C. Cohort profi le: The Southamp-
ton Women’s Survey. Int J Epidemiol 2006;35:42-8.

The Generation R Study
3

Rationale and design
3.1
36
C
ha
p
te
r 3
.1
Abstract
In this paper the Generation R Study is presented. This study examines growth, devel-
opment and health in urban children from fetal life until young adulthood. With an 
integrated approach of epidemiological, clinical and basic research, this study focuses 
on four primary areas of research: 1) growth and physical development; 2) behavioural 
and cognitive development; 3) diseases in childhood; and 4) health and healthcare for 
pregnant women and children. The general aims of the study are:
1) To describe normal and abnormal growth, development and health from fetal life 
until young adulthood in a multi-ethnic population-based cohort;
2) To identify biological, social and environmental determinants of normal and abnor-
mal growth, development and health from fetal life until adulthood;
3) To examine the eff ectiveness of current strategies for prevention and early identifi -
cation of groups at risk.
Eventually, this study has to contribute to the development of strategies for optimizing 
health and healthcare for pregnant women and children. The Generation R Study is a 
population-based prospective cohort study in Rotterdam, the Netherlands. In this urban 
setting, 10,000 subjects are planned to be examined from early fetal life until young 
adulthood. Data are collected by physical examinations, questionnaires, interviews, 
ultrasound examinations and biological samples. The study entered its pilot phase in 
December 2001 with the inclusion of pregnant women. Full participant recruitment and 
complete data collection started in 2002.
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General description 
Introduction
Knowledge about growth, development and health in contemporary urban children is 
limited. Insights are primarily based on studies in diseased populations. However, small 
variations within the normal range of growth, development and health in fetal life and 
childhood may have life-long consequences for physical and mental health. These varia-
tions and their determinants can only be studied in large-scale population-based cohort 
studies. Current population-based cohort studies are not situated in large western cities 
and do not provide information on children from ethnic minorities [1]. 
Scope of research
The Generation R Study is designed to study growth, development and health in a con-
temporary population-based multi-ethnic cohort of urban children from fetal life until 
young adulthood. The study focuses on four primary areas of research: 1) growth and 
physical development; 2) behavioural and cognitive development; 3) diseases in child-
hood; and 4) health and healthcare for pregnant women and children. Special interest 
in these areas of research is on identifi cation of early causal pathways leading to both 
normal and abnormal growth, development and health in childhood and adulthood. 
The general aims of the study are:
1) To describe normal and abnormal growth, development and health from fetal life 
until young adulthood in a multi-ethnic population-based cohort;
2) To identify biological, social and environmental determinants of normal and abnor-
mal growth, development and health from fetal life until adulthood;
3) To examine the eff ectiveness of current strategies for prevention and early identifi -
cation of groups at risk.
Eventually, this study has to contribute to the development of strategies for optimizing 
health and healthcare for pregnant women and children.
Rationale
The Generation R study is based on three main rationales. First, common physical and 
mental diseases in adult life seem to have at least part of their origin in early life. Risk 
factors for cardiovascular disease track from early childhood to adulthood [2, 3]. Social, 
emotional and physical deprivation in childhood are associated with psychopathology 
in adolescence and adult life [4, 5]. More recently, it has been suggested that in addition 
to the early postnatal phase, fetal life is also important for the development of diseases 
in later life [6, 7]. Causal pathways leading to common diseases in adult life may start in 
fetal life or infancy. Identifi cation of the etiological determinants in fetal life and infancy 
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of common diseases in adult life is important for the development of future preventive 
strategies.
Second, the largest ethnic groups in Rotterdam are the Dutch, Moroccan, Surinam-
ese and Turkish parents. Approximately 50% of the newborns in the large Dutch cities, 
including Rotterdam, have parents from ethnic minorities [8]. Knowledge about their 
growth, development and health is lacking. These children are not comparable with 
either their peers in their parents’ countries because of the environmental eff ects or with 
their Dutch peers, because of the genetic diff erences. Evaluation of their growth, devel-
opment and health will contribute to the development of specifi c strategies focused on 
the children of the largest ethnic groups. 
Third, utilization of the preventive and curative health care system seems to dif-
fer between diff erent social classes and ethnic groups [9]. Identifying determinants of 
health care utilization in pregnant women and children, especially in ethnic minorities, 
contributes to the development of new strategies and may lead to improved individual 
and community health. 
Other population-based cohort studies like the Avon Longitudinal Study of Parents 
and Children (ALSPAC) have led to important contributions to knowledge about vari-
ous health problems in pregnancy and childhood [1]. In addition to these studies, the 
Generation R Study will be focused in more detail on fetal growth and development and 
their determinants in the initial phase of the study, on ethnic specifi c health problems 
in childhood and current health care practices for pregnant women and children. As a 
consequence, not the size of the Generation R Study cohort but the ethnic variability will 
be larger and the measurements will be more detailed than in current studies.
Design
Overview
The Generation R Study is a population-based prospective cohort study on growth, 
development and health from early fetal life until young adulthood. Extensive assess-
ments are carried out in pregnant women and their partners and children. Pregnant 
women are assessed at 12 (early pregnancy), 20  (mid-pregnancy) and 30 (late pregnancy) 
weeks of gestation to collect information about fetal growth and its main determinants. 
Their partners are assessed once (Tables 1-3). All measurements are performed in one 
of the two well-equipped research centers in Rotterdam. Postnatally, their children will 
participate in a prospective birth-cohort study until young adulthood. Data collection 
until the age of 4 years is carried out in the routine child health centers. Thereafter, the 
children will regularly be invited to one of the study centers. 
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Table 1. Planned assessments until the age of 4 years
Assessments in pregnant women 
– Physical examinations: height, weight, blood pressure 
– Questionnaires: socio-economic status, ethnicity, housing, living conditions, diet, medical history, family history, drug 
use, life style habits, use of medical services 
– Interviews: expectations of future parents (only in focus cohort) 
– Biological samples: blood samples, cord blood 
– Ultrasound scans: gestational age, fetal growth and placental function and in the focus cohort fetal brain, heart, aorta 
and kidney development 
Assessments in partners of pregnant women 
– Physical examinations: height, weight, blood pressure 
– Questionnaires: socio-economic status, ethnicity, housing, living conditions, medical history, family history, drug use, 
life style habits, use of medical services 
– Interviews: expectations of future parents (only in focus cohort) 
– Biological samples: blood samples
Assessments in children until the age of 4 years 
– Physical examinations: length (height), weight, head circumference and in the focus cohort blood pressure, body 
composition and neurological development 
– Questionnaires: diet, behaviour, living conditions, drug use, use of medical services 
– Interviews: child-rearing practices (only in focus cohort) 
– Ultrasounds: brain, heart, aorta and kidney development (only in focus cohort)
– Biological samples: blood samples, urine samples, saliva samples (only in focus cohort)
Table 2. Time scheme of assessments in mothers and their partners in pregnancy and their children at birth
12 weeks 20 weeks 30 weeks Birth
Mother
Physical examination + + +
Questionnaire + + + +
Interview F
Blood sample + +
Ultrasound
 Gestational age +
 Fetal growth + +
 Placenta function F
 Fetal organ development F
Partner
Physical examination +
Questionnaire +
Interview F
Blood sample +
Child
Physical examination +
Cord blood sample +
(+ = assessment in whole cohort; F = assessment only in focus cohort)
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Focus Study
Additional detailed assessments of fetal and postnatal growth and development will 
be conducted in a subgroup of 1,000 children and their parents. This subgroup study is 
called the Generation R Focus Study. The aim of this study is to examine etiological asso-
ciations with methods that cannot be used in the whole cohort. Research questions that 
will be addressed are related to early determinants of cardiovascular disease, diabetes 
and obesity, to determinants of infant maladjustment and to interactions between the 
immune system and infectious diseases. Measurements planned in the focus study are 
demonstrated in Tables 1-3.
Study cohort
The study cohort will consist of 10,000 children who meet the inclusion criteria (Table 
4). To obtain prenatal information, all eligible pregnant women in Rotterdam and their 
partners are invited to participate. The number of newborns in Rotterdam is 7,000 per 
year. Based on a small pilot study, an overall response rate of 70% is considered as fea-
sible. Assuming this response rate, two years are expected to be needed to form a cohort 
of 10,000 newborns. A vast part of this cohort will consist of ethnic minorities (Figure 1). 
Special eff orts are undertaken to include the Dutch, other European, Moroccan, Suri-
namese and Turkish groups. Although the other ethnic groups are recruited as much as 
possible, the sample size and power of these ethnic groups are too small for all studies 
on ethnic diff erences.
Table 3. Time scheme assessments in children until the age of 48 months
Age in months
1 2 3 4 6 9 11 14 18 24 36 48
Physical examination
 Anthropometrics + + + + + + + + + + + +
 Body composition F F F F F F
 Blood pressure F F F F
Motor development (Prechtl) F + F F
Questionnaire + + + + + +
Interview F
Ultrasound
 Organ development F F F F
Biological samples 
 Blood sample F F F F
 Saliva sample F F F F F
(+ = assessment in whole cohort; F = assessment only in focus cohort)
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Focus cohort
The focus cohort will consist of 1,000 Dutch children. Dutch is defi ned as two parents and four 
grandparents born in the Netherlands. An ethnic homogeneous group is chosen to exclude 
the confounding and eff ect modifying eff ect of ethnicity. As a consequence, research proj-
ects that study ethnicity as a determinant, outcome or eff ect modifi er are not conducted 
within the focus cohort but in the whole Generation R cohort. All eligible parents whose 
children are expected to be born from April 2003 to April 2004 are invited to participate. 
Based on the pilot phase, a response rate of 80% in the focus cohort seems feasible. 
Dutch
48%
Turkish
9%
Moroccan
13%
Surinamese
7%
Dutch antilles
3%
Cape Verdian
3%
Others
17%
0%
Table 4. Eligibility criteria for pregnant women and inclusion criteria (at birth)
Eligibility criteria for pregnant women
Mother is expected to be resident in Rotterdam at date of delivery
Expected delivery date lies between June 2002 and July 2004
Legal resident of the Netherlands
Inclusion criteria at birth
Mother is resident in Rotterdam at date of delivery 
Date of birth between June 2002 and July 2004
Informed consent by one of the parents
Figure 1.  Ethnic distribution of newborns in Rotterdam
Based on children born in 2003 and 2004 (www.cos.rotterdam.nl)
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Enrolment
Midwives and obstetricians give eligible pregnant women oral information about the 
study and hand out the information package. All eligible pregnant women who visit a 
midwife or obstetrician in Rotterdam are contacted by phone by the Generation R Study 
staff  for additional information. For recruitment of pregnant women of ethnic minorities, 
translated information packages and questionnaires and study staff  from these minority 
groups are available. The study staff  is able to communicate with the pregnant women 
in Dutch, Arabic, English, French, Portuguese and Turkish. All pregnant women are asked 
to make an appointment for the fi rst ultrasound. The study staff  contacts these women 
again when they attend for their ultrasound for informed consent.
Informed consent
The study has been approved by the Medical Ethical Committee of the Erasmus Medical 
Center, Rotterdam. Pregnant women and their partners receive written and oral infor-
mation about the study. Participants are asked for their written informed consent for the 
fi ve consecutive phases of the study (prenatally, birth to 4 years, 4 to 12 years, 12 to 16 
years, from 16 years onwards). 
Main outcomes
All outcomes are related to one of the four research areas. These include: 1) growth 
and physical development; 2) behavioural and cognitive function; 3) diseases in child-
hood; and 4) health and healthcare utilization. These outcomes and research areas are 
described in more detail below.
Main determinants
Groups of determinants studied include:
– Biological determinants: including parental anthropometrics, fetal and postna-
tal growth, endocrine and immunological factors and genetic variants related to 
growth.
– Social determinants: including parental education, marital status, employment sta-
tus, income level and ethnicity defi ned by country of birth of parents and grandpar-
ents.
– Environmental determinants: including maternal and childhood diet, parental 
smoking, life style and housing.
These determinants are described in more detail below.
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Assessments 
A list of all assessments planned until the age of 4 years is shown in Tables 1-3. More 
detailed information presented in the Manual of Operations of the study is available 
upon request. 
Logistics
The logistics of the study are carried out in close collaboration with the Stichting Trom-
bosedienst Artsenlaboratorium Rijnmond, Rotterdam (STAR). The STAR collaborates in 
the recruitment of pregnant women and in all measurements in these women and their 
partners at the research centers. The logistics of the Generation R Study have been stud-
ied in the pilot phase and optimized thereafter.
Data quality, control and management 
The Generation R Study staff  and the STAR staff  are regularly centrally trained and are 
required to demon strate competency in relevant procedures before doing procedures 
for the Generation R Study. These procedures include anthropometric and blood pres-
sure measurements, venous punctures, specimen pro cessing, ultrasound examinations 
and data entry. All measurements are checked by examination of the data including 
the means, standard deviations and data outliers and their diff erences between staff  
members. Data on intra- and inter-observer reproducibility of the ultrasound scans 
are obtained by studies in small subgroups. Data collected at the research centers are 
entered onto forms and into the electronic database. All principal investigators have 
access to their own data for read-only purposes. After data collection is complete, the 
data are cleaned and distributed to the principal investigators for analyses. 
Biological samples 
All biological samples collected in the Generation R Study are stored at the STAR. The 
amount of venous blood taken is 35 and 20 ml at 12 and 20 weeks, respectively, from the 
mother, 10 ml from her partner and 20 ml from the newborn (cord blood). These plasma 
and serum samples are distrib uted in small aliquots (each 250 μl), and stored at –80oC. 
DNA is extracted from whole blood samples. A urine sample is collected and stored for 
future measurements. 
Time schedule 
The Generation R Study entered its pilot phase in December 2001. Full participant 
recruitment and com plete data collection started in 2002. A cohort of 10,000 newborns 
is expected to be completed in 2004. The whole study is expected to run until all chil-
dren have reached the age of 20 years.
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Research projects
According to the main outcome measures, all research projects in the Generation R 
Study are embedded in one of the four research areas: 1) growth and physical develop-
ment; 2) behavioural and cognitive function; 3) diseases in childhood; and 4) health and 
healthcare utilization. A description of the specifi c aims, measurements and projects in 
these research areas is given here in detail.
Growth and physical development
Main research aims 
1) To identify biological, social and environmental determinants of normal and abnor-
mal growth and physical development patterns;
2) To identify fetal and infant determinants of risk factors for cardiovascular disease, 
diabetes and obesity.
Specifi c measurements planned until the age of 4 years
– Parental physical examination (whole cohort): height, weight, blood pressure;
– Fetal growth (whole cohort): gestational age (crown-rump length, biparietal diam-
eter at 10-12 weeks of gestation), fetal growth (biparietal diameter, head circumfer-
ence, abdominal circumference, femur length at 20 and 30 weeks of gestation);
– Fetal blood fl ow distribution and haemodynamic placenta function (focus cohort): 
pulsatility index in the abdominal aorta, medial cerebral artery, uterine artery and 
umbilical artery (30 weeks of gestation);
– Postnatal growth (whole cohort): length (height), weight, head circumference (at 1, 
2, 3, 4, 6, 9, 11, 14, 18, 24, 36 and 48 months);
– Motor development: Prechtl scales (whole cohort at 3 months, focus cohort at 1, 6, 
14 months);
– Body composition (focus cohort): Skinfold thickness (at 1, 6, 14, 24, 36 and 48 
months), dual energy X absorptiometry-scan (at 6, 24 and 48 months); 
– Nutrition (whole cohort): Maternal diet (at 12 weeks of gestation) and childhood diet 
(2, 6, 14 and 24 months and yearly thereafter) by food frequency questionnaires; 
– Risk factors for cardiovascular disease (focus cohort): Blood pressure (at 1, 6, 24, and 
48 months), blood lipids (at birth, 6, 24 and 48 months), left ventricular function 
and renal size (at 30 weeks prenatally and 1, 6, 24 and 48 months postnatally), left 
ventricular mass (at 1, 6, 24 and 48 months);
– Risk factors for type 2 diabetes (focus cohort): insulin-glucose ratios (at 6 and 24 
months), oral glucose tolerance tests (at 48 months);
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– Genetic variations (focus cohort): polymorphisms related to insulin, insulin-like 
growth factors, growth hormone and cortisol activity.
Specifi c projects 
Fetal and postnatal growth patterns
There is incomplete knowledge about determinants of fetal and postnatal growth. As 
small variations in fetal and early postnatal growth may have life long consequences, 
it is important to obtain insight in the determinants of normal and abnormal fetal and 
postnatal growth patterns [6]. The following research questions will be addressed: 1) 
What are normal and abnormal fetal and postnatal growth patterns in diff erent ethnici-
ties? 2) What are the biological, social and environmental determinants of these growth 
patterns? 
Ethnic diff erences in birth outcomes 
Perinatal death, low birth weight and preterm birth seem to be more prevalent in lower 
socio-economic status and ethnic minority groups [10, 11]. Insight in the underlying 
factors that lead to adverse birth outcomes and pregnancy complications like pre-
eclampsia in these groups is important for the development of group specifi c preventive 
strategies. Research questions that will be addressed include: 1) What is the prevalence 
of low birth weight and preterm birth in diff erent ethnic and socio-economic groups? 
2) What is the prevalence of specifi c determinants of these adverse birth outcomes in 
these diff erent groups? 3) Do these specifi c determinants underlie the diff erences in 
birth outcomes? 
Early determinants of obesity 
Childhood obesity is a major health problem and seems to be predictive for obesity, 
cardiovascular disease and diabetes in adulthood [12]. This research project aims at get-
ting insight in the prevalence, determinants and consequences of childhood obesity. 
The following research questions will be addressed: 1) What is the incidence of obe-
sity in childhood? 2) What are the biological, social and behavioural determinants and 
consequences of childhood obesity? Biological determinants of special interest will be 
on endocrine factors and genetic variants related to insulin, insulin-like growth factors, 
leptin and cortisol activity. 
Fetal and infant origins of cardiovascular disease and type 2 diabetes
Small size at birth is associated with cardiovascular disease and type 2 diabetes in adult 
life [13, 14]. Fetal life and infancy may be critical periods for development of these 
diseases. This research project aims at studying these associations and the underlying 
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mechanisms. The following research questions will be addressed: 1) Which fetal and 
infant growth patterns are associated with the development of risk factors for cardiovas-
cular disease and type 2 diabetes? 2) Which environmental factors and genetic variants 
underlie these associations? This project will also study the development of risk factors 
for cardiovascular disease and type 2 diabetes from birth until young adulthood. 
Behavioural and cognitive development 
Main research aims 
1) To identify biological, social and environmental determinants of normal and abnor-
mal behavioural and cognitive development;
2) To study the long-term consequences of abnormal behavioural and cognitive devel-
opment in infancy and early childhood.
Specifi c measurements planned until the age of 4 years
– Infant behaviour (whole cohort): mother and baby scales, feeding, crying and sleep-
ing by question naires (Infant Behavior Questionnaire); problem behaviour by the 
Child Behavior Checklist (at 2, 6, 14, 24, 36 and 48 months); 
– Child cognitive function: questionnaires (whole cohort, at 6, 14, 24, 36 and 48 
months) and cognitive function tests (focus cohort, at 24 and 48 months); 
– Parental psychopathology: Brief Symptom Inventory (whole cohort, at 20 weeks of 
gestation and 2 months), Edinburgh Postnatal Depression Scale (whole cohort, 2 
months), Composite International Diagnostic Interview, Family Informant Schedule 
Criteria and 3 Minutes Speech Sample (focus cohort, at 30 weeks of gestation and 6 
months);
– Child rearing: questionnaires about grand-parental rearing practices, parental 
childhood experiences, parental attitudes regarding child rearing practices (whole 
cohort, at 20 weeks of gestation) and about child rearing (whole cohort, at 2, 6, 14, 
24, 36 and 48 months). Mother-child observation instruments (focus cohort, at 6 
and 24 months);
– Child stress reactivity (focus cohort): saliva cortisol (at 6, 14, 24, 36 and 48 months); 
– Maternal thyroid function (focus cohort): total thyroxine, free thyroxine, thyroid 
stimulating hormone (12 and 20 weeks of gestation). Total iodine in urine samples 
collected in early pregnancy;
– Fetal and infant brain development (focus cohort): ultrasound measured ventricular 
diameter, transcerebellar diameter (at 30 weeks of gestation), corpus callosum, ven-
tricular diameter and brain volume (at 1 month).
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Specifi c projects 
Infant maladjustment and problem behaviour 
Knowledge about the determinants and consequences of abnormal social and emotion-
al behavioural functioning in infancy and childhood is notably lacking. Parental psycho-
pathology may lead to problem behaviour in the off spring [15]. However, it is not known 
how this is related to parent-child interaction, adverse events and biological factors that 
infl uence infant and child behaviour. Research questions that will be addressed include: 
1) What are the prenatal and early postnatal determinants of infant maladjustment and 
childhood problem-behaviour? 2) What are the long-term consequences of problem 
behaviour in infancy and childhood on social, emotional and intellectual development? 
Determinants that will be studied include parental psychopathology, child-rearing prac-
tices and the child’s stress-reactivity, temperament and brain development.
Cognitive functioning 
Acquisition of knowledge and skills is essential for the growing and developing child. 
Early factors seem to be important determinants of cognitive functioning [7]. Impaired 
cognitive function in childhood may have life long consequences. The following research 
questions will be addressed: 1) What are the early determinants of impaired cognitive 
function in childhood? 2) What are the long-term consequences of impaired cognitive 
function in childhood? Early determinants that will be studied include socio-economic 
status, ethnicity, child-rearing practices, brain development, cortisol levels and maternal 
thyroid function.
Diseases in childhood
Main research aims
1) To study the incidence rates of common diseases and accidents in childhood;
2) To identify the biological, social and environmental determinants and long-term 
consequences of these diseases and accidents.
Common diseases in childhood of interest include infectious diseases, asthma and neu-
rological paroxysmal events.
Specifi c measurements planned until the age of 4 years
– Diseases (whole cohort): questionnaires and the general practitioners register for 
information on infectious diseases, asthma, paroxysmal events and other diseases 
(at 2, 6, 14, 24, 36 and 48 months);
– Infectious serology (focus cohort): serology of several respiratory infectious diseases 
determined (at 6, 14, 24 and 48 months);
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– Vaccination status (focus cohort): responses to Haemophilus infl uenzae B and 
meningococcal C vaccination (at 6 and 14 months) and measles vaccination (at 14 
months); 
– Immune system (focus cohort): immunophenotyping of T and B lymphocytes, 
NK cells and their subpopulations, maturation and activation of lymphocyte sub-
populations, immunoglobuline G and subclasses, A, M and E (at birth, 6, 14 and 24 
months);
– Lung function (focus cohort): static and dynamic lung function (at 48 months).
Specifi c projects
Infectious diseases and immunology
Infectious diseases are the most frequent acute diseases in childhood. The clinical 
response on infectious diseases varies between subjects. Genetic and environmental 
variations seem to be important determinants of clinical responses on infectious dis-
eases [16, 17]. This project will address the following research questions: 1) What is the 
incidence of clinical and sub-clinical infectious diseases in childhood? 2) What are the 
genetic and environmental determinants of diff erences in clinical responses on infec-
tious diseases. Special focus in this study is on the interactions between components of 
the immune system and respiratory infectious diseases.
Asthma
Asthma or asthma related symptoms are frequently seen health problems in infancy and 
childhood with consequences for later life [18]. This research project is designed to study 
the frequency, determinants and consequences of childhood asthma or asthma related 
symptoms. Special interest is on diff erences between ethnic groups. Research questions 
include: 1) What is the incidence of asthma and asthma related symptoms from birth 
until young adulthood? 2) What are the environmental and genetic determinants of 
these diseases? Development of the immune system, studied in the research project 
on infectious diseases and immunology, is also being studied in relation to asthma and 
asthma-related symptoms. 
Paroxysmal neurological disorders
The incidence of convulsive or paroxysmal disorders in Dutch children is unknown. 
Determinants and consequences of paroxysmal disorders and febrile seizures in the 
Dutch population have not been studied in a population-based study. Research ques-
tions in this project include: 1) What is the incidence of seizures, febrile convulsions and 
other paroxysmal events? 2) What are the environmental and genetic determinants and 
long-term consequences of these events? More detailed information is collected in the 
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aff ected children by questionnaires and by electro-encephalograms. The aff ected chil-
dren, their siblings and parents will participate in a study to examine genetic determi-
nants of paroxysmal disorders. 
Health and healthcare 
Main research aims
1) To identify determinants of quality of life from childhood until young adulthood;
2) To identify determinants of health care utilization in pregnancy, infancy and child-
hood;
3) To examine the eff ectiveness of current and recently developed screening pro-
grams.
Specifi c measurements planned until the age of 4 years
– Quality of life (whole cohort): questionnaires in childhood;
– Health care utilization (whole cohort): registries of midwifery practices, obstetric 
departments in hospitals, child health centers and paediatric departments; 
– Eff ectiveness of screening programmes (whole cohort): congenital malforma-
tions, development, congenital heart disease, cryptorchidism and development of 
speech.
Specifi c projects
Quality of life 
Among adults, health-related quality of life is seen as an important outcome measure 
for health care interventions. Also, health status measures are important determinants 
of health care utilization. Much less is known about health-related quality of life in chil-
dren. This project will address the following research questions: 1) What are the biologi-
cal, social and psychological determinants of health-related quality of life in children? 2) 
What are the consequences of impaired health-related quality of life among children in 
terms of health care utilization and social participation?
Health care utilization
Utilization of the health care system diff ers between diff erent ethnic and socio-economic 
status groups [19]. Research questions in this project include: 1) What is the health care 
utilization in pregnancy and in childhood? 2) What are the social, cultural and emotional 
determinants of the diff erences in healthcare utilization?
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Eff ectiveness of current and new screening programs
Screening and vaccination programmes are performed at the child health centers, 
which are part of the preventive youth health care system [11]. This project addresses 
the following research question: What is the cost-eff ectiveness of current and recently 
developed screening programmes? These programmes are focused on neonatal hearing, 
asthma-related symptoms and development of speech in ethnic minorities. The Genera-
tion R Study is an observational and not an experimental study. Therefore, this sub-study 
will be observational, resulting in comparisons with an earlier cohort (before the start of 
the Generation R Study) and in descriptives about utilization diff erences between ethnic 
or socio-economic groups.
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Abstract
The Generation R Study is a population-based prospective cohort study from fetal life 
until young adulthood. The study is designed to identify early environmental and genet-
ic causes of normal and abnormal growth, development and health from fetal life until 
young adulthood. The study focuses on four primary areas of research: 1) growth and 
physical development; 2) behavioural and cognitive development; 3) diseases in child-
hood; and 4) health and healthcare for pregnant women and children. In total, 9,778 
mothers with a delivery date from April 2002 until January 2006 were enrolled in the 
study. Of all eligible children at birth, 61% participate in the study. Data collection in the 
prenatal phase included physical examinations, questionnaires, fetal ultrasound exami-
nations and biological samples. In addition, more detailed assessments are conducted in 
a subgroup of 1,232 pregnant women and their children. The children form a prenatally 
recruited birth-cohort that will be followed until young adulthood. Eventually, results 
forthcoming from the Generation R Study have to contribute to the development of 
strategies for optimizing health and healthcare for pregnant women and children.
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Introduction
The Generation R Study is a population-based prospective cohort study from fetal life 
until young adulthood. The background and specifi c research projects of the study have 
been described in detail previously [1]. This paper focuses on the study design and 
cohort profi le in the fi rst phase of the study. 
Scope of research
The Generation R Study is designed to identify early environmental and genetic causes 
of normal and abnormal growth, development and health from fetal life until young 
adulthood. The study focuses on four primary areas of research: 1) growth and physical 
development; 2) behavioural and cognitive development; 3) diseases in childhood; and 
4) health and healthcare for pregnant women and children. The main outcomes and 
determinants are presented in Tables 1 and 2. The general aims of the study are:
1) To describe normal and abnormal growth, development and health from fetal life 
until young adulthood;
2) To identify biological, environmental and social determinants of normal and abnor-
mal growth, development and health from fetal life until young adulthood;
3) To examine the eff ectiveness of current strategies for prevention and early identifi -
cation of groups at risk.
Eventually, results from the Generation R Study will contribute to the development of 
strategies for optimizing health and healthcare for pregnant women and children.
Study area
The Generation R Study is conducted in Rotterdam, the second largest city in the Neth-
erlands. Rotterdam is situated in the Western part of the Netherlands on almost 80 kilo-
meters south from Amsterdam, the capital of the Netherlands. The total population con-
sists of about 600,000 inhabitants of almost 150 diff erent ethnicities. The study area is 
well defi ned by postal codes and covers more than half of the cities inhabitants (almost 
350,000 inhabitants). The largest ethnic groups in this population are the Dutch (56%), 
Surinamese (9%), Turkish (7%), Moroccan (6%), Dutch Antillean (3%) and Cape Verdian 
(3%) groups [2]. The percentages of the non-Dutch groups are higher in younger age 
groups [2]. The number of children born in this study area is about 4,300 per year [2]. The 
ethnic distribution of the newborns is shown in Figure 1. Measurements are conducted 
in two well-equipped research centers in the study area. Intensive collaboration was 
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established with all eight midwifery practices, three hospitals and sixteen child health 
centers located in this area. 
Table 1. Main outcomes per research area
Growth and physical development
– Fetal growth patterns and organ development
– Pregnancy complications 
– Postnatal growth patterns
– Obesity
– Risk factors for development of cardiovascular disease
– Risk factors for type 2 diabetes
Behaviour and cognitive development
– Maternal and paternal psychopathology
– Fetal and postnatal brain development
– Behaviour, psychopathology and cognition
– Neuromotor development
– Chronic pain
– Attachment
– Stress reactivity
Diseases in childhood
– Infectious diseases in childhood
– Development of the immune system
– Asthma and asthma related symptoms
– Paroxysmal neurological disorders
Health and healthcare
– Quality of life
– Health care utilization
– Eff ectiveness of screening programmes
Table 2. Main determinants 
Biological determinants
– Parental anthro pometrics and blood pressure
– Fetal and postnatal growth characteristics
– Endocrine and immunological factors
– Genetic variants
Environmental determinants
– Maternal and childhood diet
– Parental life style habits (including smoking, alcohol consumption)
– Housing conditions
Social determinants
– Parental education, employment status and household income
– Parental marital status 
– Ethnicity 
The Generation R Study: cohort profi le 57
Study design
Overview
The Generation R Study is a population-based prospective cohort study from fetal life 
until young adulthood. Mothers with a delivery date between April 2002 and January 
2006 were eligible. Extensive assessments were carried out in mothers and their part-
ners in pregnancy and are currently performed in their children (Table 3). Assessments 
in pregnancy were planned in early pregnancy (gestational age < 18 weeks), mid-preg-
nancy (gestational age 18 - 25 weeks) and late pregnancy (gestational age ≥ 25 weeks). 
The individual time scheme of these assessments depended on the specifi c gestational 
age at enrolment (Tables 4 and 5). The partners were assessed once in pregnancy. The 
children form a prenatally recruited birth-cohort that will be followed until young adult-
hood. Additionally, more detailed assessments of fetal and postnatal growth and devel-
opment are conducted in a randomly selected subgroup of Dutch children and their 
parents, referred to as the Generation R Focus Cohort. This subgroup is ethnic homo-
geneous to exclude possible confounding or eff ect modifi cation by ethnicity. Stud-
ies conducted in this subgroup examine etiological associations with more in-depth 
Dutch
48%
Turkish
9%
Moroccan
13%
Surinamese
7%
Dutch antilles
3%
Cape Verdian
3%
Others
17%
0%
Figure 1.  Ethnic distribution of newborns in Rotterdam
Based on children born in 2003 and 2004 (www.cos.rotterdam.nl)
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Table 3. Assessments in the prenatal phase
Assessments in mothers 
– Physical examinations: height, weight, blood pressure
–  Questionnaires: socio-economic status, ethnicity, housing, living conditions, diet, medical history, family history, drug 
use, life style habits, use of medical services
– Interviews: expectations of parents to be (only in focus cohort)
– Biological samples: blood and urine samples (storage, DNA)
–  Fetal ultrasounds: gestational age, fetal growth and in the focus cohort fetal brain, heart and kidney development, fetal 
blood fl ow distribution and placental function
Assessments in partners 
– Physical examinations: height, weight, blood pressure
–  Questionnaires: socio-economic status, ethnicity, housing, living conditions, medical history, family history, drug use, 
life style habits, use of medical services
– Interviews: expectations of parents to be (only in focus cohort)
– Biological samples: blood samples (storage, DNA)
Assessments in newborns at birth 
– Physical examinations: weight
– Cord blood sample (storage, DNA)
Table 4. Assessments in mothers, their partners and their children in the prenatal phase
Early 
pregnancy
Mid- 
pregnancy
Late 
pregnancy
Birth
Mother
Physical examination + + +
Questionnaire ++ + +
Interview F
Fetal ultrasound examination + + +
Additional detailed fetal ultrasound F
Blood sample + +
Urine sample + + +
Partner
Physical examination +
Questionnaire +
Interview F
Blood sample +
Child
Physical examination +
Cord blood sample +
(+ = assessment in whole cohort; F = assessment only in focus cohort)
Early pregnancy: gestational age < 18 weeks; mid-pregnancy: gestational age 18 - 25 weeks; late pregnancy: 
gestational age ≥ 25 weeks. 
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methods that cannot be applied in the whole cohort due to time, fi nancial or logistical 
constraints. The Generation R Study is approved by the Medical Ethical Committee of 
the Erasmus Medical Center, Rotterdam. Mothers and their partners received written 
and oral information about the study. Participants are asked for their written informed 
consent for the fi ve consecutive phases of the study (prenatally, birth to 4 years, 4 to 12 
years, 12 to 16 years and from 16 years onwards).
Eligibility and enrolment
Eligible mothers were those who were resident in the study area at their delivery date 
and had a delivery date from April 2002 until January 2006. We aimed to enroll mothers 
in early pregnancy (gestational age < 18 weeks) but enrolment was possible until birth 
of their child. Midwives and obstetricians informed eligible mothers about the study at 
their fi rst prenatal visit in routine care, handed out the information package and asked 
these mothers to make an appointment for the first ultrasound examination. The study 
staff  contacted these mothers by phone for additional information about the study and 
in person at the ultrasound examination to obtain informed consent. Based on the pilot 
phase, it was estimated that it was possible to contact about 80% of all eligible mothers 
in pregnancy and 70% of these mothers would be willing to participate in the study. 
Mothers who were not approached in pregnancy, were approached and enrolled in 
the fi rst months after birth of their child when newborns visit the routine child health 
Table 5. Planned time scheme of prenatal measurements in mothers (weeks)
Gestational age at 
enrolment
Postal questionnaires (see text) Visits for measurements
Mother 1 Mother 2 Mother 3 Mother 4
Early 
pregnancy
Mid- 
pregnancy
Late 
pregnancy
<12 weeks 12 15 20 30 12 20 30
13 weeks 13 15 20 30 13 20 30
14 weeks 14 16 20 30 14 20 30
15 weeks 15 17 20 30 15 20 30
16 weeks 16 18 22 30 16 22 30
17 weeks 17 19 22 30 17 22 30
18 weeks 18 20 24 30 - 18 30
19 weeks 19 21 24 30 - 19 30
20 weeks 20 22 24 30 - 20 30
21 weeks 21 23 25 30 - 21 30
22 weeks 22 24 26 30 - 22 30
23 weeks 23 25 27 30 - 23 30
24 weeks 24 - - 30 - 24 30
≥ 25 weeks ≥ 25 - - ≥ 30 - - ≥ 25
Postnatal Postnatal - - - - - -
Early pregnancy: gestational age < 18 weeks; mid-pregnancy: gestational age 18 - 25 weeks; late pregnancy: 
gestational age ≥ 25 weeks.
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centers [3]. The partners were not approached directly by the study staff  but the moth-
ers were informed about the importance of involvement of their partners in the study. 
There was no specifi c defi nition of being a partner but information was obtained about 
the biological relation of the partner with the (unborn) child. 
Eligibility criteria for enrolment in the Generation R Focus Study were enrolment 
before a gestational age of 25 weeks in the Generation R Study, Dutch ethnicity, defi ned 
as two parents and four grandparents born in the Netherlands and a delivery date 
between February 2003 and August 2005. The study staff  contacted these eligible moth-
ers in pregnancy by phone to inform them about this sub-study and to invite them for 
the fi rst additional measurements at a gestational age of 30 weeks. 
Pilot phase 
The Generation R Study entered its pilot phase in December 2001 with the recruitment 
of pregnant women from the whole city of Rotterdam. The main aim of this pilot phase 
was to test the logistics of the enrolment process. Based on the logistic results from this 
pilot phase, the defi nite study area was limited to postal codes covering the largest part 
but not the whole city. 
In the pilot phase, enrolment of mothers was restricted to a maximal gestational 
age of 24 weeks at enrolment. Since it turned out to be not feasible to approach all 
mothers in early or mid-pregnancy, the enrolment period for mothers was subsequently 
extended to the whole pregnancy until birth of their child. Full participant recruitment 
in the defi nite study area was established for mothers with a delivery date from January 
2003. Mothers enrolled in the pilot phase and living outside the defi nite study area at 
their delivery date were completely followed until birth of their child. The children of 
these mothers do not participate in postnatal follow-up studies. Until the end of preg-
nancy, data collection and quality in these mothers are similar to data collected in the 
other participants. Therefore, these mothers are part of the total cohort for research proj-
ects studying outcomes in pregnancy. All enrolled mothers living in the defi nite study 
area at delivery with a delivery date from April 2002 and January 2006 are included as 
participants in the cohort for both prenatal and postnatal follow-up studies. Separate 
pilot studies to assess the intra- and inter-observer reproducibility were conducted in 
subjects outside the cohort and were, if necessary, repeated in study participants. 
Study cohort
Pregnant women and their partners
In total, 9,778 mothers were enrolled in the study (Figure 2). Of these mothers, 91% 
(n = 8,880) was enrolled in pregnancy. Only partners from mothers enrolled in preg-
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nancy were invited to participate. In total, 71% (n = 6,347) of all partners were enrolled. 
The general characteristics of the mothers and their partners are presented in Table 6. Of 
all participating mothers, enrolment was in early pregnancy in 69% (n = 6,748), in mid-
pregnancy in 19% (n = 1,857), in late pregnancy in 3% (n = 275) and at birth of their child 
in 9% (n = 898). Of all mothers enrolled in pregnancy, 94% (n = 8,356), 6% (n = 516) and 
Enrolment
Mothers: 9,778  
(8,880 in pregnancy, 898 at birth of their child)
Partners: 6,347
Data collection in partners (n = 6,347)
Prenatal visits:    100% (n = 6,347) 
Blood samples:  84% (n = 5,326) 
Questionnaires:   82% (n = 5,177)    
Data collection in mothers (n = 8,880) 
Visits
- Early pregnancy: 76% (n = 6,748) 
- Mid-pregnancy: 93% (n = 8,241) 
- Late pregnancy: 93% (n = 8,270) 
Blood samples  
- Early pregnancy: 72% (n = 6,398) 
- Mid-pregnancy: 86% (n = 7,616) 
Questionnaires  
- Mother 1:  91% (n = 8,116) 
- Mother 2:  81% (n = 7,229) 
- Mother 3:   80% (n = 7,145) 
- Mother 4:   77% (n = 6,830) 
Expected number of mothers and children eligible
for postnatal follow-up studies 
8,411 (see text)
Live births     98% 
Induced abortion      0.3% 
Fetal, perinatal losses     1.1% 
Loss to follow-up (prenatally)      0.7%
1,195 mothers living outside definite 
study area and excluded from 
postnatal follow-up
Figure 2.  Enrolment and measurements in the fi rst phase
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0.1% (n = 8) were fi rst, second and third pregnancies in the study, respectively. A total of 
1,232 mothers were enrolled in the Generation R Focus Study. The mean age of mothers 
in our study at enrolment was similar to the age of all pregnant women in the study 
area (29.6 years in 2003) [2]. Ethnicity of participating mothers and partners was defi ned 
according the classifi cation of Statistics Netherlands [4]. This means for one specifi c per-
son that: 1) if both parents are born in the Netherlands, the ethnicity is Dutch; 2) if one 
of the parents is born in another country than the Netherlands, that country counts; 3) 
Table 6. General characteristics of the mothers and their partners 
Mothers Partners
(n = 9,778) (n = 6,347)
Gestational age at enrolment (%)
 Early pregnancy 69 -
 Mid-pregnancy 19 -
 Late pregnancy 3 -
 Birth 9 -
Pregnancy number in study (%)
 1st pregnancy 94 -
 2nd pregnancy 6 -
 3rd pregnancy 0.1 -
Age (years) 29.7 (5.3) 32.7 (5.8)
Parity (%)
 0 55 -
 1 31 -
 ≥ 2 14 -
Ethnicity (%)
 Dutch, other-European 58 70
 Surinamese 9 6
 Moroccan 7 4
 Turkish 9 6
 Dutch Antilles 4 3
 Cape Verdian 4 2
 Others 9 9
Educational level (%)
 Primary school 13 8
 Secondary school 45 41
 Higher education 42 51
Household income per month (%)
 <€ 800 9 -
 € 800-2200 36 -
 >€ 2200 55 -
 Values are percentages. *Mean (standard deviation)
 All subject characteristics, except gestational age at enrolment, are based on valid data in mothers who were 
enrolled in pregnancy.
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if both parents are born in the same country other than the Netherlands, that country 
counts; 4) if the parents are born in the diff erent countries other than the Netherlands, 
the country of mothers counts; and 5) if that person and both parents are born in dif-
ferent countries other than the Netherlands, the country of birth of that specifi c person 
counts. As expected, the largest ethnic groups were the Dutch, Surinamese, Turkish and 
Moroccan groups. The ethnic distribution diff ered only moderately from that of the 
population in the study area [2]. Mean household income in Rotterdam is about € 1,600 
per month and the percentage subjects with a secondary or higher education level in 
Rotterdam is 56% [2]. The educational level of participating mothers and their partners 
was classifi ed in groups according to the classifi cation of Statistics Netherlands [5]. Both 
household income and highest followed educational level in mothers and their partners 
in the study cohort suggest a selection towards a higher socio-economic status. How-
ever, diff erences between the population and cohort characteristics may also be due to 
selective missing values of ethnicity and socio-economic status in the questionnaires. 
Additional eff orts are currently made to complete the information on ethnicity, house-
hold income and educational level in the total cohort. 
Children at birth 
Characteristics of the live born children at birth presented in Table 7. Among these live 
births, 51% were male and 49% female. These percentages are similar to the population 
fi gures in the Netherlands and in Rotterdam [6]. Ethnicity of the children was defi ned 
using the strategy as described for the mothers and partners. The diff erences in ethnic 
distributions between all newborns in the study area and the newborns participating in 
the study are similar to the diff erences found in the mothers. 
Table 7. Characteristics of newborns
Male (%) 51
Birth weight (grams)* 3412 (561)
Gestational age (weeks)** 40 (35.4-42.1)
Ethnicity (%)
 Dutch, other-European 62
 Surinamese 8
 Moroccan 7
 Turkish 8
 Dutch Antilles 4
 Cape Verdian 3
 Other 8
Values are percentages.
*Mean (standard deviation)
** Median (95% range)
Data are based on living born children.
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Overall response
Estimation of the precise number of eligible pregnant women in the study area is diffi  cult 
since there is no satisfactory registry of pregnancies. Therefore, it was not attempted to 
identify overall response rates of pregnant women. The children form a prenatally recruit-
ed birth-cohort, thus the overall response of the study can be calculated at birth. Full par-
ticipant recruitment in the defi nite study area was established for mothers with a delivery 
date from January 2003 until January 2006. The overall response in this period represents 
the number of children born to mothers living in the study area at their delivery date and 
participating in the study as percentage of the total number of children born to mothers 
who fulfi ll these eligibility criteria (Table 8). Since data collection and data cleaning is still 
ongoing, the response rate calculation was based on children born from January 2003 
until December 2004. The number of live born children in the study area in this period 
is 8,494 [2]. A total of 5,189 living born children born in this period and their mothers 
participated in the study which gives a response rate of 61% study at birth. Children born 
in 2002 do not contribute to this response rate since the recruitment process did not cover 
the whole defi nite study area. Data of children born in 2005 are not expected to materially 
change this response rate since the enrolment rate was similar as previous years. 
Table 8. Inclusion criteria at birth
Mother resident in study area at her delivery date
Date of birth of the child between April 2002 and January 2006
Informed consent by one of the parents
Postnatal follow-up
Of all 9,778 mothers, 1,195 mothers were participants in the pilot phase since they lived 
outside the defi nite study area at their delivery date. Their children are not approached 
for postnatal follow-up studies. Of the remaining 8,583 mothers, it is expected that 98% 
(n = 8,411) have pregnancies resulting in living born children that could be approached 
for postnatal follow-up studies (Figure 2). These mothers and their children are eligible 
for postnatal follow-up studies. Based on fi gures from 2003 and 2004, it is estimated 
that about 92% of these eligible mothers are willing to continue to participate in the 
postnatal phase with their children. 
Data collection in the prenatal phase
Physical examinations
Physical examinations were planned at each visit in early pregnancy, mid-pregnancy 
and late pregnancy and included height, weight and blood pressure of both parents. 
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Overall response rates for these specifi c measurements in mothers and their partners 
are similar as the visit percentages presented in Figure 2. Since there was a wide range 
of gestational age at each visit, the physical examinations will be used in the analyses 
as gestational age adjusted measurements in early pregnancy, mid-pregnancy and late 
pregnancy.
Questionnaires
Mothers received four postal questionnaires and their partner received one postal ques-
tionnaire in the prenatal phase (Table 4). Each questionnaire comprises about 25 pages. 
Topics in these questionnaires were:
– Mother 1: medical history, family history, previous and current pregnancies, quality 
of life, life style habits, housing conditions, ethnicity, educational level;
– Mother 2: diet, including macronutrients and micronutrients;
– Mother 3: current pregnancy, quality of life, life style habits, psychopathology;
– Mother 4: current pregnancy, quality of life, life style habits, working conditions, 
household income, self-esteem;
– Partner: medical history, family history, life style habits, educational level, psychopa-
thology.
Overall response rates for these questionnaires varied from 77% to 91% (Figure 2). How-
ever, the response rates of specifi c questions may be lower due to missing values within 
questionnaires. Because of a variety of logistic reasons, some mothers did not receive 
one or more questionnaires. Additional eff orts are currently made to complete the infor-
mation on the time independent population descriptives (medical history, ethnicity, 
educational level, working conditions and household income).
Fetal ultrasound examinations
Fetal ultrasound examinations were performed at each prenatal visit. Overall response 
rates for these ultrasound examinations were in general similar to the visit percentages 
given in Figure 2. These ultrasound examinations were used for both establishing ges-
tational age and assessing fetal growth patterns. Establishing gestational age by using 
the fi rst day of the last menstrual period is not reliable for a variety of reasons including 
the large number of women who do not know their exact date, have irregular menstrual 
cycles or amenorrhea, use oral contraceptive pills or bleed in early pregnancy [7]. Estab-
lishing gestational age with fetal ultrasound examinations seems to overcome most 
of these problems. The major disadvantage of using measurements of the ultrasound 
examinations for establishing gestational age is that it does not allow growth studies 
of these measurements since no growth variability between subjects is assumed [8]. 
Pregnancy dating-curves were derived in a sub-sample of the cohort including subjects 
with complete data on both the fi rst day of the last menstrual period and crown-rump 
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length or biparietal diameter. Subsequently, gestational age at prenatal enrolment and, 
as a consequence, at delivery was retrospectively established by crown-rump length 
or biparietal diameter measured in early pregnancy or mid-pregnancy. Subsequently, 
longitudinal curves of all fetal growth measurements (head circumference, biparietal 
diameter, abdominal circumference and femur length) were created resulting in stan-
dard deviation scores for all of these specifi c growth measurements. Methods to exam-
ine fetal growth patterns will be developed especially focused on fetal growth retarda-
tion in diff erent periods of pregnancy and on identifying diff erences between groups. 
These dating and growth curves and methods to examine fetal growth patterns will be 
published separately. 
Blood and urine samples
The planned amounts of venous blood taken were 35 and 20 ml in early pregnancy and 
mid-pregnancy, respectively, from the mother and 10 ml from her partner in the pre-
natal phase. Plasma and serum samples were distrib uted in small aliquots (each 250 µl) 
and are currently stored at –80oC. These blood samples are used for DNA extraction and 
stored for future studies relating genetic variants to various phenotypes and for future 
measurements of a variety of biomarkers for exposures and phenotypes themselves. 
DNA is extracted from whole blood samples. Among the participating mothers and part-
ners, response rates for blood samples were 97% (from all visits) and 84%, respectively 
(Figure 2). Missing values of blood samples are mainly caused by the lack of consent. 
DNA extraction in children is carried out from cord blood samples and will postnatally 
be completed by saliva samples. Urine samples of mothers have been collected from 
February 2004 until November 2005 and are stored for future measurements.
Pregnancy complications and outcomes
The obstetric records of all mothers are looked up in the hospitals and midwifery prac-
tices. Specialists in the relevant fi eld code items in these records. The major pregnancy 
outcomes, including live births, induced abortion and fetal or perinatal loss, are known 
in 99% of all enrolled mothers. In all children known to be born alive, information about 
gender, birth weight and gestational age is available.
Data collection in the postnatal phase
Postnatal assessments from birth until the age of 4 years are currently conducted and 
include:
– Physical examinations: length (height), weight, head circumference, neurological 
development and in the focus cohort blood pressure and body composition; 
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– Questionnaires: diet, behaviour, cognition, living conditions, drug use, diseases, use 
of medical services;
– Routine health care: screening assessments performed in the routine child health 
centers; 
– Ultrasound examinations: in the focus cohort brain, heart and kidney develop-
ment;
– Biological samples: in the focus cohort blood and saliva samples.
The details and time scheme of these measurements have been described in detail 
previously [1]. Current plans for measurements from the age of 4 years are focused on 
regular hands-on assessments in 2 to 3 hours sessions in the whole cohort and on postal 
questionnaires for the children and their parents.
Data management and statistical power
Data preparation
Data collected by measurements at the research centers are directly entered onto writ-
ten forms and into the electronic database. Data collected by questionnaires are scanned 
and manually entered into an electronic database by a commercial bureau. Random 
samples of all questionnaires are double checked by study staff  members to monitor 
the quality of this manual data entry process. The percentage of mistakes is kept as low 
as possible and does not exceed 3% per questionnaire. Open text fi elds are entered into 
the electronic database exactly as they are fi lled in on the questionnaires. In a secondary 
stage, these open text fi elds are cleaned and coded by a specialist in the relevant fi eld. All 
measurements are centrally checked by examination of the data including their ranges, 
distributions, means, standard deviations, outliers and logical errors. Data outliers and 
missing values are checked on the original forms. The data of one specifi c measurement 
are only distributed for analyses after data collection and preparation is completed for 
that measurement for the whole cohort.
Privacy protection
Datasets needed for answering specifi c research questions are centrally built from diff er-
ent databases. All information in these datasets that enables identifi cation of a particular 
participant (including identifi cation number used for the logistics of the study, names 
and dates) is excluded before distribution to the researchers. The datasets for researchers 
include subject unique identifi cation numbers that enable feedback about one subject 
to the data manager but do not enable identifi cation of that particular subject. 
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Statistical power
Due to expected missing values and loss to follow-up, it is unlikely that most future 
analyses in the study will be based on data in all subjects. Therefore, power calculations 
demonstrated in Tables 9 and 10 are based on 7,000 subjects in the whole cohort and 
700 subjects in the focus cohort. Table 9 demonstrates that for a normally distributed 
continuous outcome it is possible to detect with a type I error of 5% and a type II error of 
20% (power 80%) a diff erence of 0.11 SD in the whole cohort and of 0.35 SD in the focus 
cohort if 10% of all subjects has the relevant exposure. Table 10 presents for dichotomous 
outcomes that with the same type I and II errors, it is possible to detect a relative risk 
of 1.39 in the whole cohort and of 2.48 in the focus cohort if 10% of all subjects has the 
relevant exposure and the 1 year incidence of the outcome of interest is 10%. Rates of 
most dichotomous environmental and genetic exposures in the Generation R Study are 
expected to vary generally between 10 and 20%. The presented power calculations are 
rather conservative since most studies will assess the eff ects of continuously instead of 
dichotomous measured exposures and studies may be focused on outcomes collected 
in more than only one year. Furthermore, the Generation R Study has a large number of 
measurements repeated over time, which may increase the accuracy of measuring the 
true underlying value and may thereby increase the statistical power for these measure-
ments. 
Table 9. Eff ects sizes in standard deviation that minimally can be detected according to the prevalence of the 
exposure
Proportion exposed
Whole cohort
(n = 7,000)
Focus cohort
(n = 700)
50% 0.067 0.212
25% 0.077 0.276
10% 0.112 0.353
5% 0.154 0.486
1% 0.337 1.064
The presented eff ect sizes are detectable proportions of the standard deviation with a type I error of 5% and a type 
II error of 20% (power 80%).
Strengths and limitations
Strengths
The design of the Generation R Study is optimal for identifi cation of determinants in the 
earliest phase of life, unbiased data collection and controlling for potential confound-
ers.
Results from existing cohort studies in children suggest the importance of early life 
for various health conditions in later life and have initiated several birth-cohort studies 
The Generation R Study: cohort profi le 69
[9-11]. Compared to other planned or recently started prospective birth-cohort stud-
ies, the size of the Generation R Study cohort is not larger but the measurements are 
more detailed [12-16]. The cohort is large enough to detect small eff ects of early envi-
ronmental and genetic determinants on a variety of outcomes (Table 9-10). The detailed 
longitudinal fetal growth examinations enable studies into both various environmental 
and genetic determinants and into postnatal consequences of fetal growth and devel-
opment patterns. Currently, plans are being made to carry out similar detailed regular 
measurements in children in the whole cohort from the age of 4 years onwards. 
The study cohort is rather unique since it comprises contemporary urban children 
including about 50% from ethnic minorities. The largest ethnic minority groups in this 
population are the Surinamese, Turkish, Moroccan, Dutch Antillean and Cape Verdian 
groups. Knowledge about the growth, development and health of these groups is lack-
ing. Other birth-cohort studies do not provide information about these ethnic groups. 
The Generation R Study enables studies into determinants of ethnic specifi c health 
problems and health care utilization habits and may contribute to the development of 
ethnic specifi c strategies for pregnant women and children. 
Table 10. Relative risks that minimally can be detected according to the prevalence of the exposure
Incidence (1 year) of outcome of interest
Whole cohort (n = 7,000) Focus cohort (n = 700)
Proportion 
exposed
10% 5% 1% 10% 5% 1%
50% 1.23 1.33 1.83 1.83 2.28 4.94
25% 1.26 1.38 1.94 1.96 2.46 5.41
10% 1.39 1.56 2.42 2.48 3.26 7.92
5% 1.55 1.80 3.09 3.20 4.39 11.74
1% 2.36 3.04 6.83 7.75 11.61 37.55
The presented eff ect sizes are detectable relative risks with a type I error of 5% and a type II error of 20% (power 80%).
Limitations
Of all eligible children at birth, 61% participate in the study. National and regional reg-
istries do not have subject characteristics in all eligible children and their parents that 
enables detailed non-response analyses. However, the percentages of mothers from 
ethnic minorities and lower socio-economic status and the percentages of mothers or 
children with medical complications are lower among the participants than expected 
from the population fi gures in Rotterdam [2]. This selection towards a more affl  uent and 
healthy study population may be related to some determinants and outcomes sepa-
rately, aff ecting the frequency rates and, as a consequence, the statistical power and 
generalizibility of the results. The prevalence and incidence rates found in the study 
should therefore carefully be interpreted considering the role of potential selection 
mechanisms. This selection leads only to bias in etiological association studies if the 
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selection mechanisms are related to both the determinant and outcome. Although we 
do not expect that this is generally the case, the potential for selection bias should be 
considered in each analysis. Since the main aim of the study is to examine etiological 
associations of early determinants with outcomes in later life instead of disease frequen-
cy rates per se, major eff orts are made to keep the follow-up rates as high as possible 
and to prevent selective loss to follow-up.
Collaboration
The Generation R Study is conducted by several research groups from the Erasmus Medi-
cal Center Rotterdam in close collaboration with the Erasmus University Rotterdam and 
the Municipal Health Service Rotterdam area. Since the data collection is still ongoing 
and growing, the number of collaborating research groups in and outside the Nether-
lands is expected to increase in the coming years. The study has an open policy in regard 
to collaboration with other research groups. Request for collaboration should primarily 
be pointed to Albert Hofman (a.hofman@erasmusmc.nl). These requests are discussed 
in the Generation R Study Management Team regarding their study aims, overlap with 
ongoing studies, logistic consequences and fi nancial contributions. After approval of 
the project by the Generation R Study Management Team and the Medical Ethical Com-
mittee of the Erasmus Medical Center, the collaborative research project is embedded in 
one of the four research areas supervised by the specifi c principal investigator.
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Active and passive maternal smoking 
in pregnancy and the risk of low birth 
weight and preterm birth
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Abstract
Background: Maternal smoking in pregnancy is associated with low birth weight. The 
aims of this study were to examine the associations of active and passive smoking in 
diff erent periods of pregnancy with low birth weight and preterm birth and to examine 
the eff ects of changing smoking habits. 
Methods: This study was embedded in the Generation R Study, a population-based pro-
spective cohort study from fetal life until adulthood. Active and passive smoking were 
assessed by questionnaires in early pregnancy, mid-pregnancy and late pregnancy. The 
present analysis was based on 7,098 subjects.
Results: Active smoking until pregnancy was known, was not associated with low birth 
weight and preterm birth. Continued active smoking after pregnancy was known, was 
associated with low birth weight (adjusted odds ratio 1.64 (95% confi dence interval: 
1.24, 2.16)) and preterm birth (adjusted odds ratio 1.36 (95% confi dence interval: 1.04, 
1.78)). The strongest associations were found for active maternal smoking in late preg-
nancy. Passive maternal smoking in late pregnancy was only weakly associated with a 
continuously measured birth weight (diff erence -38 (95% confi dence interval: -74, -3) 
grams between never or occasional and daily passive smoking). For all active smoking 
categories in early pregnancy, quitting to smoke was associated with a higher birth 
weight than continuing to smoke. 
Conclusion: Active and passive smoking in late pregnancy are associated with adverse 
eff ects on weight and gestational age at birth. Health care strategies for pregnant wom-
en should be aimed at quitting to smoke completely rather than reducing the number 
of cigarettes.
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Introduction
Low birth weight and preterm birth are the most important risk factors for perinatal 
morbidity and mortality and seem to increase the risk of developing cardiovascular dis-
ease in adulthood [1, 2]. Active maternal smoking in pregnancy is the most important 
modifi able risk factor for low birth weight and preterm birth in Western countries [3, 
4]. Birth weight in the off spring of smoking mothers is 150 to 250 grams lower than 
in the off spring of non-smoking mothers [3, 4]. Although a dose-response relationship 
between the number of cigarettes smoked per day and birth weight has been described, 
the detrimental eff ect of smoking seems already to occur in the lowest levels of active 
maternal smoking [5]. The eff ect of changing smoking habits in pregnancy on birth 
weight is not well known. Previous studies suggested that quitting maternal smoking 
after the fi rst trimester leads to a normal birth weight, but were not conclusive [6, 7]. The 
eff ect of reducing the number of cigarettes smoked in pregnancy on birth weight is not 
well known [8, 9]. 
More recently, it has been suggested that passive maternal smoking in pregnancy 
is also associated with low birth weight [10]. Studies suggested that birth weight is 
25 to 75 grams lower in the off spring of mothers exposed to environmental smoke in 
pregnancy than in the off spring of mothers not exposed [10, 11]. To our knowledge, no 
studies examined the associations of passive smoking in diff erent periods of pregnancy 
and of reducing the number of hours exposed to environmental smoke in pregnancy 
with birth weight. 
In a population-based cohort study among pregnant women and their children, 
we examined the associations of active and passive smoking in diff erent periods of 
pregnancy with low birth weight and preterm birth in the off spring. We also examined 
whether changing smoking habits from early to late pregnancy was associated with 
benefi cial eff ects on birth weight in the off spring.
Methods
Design
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life until young adulthood. This study is designed to identify 
early environmental and genetic determinants of growth, development and health in 
fetal life, childhood and adulthood and has been described previously in detail [12, 13]. 
Briefl y, the cohort includes 9,778 mothers and their children of diff erent ethnicities liv-
ing in Rotterdam, the Netherlands. Enrolment was aimed in early pregnancy (gestational 
age < 18 weeks) but was possible until birth of the child. Mothers were informed about 
78
C
ha
p
te
r 4
.1
the study by routine health care workers (midwives, obstetricians) in pregnancy and 
were enrolled in the study at their routine ultrasound examination in pregnancy. 
Mothers who were missed in pregnancy, were approached and enrolled in the 
fi rst month after birth of their child at the routine child health centers. Assessments in 
pregnancy, including physical examinations, fetal ultrasounds and questionnaires, were 
planned in early pregnancy (gestational age < 18 weeks), mid-pregnancy (gestational 
age 18-25 weeks) and late pregnancy (gestational age ≥ 25 weeks). Mothers enrolled in 
early pregnancy (69%) had three assessments planned (in early, mid- and late pregnan-
cy) whereas those enrolled in mid-pregnancy (19%) had two assessments (in mid- and 
late pregnancy) and those enrolled in late pregnancy (3%) had one assessment (in late 
pregnancy) planned. The individual time scheme of these assessments depended on the 
specifi c gestational age at enrolment [13]. Mothers enrolled after birth of their off spring 
(9%) had no prenatal assessments [12, 13]. All children were born between April 2002 
and January 2006 and form a prenatally enrolled birth-cohort that is currently followed 
until young adulthood. Of all eligible children in the study area, 61% participated at 
birth in the study [13]. The study has been approved by the Medical Ethical Committee 
of the Erasmus Medical Center, Rotterdam. Written informed consent was obtained from 
all participants. 
Active and passive maternal smoking
Information about active and passive maternal smoking was obtained by postal ques-
tionnaires in early, mid- and late pregnancy [13]. Active maternal smoking at enrolment 
was assessed in the fi rst questionnaire by asking whether mother smoked in pregnancy 
(no, until pregnancy was known, continued after pregnancy was known). This question-
naire was sent to all mothers, independent of their gestational age at enrolment. In the 
second and third questionnaire, the mothers were asked whether they smoked in the 
past 2 months (no, yes) in mid- and late pregnancy, respectively. Mothers who reported 
in the fi rst questionnaire to have smoked until pregnancy was known (n = 861) but still 
reported to smoke in the second or third questionnaire (n = 270), were reclassifi ed into 
the ’continued smoking after pregnancy was known’ category. The same strategy was 
used for mothers who reported not to smoke in the fi rst questionnaire (n = 5,372) but 
smoked in the second or third questionnaire (n = 83). Among the smoking mothers, the 
number of cigarettes was assessed in the following six categories: less than one per day; 
one to two per day; three to four per day; fi ve to nine per day; ten to nineteen per day; 
and twenty or more per day. To increase the number of subjects, these categories were 
combined and reclassifi ed into previously used categories: 1) non-smoking; 2) less than 
fi ve cigarettes per day; 3) fi ve to nine cigarettes per day; and 4) ten or more cigarettes per 
day [11]. Passive maternal smoking was assessed in each questionnaire as the number of 
hours per day that mothers were exposed to environmental smoke at home and at work. 
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For both exposure to smoke at home and at work, the following categories were used: 1) 
never or occasionally; 2) less than one hour per day; 3) one to three hours per day; and 4) 
more than three hours per day. Per questionnaire, all subjects were reclassifi ed into the 
highest reported category of the exposure either at home or at work. 
Covariates 
Information about educational level, ethnicity and parity was obtained by the fi rst 
questionnaire at enrolment in the study. Maternal alcohol consumption was assessed in 
early, mid- and late pregnancy by questionnaire. Maternal anthropometrics, including 
height and weight, were measured without shoes and heavy clothing and body mass 
index was calculated (weight/height2 (kg/m2)) in early, mid- and late pregnancy during 
visits at the research center. 
Birth outcomes
Date of birth, birth weight and gender were obtained from midwife and hospital reg-
istries. Gestational age was established by fetal ultrasound examination because using 
last menstrual period has several limitations, including the large number of women who 
do not know their exact last menstrual period date or have irregular cycles [14].
Population for analysis 
Of the total of 9,778 mothers, 91% (n = 8,880) was enrolled in pregnancy [13]. Those 
without information about smoking in pregnancy in the fi rst questionnaire were exclud-
ed from the analyses (14%, n = 1,249). Of the remaining 7,631 mothers, those with twin 
pregnancies (n = 81), fetal deaths (n = 100) or missing birth outcomes (n = 352) were 
excluded. Categories of active smoking habits were similarly distributed at baseline 
among those with singleton live birth as outcome and those lost to follow-up. The asso-
ciations of maternal smoking habits in pregnancy with birth outcomes were analyzed in 
the remaining 7,098 mothers. Of these mothers, 4% (n = 290) were second or third preg-
nancies in the study. Since there were no diff erences in results after exclusion of these 
subjects, they were included in the analyses presented. Analyses focused on smoking 
categories in diff erent periods of pregnancy were restricted to mothers enrolled in early 
pregnancy to minimize misclassifi cation of smoking in pregnancy period. Since both 
active and passive smoking were strongly correlated between mid- and late pregnancy 
(Spearman correlation coeffi  cient r = 0.8, p < 0.01 for active smoking, r = 0.7, p < 0.01 
for passive smoking), we did not have enough mothers to assess the separate eff ects of 
smoking in mid- and late pregnancy. Therefore, analyses were focused on early and late 
pregnancy. Of all mothers enrolled in early pregnancy (n = 5,502), the associations of 
active smoking in early pregnancy (until pregnancy was known) with birth outcomes, 
were assessed in those in whom information about the number of actively smoked 
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cigarettes was available and did not actively smoke after their pregnancy was known 
(n = 4,541) to exclude confounding by continued smoking. Among mothers enrolled 
in early pregnancy, information about the number of actively smoked cigarettes in late 
pregnancy was available in 83% (n = 4,580). The analyses with passive smoking in early 
pregnancy as determinant were conducted among non-actively smoking mothers with 
information about the hours of passive smoking in early pregnancy and who were never 
or occasionally exposed to passive smoking in mid- or late pregnancy (n = 3,334). In late 
pregnancy, the associations of passive smoking with birth outcomes were also analyzed 
among non-actively smoking mothers with information about passive smoking (n = 
3,862).
Data analysis
First, the associations of active maternal smoking habits at any time during pregnancy 
with low birth weight and preterm birth were assessed using multiple logistic regression 
models. Low birth weight was defi ned as birth weight below the 10th percentile in the 
study cohort (2850 grams) and was based on infants born at a gestational age of 37 
weeks or more. Preterm born children were excluded from the models with low birth 
weight as dependent variable. Preterm birth was defi ned as a gestational age of less 
than 37 weeks at delivery. These logistic regression models were adjusted for life style 
and socio-economic status related variables at enrolment (maternal body mass index, 
alcohol consumption, educational level) and additionally for known determinants of 
low birth weight and preterm birth (maternal age, height, ethnicity and parity and infant 
gender). Second, the associations of active and passive smoking categories in early and 
late pregnancy with continuously measured birth weight, low birth weight and preterm 
birth were assessed using multiple linear and logistic regression models. These models 
were adjusted for the same potential confounders. In these models, alcohol consump-
tion and body mass index were measured in the same period of pregnancy as maternal 
smoking. All models with low birth weight and continuously measured birth weight as 
dependent variable were additionally adjusted for gestational age. Third, the associa-
tions of patterns of change in active and passive smoking categories from early to late 
pregnancy with birth weight were analyzed within strata of active and passive smokers 
in early pregnancy. Within these strata, mothers with the same active or passive smoking 
category in early and late pregnancy were the reference group. All measures of associa-
tion are presented with their 95% confi dence intervals (CI). All statistical analyses were 
performed using the Statistical Package of Social Sciences version 11.0 for Windows 
(SPSS Inc, Chicago, IL, USA).
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Results
Subject characteristics
Characteristics of the mothers per smoking category are presented in Table 1. Of all 
mothers, 25.5% (n = 1,809) reported to actively smoke in early pregnancy and 17.2% 
(n = 1,218) continued smoking after pregnancy was known. The age in the whole cohort 
ranged from 15.3 to 46.3 years with a mean of 29.8 years and was lowest in mothers who 
Table 1. Maternal characteristics 
Smoking in pregnancy (n = 7,098)
Non-smoking
Until pregnancy 
was known
Continued after 
pregnancy was known
n = 5,289 n = 591 n = 1,218
Age (years) 30.1 (5.1) 29.4 (5.2) 28.3 (5.8)
Height (cm) 167.4 (7.5) 168.3 (7.0) 167.1 (7.0)
Weight (kg) 69.3 (13.2) 69.4 (12.8) 70.2 (14.0)
Body mass index (kg/m2) 24.7 (4.5) 24.5 (4.5) 25.2 (4.8)
Parity ≥ 1 (%) 45.2 31.7 45.7
Alcohol consumption (%)
 No 60.1 29.1 54.5
 Until pregnancy was known 24.2 50.6 27.9
 Continued 15.8 20.3 17.6
Education (%)
 Primary school 10.6 12.2 21.0
 Secondary school 41.6 44.9 60.5
 Higher education 47.8 42.9 18.6
Ethnicity (%)
 Dutch, other-European 57.6 62.9 57.1
 Surinamese 8.4 12.4 10.4
 Turkish 7.7 7.5 16.2
 Moroccan 8.1 1.2 1.9
 Cape Verdian 3.7 4.6 4.8
 Antillean 3.4 2.9 3.8
 Others 11.0 8.5 5.8
1st Child of the same mother in study (%) 95.8 95.2 96.6
Enrolment in study in early pregnancy (%) 76.4 85.8 78.2
Birth outcomes
 Birth weight (grams) 3454 (552) 3441 (559) 3251 (545)
 Gestational age (weeks)* 40.0 (37.0 – 42.0) 40.0 (36.9 – 42.0) 39.9 (36.1 – 42.0)
Values are means (standard deviation) or percentages. * Median (90% range). Data were missing on height (n = 11), 
weight (n = 27), body mass index(n = 38), parity (n = 409), alcohol consumption (n = 19), educational level (n = 218) 
and ethnicity (n =60).
82
C
ha
p
te
r 4
.1
continued smoking after pregnancy was known. Also the percentage of mothers with 
higher educational level was lowest in this group. In the whole cohort, the largest ethnic 
groups were the Dutch and other-European (58.0%), Surinamese (9.1%), Turkish (9.1%) 
and Moroccan women (6.5%). Table 1 demonstrates that the percentages of Turkish 
mothers and Moroccan mothers were highest (16.2%) and lowest (1.9%), respectively, 
among those who continued smoking after pregnancy was known. Mean off spring birth 
weight was 3454 (SD 552) grams for mothers who did not smoke in pregnancy and 3251 
(SD 545) grams for mothers who continued smoking after pregnancy was known. Of all 
children, 5.7% was born before a gestational age of 37 weeks. 
For the 5,502 mothers who were enrolled in early pregnancy, the distributions of active 
and passive smoking categories in early pregnancy for various subject characteristics are 
presented in Table 2. The youngest age group showed the highest percentages of active 
and passive smoking. Among mothers using alcohol consumptions in early pregnancy, 
31.0% actively smoked, whereas this percentage was 20.6% among mothers who did not 
use alcohol consumptions. Mothers with the highest educational level showed the lowest 
percentages of active and passive smoking. Both the percentages of active and passive 
smoking varied between the ethnic groups and were highest among Turkish women. 
Table 2. Distribution of active and passive maternal smoking categories for subject characteristics in early 
pregnancy (n = 5,502)
Active smoking (n = 5,479) Passive smoking (n = 5,349)
Non-
smoking
< 5 
cigarettes 
per day
5 - 9 
cigarettes 
per day
> 9 
cigarettes 
per day a
Never / 
occasionally
< 1 hour 
per day
1 - 3 hours 
per day
> 3 hours 
per day
(74.5%)  (13.5%) (6.9%) (5.2%) (71.3%)  (10.2%) (7.0%) (11.4%)
Age (years) (n = 5,502)
 < 28 years (33.4%) 66.9 18.2 8.5 6.3 59.9 13.0 9.7 17.4
 28-32 years (30.9%) 78.3 11.8 5.7 4.3 75.2 10.3 5.4 9.1
 > 32 years (35.8%) 78.2 10.6 6.4 4.8 78.4 7.6 6.1 7.8
Body mass index (kg/m2) (n = 5,476)
 < 22 kg/m2 (31.8%) 75.0 14.8 6.0 4.1 74.1 9.2 6.1 10.6
 22-25 kg/m2 (33.3%) 75.3 13.7 6.5 4.5 72.9 10.5 6.7 9.8
 > 25 kg/m2 (34.8%) 73.1 12.0 8.2 6.7 67.2 10.9 8.2 13.8
Alcohol consumption (n = 5,488)
 No (53.5%) 79.3 10.7 5.8 4.1 68.1 11.7 7.8 12.5
 Yes (46.5%) 69.1 16.5 8.1 6.4 71.9 10.7 6.3 11.2
Education (n = 5,355)
 Primary school (10.9%) 62.1 16.5 11.1 10.3 58.0 12.1 9.4 20.5
 Secondary school (44.2%) 68.6 15.9 9.4 6.2 61.5 12.5 9.3 16.7
 Higher education (44.9%) 83.5 10.1 3.5 2.9 84.0 7.6 4.2 4.1
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Active smoking habits during pregnancy
Table 3 presents the adjusted odds ratios (aOR) for the associations of active maternal 
smoking in pregnancy with low birth weight and preterm birth. Smoking until preg-
nancy was known, was not associated with an increased risk of low birth weight and 
preterm birth. In all models, continued smoking after pregnancy was known, was associ-
ated with low birth weight (aOR 1.64 (95% CI: 1.24, 2.16)) and preterm birth (aOR 1.36 
(95% CI: 1.04, 1.78)).
Active and passive maternal smoking categories in early and late pregnancy
Table 4 and 5 present the associations of active and passive smoking categories in early 
and late pregnancy with continuously measured birth weight, low birth weight and 
preterm birth. Active smoking categories until pregnancy was known, were not asso-
ciated with low birth weight and preterm birth (Table 4). Active maternal smoking in 
late pregnancy was strongly associated with continuously measured birth weight. The 
largest eff ect estimate was seen for smoking fi ve to nine cigarettes per day (diff erence in 
birth weight -200 (95% CI: -277, -122) grams). The risk of low birth weight was increased 
in mothers who smoked fi ve to nine cigarettes per day (aOR 1.83 (95% CI: 1.07, 3.13)) 
and who smoked more than nine cigarettes per day (aOR 2.08 (95% CI: 1.00, 4.34)). We 
found only an increased risk of preterm birth for smoking more than nine cigarettes 
per day (aOR 2.52 (95% CI: 1.36, 4.67)). Among non-actively smoking mothers, passive 
smoking in early and late pregnancy was not associated with continuously measured 
Table 2 (continued).
Active smoking (n = 5,479) Passive smoking (n = 5,349)
Non-
smoking
< 5 
cigarettes 
per day
5 - 9 
cigarettes 
per day
> 9 
cigarettes 
per day a
Never / 
occasionally
< 1 hour 
per day
1 - 3 hours 
per day
> 3 hours 
per day
(74.5%)  (13.5%) (6.9%) (5.2%) (71.3%)  (10.2%) (7.0%) (11.4%)
Parity (n = 5,201)
 0 (57.7%) 73.6 14.3 6.9 5.2 68.9 11.6 7.0 12.6
 ≥ 1 (42.3%) 76.2 11.7 7.4 4.6 75.2 8.8 6.9 9.1
Ethnicity (n = 5,457)
 Dutch / European (61.6%) 74.5 12.2 7.5 5.9 73.8 9.4 6.5 10.3
 Surinamese (8.6%) 69.3 20.4 5.6 4.7 63.8 13.0 7.9 15.2
 Turkish (8.2%) 62.4 20.6 11.4 5.6 55.9 13.2 12.3 18.5
 Moroccan (5.7%) 94.2 3.5 1.9 0.3 75.1 11.7 5.1 8.1
 Cape Verdian (3.8%) 68.3 16.1 8.3 7.3 66.5 13.4 6.7 13.4
 Antillean (2.9%) 72.2 19.0 5.7 3.2 62.6 13.5 7.1 16.8
 Others (9.2%) 82.1 11.4 3.2 3.2 78.1 6.8 6.4 8.7
Values are percentages. 
a Within this category, 79% of the subjects smoked 10 to 19 cigarettes per day
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birth weight, low birth weight and preterm birth (Table 5). However, weak tendencies 
for daily passive smoking in late pregnancy with continuously measured birth weight 
were found (diff erence in birth weight -29 (95% CI: -78, 19) grams for less than one hour 
per day, -50 (95% CI: -114, 15) grams for one to three hours per day and -44 (95% CI: 
-108, 20) grams for more than three hours per day). Combining these categories in two 
larger groups of 1) never or occasional passive smoking and 2) daily passive smoking 
demonstrated a diff erence in birth weight of -38 (95% CI: -74, -3) grams for daily passive 
smoking in late pregnancy compared to never or occasional passive smoking (results 
not shown in Table 5).
Table 3. Odds ratios for the associations of active smoking habits in pregnancy with low birth weight and preterm 
birth
Odds ratio for low birth weight 
Active smoking in pregnancy
n = 6,692 a
Model A Model B Model C
Non-smoking 
n = 5,007
Reference Reference Reference
Until pregnancy was known
n = 558
1.16 (0.81, 1.65) 1.15 (0.80, 1.67) 1.03 (0.68, 1.55)
Continued after pregnancy was known
n = 1,127
1.73 (1.37, 2.19)** 1.57 (1.22, 2.02)** 1.64 (1.24, 2.16)**
Odds ratio for preterm birth
Active smoking in pregnancy
n = 7,098
Model A Model B Model C
Non-smoking 
n = 5,289
Reference Reference Reference
Until pregnancy was known
n = 591
1.05 (0.73, 1.52) 1.11 (0.76, 1.62) 0.94 (0.63, 1.40)
Continued after pregnancy was known
n = 1,218
1.43 (1.12, 1.83)** 1.36 (1.04, 1.76)* 1.36 (1.04, 1.78)*
Values are odds ratios (95% confi dence interval). 
Model A: unadjusted.
Model B: adjusted for maternal body mass index, alcohol consumption, educational level.
Model C: adjusted for maternal body mass index, alcohol consumption, educational level, height, ethnicity, parity 
and age and infant gender.
a Preterm born children excluded
 All models with low birth weight as dependent variable are additionally adjusted for gestational age.
*p-value < 0.05, **p-value < 0.01
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Changing smoking patterns in pregnancy
Table 3 shows that mothers who quitted smoking after their pregnancy was known, 
did not have an increased risk of having a low birth weight infant. Table 6 presents the 
eff ect of changing smoking categories from early to late pregnancy on birth weight for 
diff erent categories of active and passive smoking in early pregnancy. For all categories 
of active smoking in early pregnancy, a higher birth weight was found for quitting to 
smoke. Reducing the number of actively smoked cigarettes from fi ve to nine per day or 
more than nine per day in early pregnancy to less than fi ve per day in late pregnancy 
without stopping completely was associated with smaller, non-signifi cant, changes of 
birth weight. We did not fi nd associations between changing the hours of passive smok-
ing from early to late pregnancy and birth weight. 
Table 4. Associations of active smoking categories in early and late pregnancy with birth outcomes 
Diff erence in birth weight 
(grams) a
Adjusted odds ratio for 
low birth weight b, c
Adjusted odds ratio for 
preterm birth b
Early pregnancy 
(until pregnancy was 
known, < 18 weeks)
n = 4,541 n = 4,301 n = 4,541
Non-smoking
Reference
n = 4,022
Reference
n = 3,811
Reference
n = 4,022
< 5 cigarettes per day
44 (-9, 96)
n = 298
0.74 (0.40, 1.38)
n = 283
0.85 (0.47, 1.52)
n = 298
5 - 9 cigarettes per day
-9 (-92, 73)
n = 106
1.42 (0.62, 3.32)
n = 102
0.68 (0.25, 1.88)
n = 106
> 9 cigarettes per day
45 (-37, 128)
n = 115
0.48 (0.14, 1.62)
n = 105
1.48 (0.73, 3.02)
n = 115
Late pregnancy
(≥ 25 weeks)
n = 4,580 n = 4,345 n = 4,580
Non-smoking
Reference
n = 3,897
Reference
n = 3,707
Reference
n = 3,897
< 5 cigarettes per day
-100 (-150, -49)**
n = 327
1.43 (0.87, 2.36)
n = 310
1.06 (0.62, 1.82)
n = 327
5 - 9 cigarettes per day
-165 (-224, -107)**
n = 225
1.83 (1.07, 3.13)*
n = 211
1.25 (0.70, 2.23)
n = 225
> 9 cigarettes per day
-200 (-277, -122)**
n = 131
2.08 (1.00, 4.34)
n = 117
2.52 (1.36, 4.67)**
n = 131
a Values are regression coeffi  cients (95% confi dence interval) and number of subjects per smoking category. b Values 
are odds ratios (95% confi dence interval) and number of subjects per smoking category. c Preterm born children 
excluded. All models are adjusted for maternal body mass index, alcohol consumption, educational level, ethnicity, 
parity, height and age and infant gender. All models with birth weight and low birth weight as dependent variable 
are additionally adjusted for gestational age. Active smoking models in early pregnancy are based on mothers who 
did not actively smoke after pregnancy was known. 
*p-value < 0.05, **p-value < 0.01
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Discussion
This population-based prospective cohort study showed associations of active maternal 
smoking in late pregnancy with low birth weight and preterm birth. Passive smoking in 
pregnancy was weakly associated with a lower birth weight in the off spring. Quitting 
active smoking after pregnancy was known, was associated with a higher birth weight 
in the off spring compared to continued smoking or reducing the numbers of cigarettes 
without quitting completely.
Methodological considerations
The strength of this study is the population-based cohort with a large number of sub-
jects studied from early pregnancy. To our knowledge, this is the largest cohort study 
examining the associations between maternal smoking in pregnancy and birth weight 
Table 5. Associations of passive smoking categories in early and late pregnancy with birth outcomes
Diff erence in birth weight 
(grams) a
Adjusted odds ratio for 
low birth weight b, c
Adjusted odds ratio for 
preterm birth b
Early pregnancy 
(< 18 weeks)
n = 3,334 n = 3,173 n = 3,334
Never / occasionally
Reference
n = 2,689
Reference
n = 2,563
Reference
n = 2,689
< 1 hour per day
1 (-50, 53)
n = 307
0.81 (0.45, 1.45)
n = 290
1.03 (0.60, 1.77)
n = 307
1 - 3 hours per day
-18 (-88, 52)
n = 160
1.59 (0.79, 3.14)
n = 154
0.79 (0.34, 1.83)
n = 160
> 3 hours per day
-38 (-105, 29)
n = 178
1.25 (0.61, 2.56)
n = 166
0.94 (0.46, 1.91)
n = 178
Late pregnancy
(≥ 25 weeks)
n = 3,862 n = 3,674 n = 3,862
Never / occasionally
Reference
n = 3,126
Reference
n = 2,977
Reference
n = 3,126
< 1 hour per day
-29 (-78, 19)
n = 344
1.23 (0.74, 2.04)
n = 327
0.90 (0.54, 1.53)
n = 344
1 - 3 hours per day
-50 (-114, 15)
n = 194
0.92 (0.43, 1.99)
n = 182
1.04 (0.53, 2.05)
n = 194
> 3 hours per day
-44 (-108, 20)
n = 198
1.35 (0.71, 2.59)
n = 188
0.66 (0.30, 1.44)
n = 198
a Values are regression coeffi  cients (95% confi dence interval) and number of subjects per smoking category. b Values 
are odds ratios (95% confi dence interval) and number of subjects per smoking category. c Preterm born children 
excluded. All models are adjusted for maternal body mass index, alcohol consumption, educational level, ethnicity, 
parity, height and age and infant gender. All models with birth weight and low birth weight as dependent variable 
are additionally adjusted for gestational age. Passive smoking models in early pregnancy are based on mothers 
who did not passively smoke in mid- or late pregnancy 
Active and passive maternal smoking and birth outcomes 87
with data on both active and passive smoking in diff erent trimesters of pregnancy pub-
lished so far. Follow-up until birth was available for 93% and information about a large 
number of potential confounders was available in this study. 
Information about smoking in pregnancy at enrolment was missing in 14% of all 
prenatally enrolled mothers. In the off spring of these mothers, birth weight was 41 (95% 
CI: 6, 76) grams lower. Non-response for the main determinant may be selective if the 
percentage of smoking mothers is higher among those without than those with infor-
mation about smoking. This would probably lead to loss of power and underestimation 
of the estimated adverse eff ects of smoking on birth outcomes. Among mothers with 
information about their smoking habits at baseline, categories of smoking habits were 
similarly distributed among those lost to follow-up and those with a singleton live birth 
as pregnancy outcome. Lost to follow-up would lead to selection bias if the associa-
tions of maternal smoking in pregnancy with low birth weight and preterm birth diff er 
between those lost to follow-up and those with singleton live birth as pregnancy out-
come. This seems unlikely but can not be excluded. 
Information about maternal smoking in pregnancy was collected by questionnaires 
in pregnancy without reference to the birth outcomes. Although assessing smok-
Table 6. Associations of changing active and passive smoking habits in pregnancy with birth weight 
Active smoking Late pregnancy (≥ 25 weeks)
Early pregnancy
 (< 18 weeks)
Quitted a
< 5 cigarettes
 per day
5 - 9 cigarettes 
per day
> 9 cigarettes 
per day
< 5 cigarettes per day
n = 579
144 (66, 221)**
n = 278
Reference
n = 221
-41 (-157, 73)
n = 71
-137 (-445, 171)
n = 9
5 - 9 cigarettes per day
n = 306
154 (27, 281)*
n = 91
126 (-33, 285 )
n = 44
Reference
n = 121
23 (-126, 173)
n = 50
> 9 cigarettes per day
n = 223
187 (14, 360)*
n = 98
109 (-125, 343)
n = 30
-26 (-251, 198)
n = 27
Reference
n = 68
Passive smoking Late pregnancy (≥ 25 weeks)
Early pregnancy
 (< 18 weeks)
Never / occasionally < 1 hour per day 1 - 3 hours per day > 3 hours per day
< 1 hour per day
n = 301
13 (-82, 109)
n =120
Reference
n = 138
20 (-112, 153)
n = 30
-66 (-242, 110)
n =13
1 - 3 hours per day
n = 159
105 (-48, 258)
n = 33
37 (-119, 192 )
n = 45
Reference
n = 60
53 (-122, 228)
n = 21
> 3 hours per day
n = 171
12 (-123, 147)
n = 33
25 (-140, 190)
n = 14
49 (-58, 158)
n = 34
Reference
n = 90
Values are regression coeffi  cients (95% CI) and refl ect the diff erence in birth weight compared to the reference 
group. All models were adjusted for maternal change in maternal body mass index, height, alcohol consumption, 
educational level, ethnicity, parity and age and fetal gestational age and gender. a Includes mothers who 
immediately quitted active smoking after their pregnancy was known and mothers who quitted smoking between 
early and late pregnancy.
*p-value < 0.05, **p-value < 0.01
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ing habits in pregnancy by questionnaires seems to be a valid method, misclassifi ca-
tion may occur [15]. Underreporting of maternal smoking across the various smoking 
categories may be present. The diff erence in birth weight between the off spring of 
non-smoking and low to moderate smoking mothers may be overestimated if under-
reporting would be selectively present among heavy smoking mothers who report low 
to moderate smoking. To overcome these limitations, other studies used biomarkers 
of tobacco exposure including cotinine in maternal urine samples [16, 17]. However, 
low correlations between cotinine levels and self reported smoking habits have been 
demonstrated [18]. Possible explanations for these low correlations include inaccurate 
maternal reporting of smoking habits in pregnancy, use of categories of number of ciga-
rettes smoked in questionnaires and individual diff erences in inhalation, absorption and 
metabolism. Previous studies demonstrated that use of cotinine levels is not superior 
to self-report in studying the eff ect of maternal smoking in pregnancy on birth weight 
[5, 19]. We assessed smoking as categorical and not as continuous variable since data 
collection and data cleaning are more easily conducted in a large cohort. Inherently, this 
diminishes power to identify exposure eff ects because information within categories is 
lost. Maternal passive smoking was assessed as hours exposed to environmental smoke 
at home and at work. This method may introduce error since it does not include expo-
sure to smoke outside work and home.
Main outcomes in our study were low birth weight and preterm birth. Additional 
models with continuously measured birth weight as outcome were adjusted for gesta-
tional age since interest in these models was in fetal growth retardation. Fetal growth 
retardation due to maternal smoking in pregnancy does not have to lead to low birth 
weight if the fetus was supposed to grow on the upper percentiles. Misclassifi cation in 
the outcome, as measure of fetal growth retardation, can therefore not be excluded.
Active maternal smoking in pregnancy
As in previous studies, we found strong associations between active smoking in preg-
nancy and low birth weight and preterm birth [3, 4, 20]. These associations were inde-
pendent of potential confounders. Active smoking in late pregnancy was strongly asso-
ciated with low birth weight and preterm birth. The detrimental eff ect was already seen 
in the lowest smoking category. This is in line with other studies demonstrating that 
low levels of maternal smoking measured by questionnaires and urine cotinine levels 
have already substantial eff ects on birth weight [15, 21]. Changing smoking habits in 
pregnancy seems to be most benefi cial when mother quits smoking in early pregnancy. 
No diff erences in birth weight were observed between the off spring of mothers who 
quitted smoking after their pregnancy was known and the off spring of mothers who 
never smoked. Previous studies supported this fi nding and even described an increase 
in birth weight in the off spring of mothers who quitted smoking in early pregnancy [6]. 
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This may be partly explained by an increase in maternal body mass index in pregnancy 
in mothers who quit smoking in pregnancy. Reducing the number of cigarettes from 
more than fi ve per day to less than fi ve per day without quitting completely, was associ-
ated with smaller benefi cial eff ects on birth weight. However, since we had only a small 
number of mothers who smoked more than fi ve cigarettes per day in early pregnancy 
that reduced the number of cigarettes without quitting and we used smoking as catego-
rized variable, our study may lack power to demonstrate small eff ects of reducing the 
number of cigarettes. 
Passive maternal smoking in pregnancy
Our results demonstrated weak associations of maternal passive smoking in late preg-
nancy with birth weight. The previously suggested eff ect sizes of passive maternal 
smoking on decrease in birth weight in the off spring ranged from 25 to 75 grams [10]. 
Our results are in line with these studies. However, studies in large cohorts examining 
the eff ect of passive maternal smoking on low birth weight did not measure passive 
smoking in various periods of pregnancy [11]. We found only a weak eff ect of passive 
smoking in late pregnancy on birth weight. Both quitting and reducing the number of 
hours of passive smoking were not associated with benefi cial eff ects on birth weight in 
the off spring. This may be explained by the overall small eff ect size of passive maternal 
smoking and the small number of subjects in which the number of hours of passive 
smoking changed in our study.
Study implications
Our study showed that active maternal smoking, especially in late pregnancy, is associ-
ated with an increased risk of low birth weight and preterm birth in the off spring. Health 
care strategies for pregnant women should be primarily aimed at quitting smoking 
completely in early pregnancy rather than reducing the number of cigarettes. Passive 
smoking should be prevented in pregnant women. Since birth weight is only a crude 
measure of fetal growth, studies focused on fetal growth patterns are necessary.
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Abstract
Background: Maternal smoking in pregnancy is associated with low birth weight. Low 
birth weight is a crude measure of fetal growth. The aim of this study was to examine the 
associations of smoking in pregnancy with diff erent fetal growth characteristics.
Methods: This study was embedded in the Generation R Study, a population-based 
prospective cohort study from fetal life until adulthood. Smoking was assessed by 
questionnaires in early, mid- and late pregnancy. Fetal growth measurements used for 
the present study included head circumference, abdominal circumference and femur 
length measured in mid- and late pregnancy. The present analysis was based on 7,098 
subjects. 
Results: Continued maternal smoking after pregnancy was known, was associated with 
reduced fetal growth of head circumference (-0.56 (95% confi dence interval: -0.73, -0.40) 
mm per week), abdominal circumference (-0.58 (95% confi dence interval: -0.81, -0.34) 
mm per week) and femur length (-0.19 (95% confi dence interval: -0.23, -0.14) mm per 
week). Maternal smoking until pregnancy was known, was associated with an increased 
abdominal circumference growth (0.35 (95% confi dence interval: 0.05, 0.65) mm per 
week). Continued maternal smoking was associated with smaller fetal femur length 
from mid-pregnancy (gestational age 18 - 25 weeks) onwards and smaller head and 
abdominal circumference from late pregnancy (gestational age ≥ 25 weeks). Analyses 
with standard deviation scores for the growth characteristics, demonstrated the largest 
eff ect estimates for femur length.
Conclusion: Maternal smoking in pregnancy is associated with reduced growth of fetal 
head circumference, abdominal circumference and femur length. The larger eff ect on 
femur length suggests that smoking in pregnancy aff ects primarily peripheral tissues.
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Introduction
Maternal smoking in pregnancy is the most important modifi able risk factor for low birth 
weight in Western countries [1, 2]. Birth weight is 150 to 250 grams lower in the off spring 
of mothers who smoke in pregnancy [1, 2]. Smoking in pregnancy leads to low birth 
weight by decreased fetal supplies of both nutrients and oxygen and subsequently fetal 
growth retardation. Since low birth weight is only a proxy for fetal growth retardation, it 
is an inappropriate measure for assessing the adverse eff ects of smoking in pregnancy 
on fetal growth and development. Fetal growth retardation may lead to normal birth 
weight if the fetus is actually supposed to grow on the upper percentiles based on the 
genetic growth potential. Detailed anthropometric measurements at birth including 
length, head circumference and abdominal circumference may be more informative 
than weight but are also the result of various fetal growth patterns. 
A limited number of previous studies examined the eff ect of maternal smoking in 
pregnancy on fetal growth [3-8]. These studies suggested that maternal smoking in 
pregnancy is associated with impaired fetal growth from a gestational age of 20 weeks 
onwards. However, these studies were conducted in small groups or in hospital-based 
populations, were not able to adjust for all potential confounders and did not examine 
the eff ects of maternal smoking on various fetal growth characteristics in diff erent peri-
ods of pregnancy. This may be relevant for identifying specifi c critical periods for the 
eff ect of maternal smoking on fetal growth.
We examined in a population-based cohort study in pregnant women the asso-
ciations of maternal smoking in pregnancy with longitudinally measured fetal growth 
characteristics. 
Methods
Design
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life until young adulthood. This study is designed to identify ear-
ly environmental and genetic determinants of growth, development and health in fetal 
life, childhood and adulthood and has been described previously in detail [9, 10]. Briefl y, 
the cohort includes 9,778 mothers and their children of diff erent ethnicities living in Rot-
terdam, the Netherlands. Enrolment was aimed in early pregnancy (gestational age < 18 
weeks) but was possible until birth of the child. Mothers were informed about the study 
by routine health care workers in pregnancy (midwives, obstetricians) and were enrolled 
in the study at their routine fetal ultrasound examination in pregnancy. Mothers who 
were missed in pregnancy, were approached and enrolled in the fi rst month after birth 
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of their child at the routine child health centers. Assessments in pregnancy, including 
physical examinations, fetal ultrasound examinations and questionnaires, were planned 
in early pregnancy (gestational age < 18 weeks), mid-pregnancy (gestational age 18-
25 weeks) and late pregnancy (gestational age ≥ 25 weeks). Mothers enrolled in early 
pregnancy (69%) had three assessments planned (in early, mid- and late pregnancy) 
whereas those enrolled in mid-pregnancy (19%) had two assessments (in mid- and 
late pregnancy) and those enrolled in late pregnancy (3%) had one assessment (in late 
pregnancy) planned. The individual time scheme of these assessments depended on 
the specifi c gestational age at enrolment [10]. Mothers enrolled after birth of their off -
spring (9%) had no prenatal assessments. All children were born between April 2002 and 
January 2006 and form a prenatally enrolled birth-cohort that is currently followed until 
young adulthood. Of all eligible children in the study area, 61% participated at birth in 
the study [10]. The study has been approved by the Medical Ethical Committee of the 
Erasmus Medical Center, Rotterdam. Written informed consent was obtained from all 
participants.
Maternal smoking
Information about maternal smoking was obtained by postal questionnaires in early, 
mid- and late pregnancy [10]. Maternal smoking at enrolment was assessed in the fi rst 
questionnaire by asking whether mother smoked in pregnancy (no, until pregnancy 
was known, continued after pregnancy was known). This questionnaire was sent to all 
mothers, independent of their gestational age at enrolment. In the second and third 
questionnaire, the mothers were asked whether they smoked in the past 2 months (no, 
yes) in mid- and late pregnancy, respectively. Mothers who reported in the fi rst question-
naire to have smoked until pregnancy was known (n = 861) but still reported to smoke in 
the second or third questionnaire (n = 270), were reclassifi ed into the ’continued smok-
ing after pregnancy was known’ category. The same strategy was used for mothers who 
reported not to smoke in the fi rst questionnaire (n = 5,372) but smoked in the second or 
third questionnaire (n = 83). Among the smoking mothers, the number of cigarettes was 
assessed in the following six categories: less than one per day; one to two per day; three 
to four per day; fi ve to nine per day; ten to nineteen per day; and twenty or more per day. 
To increase the number of subjects, these categories were combined and reclassifi ed 
into the following categories: 1) non-smoking; 2) less than fi ve cigarettes per day; 3) fi ve 
to nine cigarettes per day; and 4) ten or more cigarettes per day. 
Fetal ultrasound examinations
Fetal ultrasound examinations were carried out at the visits at one of the research cen-
ters in early, mid- and late pregnancy. These fetal ultrasound examinations were used for 
both establishing gestational age and assessing fetal growth characteristics. Gestational 
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age was established by fetal ultrasound examination because using last menstrual peri-
od has several limitations including the large number of women who do not know their 
exact last menstrual period date or have irregular menstrual cycles [11]. Pregnancy dat-
ing curves were constructed on subjects in the study with complete data on gestational 
age measured by ultrasound and last menstrual period. Crown-rump length was used 
for pregnancy dating until a gestational age of 12 weeks (crown-rump length smaller 
than 80 mm) and biparietal diameter was used for pregnancy dating thereafter (ges-
tational age from 12 weeks onwards, biparietal diameter larger than 20 mm) [12, 13]. 
Fetal growth measurements used for the present study included head circumference, 
abdominal circumference and femur length measured in mid- and late pregnancy. Early 
pregnancy was not included since these fetal ultrasound examinations were primarily 
performed to establish gestational age. Growth characteristics were measured to the 
nearest millimeter using standardized ultrasound procedures [14]. Gestational age 
adjusted standard deviation scores were constructed for all fetal growth measurements. 
These were based on reference growth curves from the whole study population. The 
median (95% range) gestational age for the fetal ultrasound examinations in early, mid- 
and late pregnancy was 13.1 (9.3 - 17.5) weeks, 20.5 (18.4 - 23.3) weeks and 30.4 (27.9 
- 33.0) weeks, respectively. For mothers who had more than one ultrasound examination 
in one of these periods, only the ultrasound examination closest to the median of these 
visits was included in the present study.
Covariates 
Information about educational level, ethnicity and parity was obtained by the fi rst ques-
tionnaire at enrolment in the study. Maternal anthropometrics, including height (m) and 
weight (kg), were measured without shoes and heavy clothing and body mass index was 
calculated (weight/height2 (kg/m2)) in early, mid- and late pregnancy during visits at the 
research center. 
Population for analysis 
Of the total of 9,778 mothers, 91% (n = 8,880) was enrolled in pregnancy [10]. Mothers 
without information about smoking in pregnancy in the fi rst questionnaire were exclud-
ed from the present study (14%, n = 1,249). Of the remaining 7,631 mothers, those with 
twin pregnancies (n = 81), fetal deaths (n = 100) or missing birth outcomes (n = 352) 
were excluded since main interest was in low risk singleton pregnancies. Categories of 
active smoking habits were similarly distributed at baseline among those with single-
ton live birth as pregnancy outcome and those lost to follow-up. The associations of 
maternal smoking habits during pregnancy with longitudinally measured fetal growth 
characteristics were analyzed in the remaining 7,098 mothers. Of these mothers, 4.1% 
were second (n = 284) or third (n = 6) pregnancies in the study. Since there were no 
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diff erences in results after exclusion of these subjects, they were included in the analy-
ses presented. Analyses focused on smoking categories in mid- and late pregnancy were 
restricted to mothers who enrolled in the study in early pregnancy (n = 5,502) to mini-
mize misclassifi cation of smoking in pregnancy period. Of these mothers, information 
about smoking and fetal growth was available in 85% (n = 4,655) in mid-pregnancy and 
in 83% (n = 4,542) in late pregnancy.
Data analysis
The associations between maternal smoking habits during pregnancy and repeatedly 
measured growth characteristics (head circumference, abdominal circumference, femur 
length) were analyzed using unbalanced repeated measurement analysis. The best 
fi tting models were constructed using fractional polynomials of gestational age [15]. 
Maternal smoking during pregnancy (no, until pregnancy was known, continued after 
pregnancy was known) was included in these models as interaction term with gesta-
tional age (p-value < 0.05). The models can be written as: 
Head circumference = β
0
 + β
1
*smoking + β
2
*gestational age2 + β
3
*gestational 
age2*ln(gestational age) + β
4
*smoking*gestational age.
Femur length = β
0
 + β
1
*smoking + β
2
*gestational age + β
3
*gestational age3 + 
β
4
*smoking*gestational age.
The model structure for abdominal circumference was similar as the model for head cir-
cumference. In these models, ‘β
0
 + β
1
*smoking’ refl ects the intercept and ‘β
2
*gestational 
age2 + β
3
*gestational age2*ln (gestational age)’ for head circumference and abdominal 
circumference and ‘β
2
*gestational age + β
3
*gestational age3’ for femur length refl ect 
the slope of growth per week. The terms including ‘β
4
’ refl ects the diff erences in growth 
of each fetal characteristic between the maternal smoking categories. All models were 
additionally adjusted for life style and socio-economic status related confounders 
(maternal body mass index, educational level) and other known determinants of fetal 
growth (maternal age, height, ethnicity and parity and fetal gender) [1]. Using the same 
strategy, additional models were constructed for standard deviation scores of these 
growth characteristics. The best fi tting model for these growth characteristics included 
the terms: 
Standard deviation score = β
0
 + β
1
*smoking + β
2
*gestational age + β
3
*gestational age-2 
+ β
4
*smoking*gestational age
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This model was used for head circumference, abdominal circumference and femur 
length. The associations of categories of the number of cigarettes smoked per day with 
these standard deviation scores in mid- and late pregnancy were assessed using mul-
tiple regression models.These models were adjusted for maternal body mass index and 
educational level and subsequently for maternal age, height, ethnicity and parity and 
fetal gender. All measures of association are presented with their 95% confi dence inter-
vals (CI). The statistical analyses were performed using the Statistical Analysis System 
version 8.2 (SAS, Stata corporation, College station, TX, USA), including the Proc Mixed 
module for unbalanced repeated measurements [16]. 
Results
Subject characteristics
Characteristics of the mothers per smoking category are presented in Table 1. Of all 
mothers, 25.5% (n = 1,809) reported to actively smoke in early pregnancy and 17.2% (n 
= 1,218) continued smoking after pregnancy was known. The age in the whole cohort 
ranged from 15.3 to 46.3 years with a mean of 29.8 years and was lowest in mothers who 
continued smoking after pregnancy was known. Also the percentage of mothers with 
higher educational level was lowest in this group. In the whole cohort, the largest ethnic 
groups were the Dutch and other-European (58.0%), Surinamese (9.1%), Turkish (9.1%) 
and Moroccan women (6.5%). Table 1 demonstrates that the percentages of Turkish 
mothers and Moroccan mothers were highest (16.2%) and lowest (1.9%), respectively, 
among those who continued smoking after pregnancy was known. Mean off spring birth 
weight was 3454 (SD 552) grams for mothers who did not smoke in pregnancy and 3251 
(SD 545) grams for mothers who continued smoking after pregnancy was known. 
Maternal smoking habits during pregnancy 
The associations between maternal smoking habits during pregnancy and longitudinally 
measured fetal growth characteristics are presented in Table 2. Compared to non-smok-
ing, smoking until pregnancy was known was not associated with growth diff erences 
in head circumference and femur length. Growth of the fetal abdominal circumference 
was higher among mothers who quitted smoking after their pregnancy was known 
compared to non-smokers (0.35 (95% CI: 0.05, 0.65) mm per week). In the fully adjusted 
models, continued smoking after pregnancy was known was inversely associated with 
fetal growth of the head circumference (-0.56 (95% CI: -0.73, -0.40) mm per week), 
abdominal circumference (-0.58 (95% CI: -0.81, -0.34) mm per week) and femur length 
(-0.19 (95% CI: -0.23, -0.14) mm per week). Figure 1 presents the estimated diff erences 
in standard deviation scores for fetal head circumference, abdominal circumference and 
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femur length between mothers who did not smoke in pregnancy and mothers who con-
tinued to smoke after pregnancy was known. Diff erences between non-smoking and 
continued smoking after pregnancy was known, increased with increasing gestational 
age for all three fetal growth characteristics. The largest eff ect was seen for femur length. 
No diff erences in fetal growth characteristics, expressed as standard deviation scores, 
were found between non-smoking mothers and mothers who smoked until pregnancy 
was known (not presented in Figure 1). 
Table 1. Maternal characteristics 
Smoking in pregnancy (n = 7,098)
Non-smoking
Until pregnancy 
was known
Continued after 
pregnancy was known
n = 5,289 n = 591 n = 1,218
Age (years) 30.1 (5.1) 29.4 (5.2) 28.3 (5.8)
Height (cm) 167.4 (7.5) 168.3 (7.0) 167.1 (7.0)
Weight (kg) 69.3 (13.2) 69.4 (12.8) 70.2 (14.0)
Body mass index (kg/m2) 24.7 (4.5) 24.5 (4.5) 25.2 (4.8)
Parity ≥ 1 (%) 45.2 31.7 45.7
Education (%)
 Primary school 10.6 12.2 21.0
 Secondary school 41.6 44.9 60.5
 Higher education 47.8 42.9 18.6
Ethnicity (%)
 Dutch, other-European 57.6 62.9 57.1
 Surinamese 8.4 12.4 10.4
 Turkish 7.7 7.5 16.2
 Moroccan 8.1 1.2 1.9
 Cape Verdian 3.7 4.6 4.8
 Antillean 3.4 2.9 3.8
 Others 11.0 8.5 5.8
1st Child of the same mother in study (%) 95.8 95.2 96.6
Enrolment in study in early pregnancy (%) 76.4 85.8 78.2
Ultrasound for fetal growth (%)
 Mid-pregnancy 93.8 96.6 94.0
 Late pregnancy 93.9 97.0 93.7
Birth outcomes
 Birth weight (grams) 3454 (552) 3441 (559) 3251 (545)
 Gestational age (weeks)* 40.0 (37.0 – 42.0) 40.0 (36.9 – 42.0) 39.9 (36.1 – 42.0)
Values are means (standard deviation) or percentages. * Median (90% range). Data were missing on height (n = 11), 
weight (n = 27), body mass index (n = 38), parity (n = 409), educational level (n = 218) and ethnicity (n =60).
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Table 2. Associations between maternal smoking habits during pregnancy and fetal growth 
Diff erence in head circumference growth  (mm/week)
Smoking category Model A Model B
Non-smoking Reference Reference
Until pregnancy was known 0.05 (-0.16, 0.26) 0.10 (-0.11, 0.31)
Continued after pregnancy was known -0.62 (-0.77, -0.46)** -0.56 (-0.73, -0.40)**
Diff erence in abdominal circumference growth (mm/week)
Smoking category Model A Model B
Non-smoking Reference Reference
Until pregnancy was known 0.23 (-0.07, 0.52) 0.35 (0.05, 0.65)*
Continued after pregnancy was known -0.68 (-0.90, -0.46)** -0.58 (-0.81, -0.34)**
Diff erence in femur length growth  (mm/week)
Smoking category Model A Model B
Non-smoking Reference Reference
Until pregnancy was known 0 (-0.06, 0.06) 0 (-0.05, 0.06)
Continued after pregnancy was known -0.18 (-0.22, -0.14)** -0.19 (-0.23, -0.14)**
Values are regression coeffi  cients (95% confi dence interval) and refl ect the diff erence in growth (mm/week) for 
each characteristic. 
Model A: unadjusted.
Model B: adjusted for maternal age, body mass index, height, educational level, ethnicity and parity and fetal 
gender.
*p-value < 0.05, **p-value < 0.01
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Figure 1. Standard deviation scores of fetal head circumference, abdominal circumference and femur length in 
mothers who continued to smoke after pregnancy was known
Values are estimates based on regression models (repeated measurements) and refl ect the standard deviation 
score for each growth characteristic in off spring of mothers who continued smoking after pregnancy was known 
compared to off spring of mothers who did not smoke in pregnancy.
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Mid-pregnancy and late pregnancy smoking categories 
Maternal smoking in mid-pregnancy was not associated with head circumference and 
abdominal circumference (Table 3). Smoking of less than fi ve cigarettes per day was 
associated with a smaller femur length (standard deviation score -0.12 (95% CI: -0.23, 
-0.01)). We did not fi nd an association between smoking fi ve to nine cigarettes per day 
and femur length. A strong inverse association with femur length was found for smoking 
more than nine cigarettes per day (standard deviation score -0.37 (95% CI: -0.55, -0.18)).
The associations of maternal smoking in late pregnancy with fetal growth characteris-
tics are given in Table 4. In the unadjusted models, all categories of maternal smoking were 
inversely associated with head circumference, abdominal circumference and femur length. 
For all three growth characteristics, the largest eff ect estimates were found for the high-
est smoking category, which includes mothers smoking more than 9 cigarettes per day 
(standard deviation scores -0.26 (95% CI: -0.45, -0.08) for head circumference, -0.25 (95% CI: 
-0.43, -0.06) for abdominal circumference and -0.40 (95% CI: -0.57, -0.22) for femur length).
Table 3. Associations of maternal smoking with fetal growth characteristics in mid-pregnancy (18-25 weeks) 
Diff erence in head circumference (standard deviation score)
Smoking in mid-pregnancy Model A Model B Model C
Non-smoking Reference Reference Reference
< 5 per day -0.14 (-0.25, -0.03)* -0.11 (-0.22, 0.01) -0.09 (-0.21, 0.02)
5 - 9 per day -0.10 (-0.24, 0.04) -0.05 (-0.20, 0.09) -0.04 (-0.19, 0.10)
> 9 per day -0.11 (-0.29, 0.07) -0.04 (-0.22, 0.15) -0.03 (-0.23, 0.16)
Diff erence in abdominal circumference (standard deviation score)
Smoking in mid-pregnancy Model A Model B Model C
Non-smoking Reference Reference Reference
< 5 per day -0.10 (-0.21, 0) -0.08 (-0.19, 0.03) -0.06 (-0.17, 0.05)
5 - 9 per day -0.03 (-0.16, 0.11) 0.02 (-0.12, 0.16) -0.01 (-0.15, 0.13)
> 9 per day 0 (-0.17, 0.17) 0.06 (-0.12, 0.24) 0.07 (-0.11, 0.25)
Diff erence in femur length (standard deviation score)
Smoking in mid-pregnancy Model A Model B Model C
Non-smoking Reference Reference Reference
< 5 per day -0.12 (-0.23, -0.02)* -0.13 (-0.24, -0.02)* -0.12 (-0.23, -0.01)*
5 - 9 per day 0 (-0.13, 0.14) -0.01 (-0.15, 0.13) -0.02 (-0.16, 0.12)
> 9 per day -0.31 (-0.49, -0.14)** -0.35 (-0.52, -0.17)** -0.37 (-0.55, -0.18)**
Values are regression coeffi  cients (95% confi dence interval) and refl ect the diff erence in growth characteristic (gestational 
age adjusted standard deviation score). 
Total number of subjects: n = 4,655; non-smoking: n = 3,940; less than fi ve per day: n = 376; fi ve to nine per day: n = 212; 
more than nine per day: n = 127. 
Model A: unadjusted.
Model B: adjusted for maternal body mass index and educational level.
Model B: adjusted for maternal body mass index, educational level, age, height, ethnicity and parity and fetal gender.
*p-value < 0.05, **p-value < 0.01
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Discussion
This population-based prospective cohort study showed associations between mater-
nal smoking in pregnancy and impaired growth of fetal head circumference, abdominal 
circumference and femur length. Diff erences between non-smoking mothers and moth-
ers who continued to smoke after pregnancy was known, increased with increasing ges-
tational age, resulting in smaller femur length from mid-pregnancy and smaller head 
circumference and abdominal circumference from late pregnancy.
Methodological considerations
The strength of this study is the population-based cohort with a large number of subjects 
studied from early pregnancy. To our knowledge, this is the largest cohort study examin-
Table 4. Associations of maternal smoking with fetal growth characteristics in late pregnancy (≥ 25 weeks) 
Diff erence in head circumference (standard deviation score)
Smoking in late pregnancy Model A Model B Model C
Non-smoking Reference Reference Reference
< 5 per day -0.24 (-0.35, -0.12)** -0.17 (-0.29, -0.05)** -0.17 (-0.29, -0.05)**
5 - 9 per day -0.15 (-0.29, -0.02)* -0.08 (-0.22, 0.06) -0.08 (-0.23, 0.06)
> 9 per day -0.29 (-0.47, -0.11)** -0.23 (-0.41, -0.05)* -0.26 (-0.45, -0.08)**
Diff erence in abdominal circumference (standard deviation score)
Smoking in late pregnancy Model A Model B Model C
Non-smoking Reference Reference Reference
< 5 per day -0.21 (-0.32, -0.10)** -0.18 (-0.30, -0.06)** -0.15 (-0.27, -0.03)*
5 - 9 per day -0.22 (-0.35, -0.08)** -0.17 (-0.31, -0.04)* -0.19 (-0.32, -0.05)**
> 9 per day -0.22 (-0.40, -0.05)* -0.19 (-0.37, -0.01)* -0.25 (-0.43, -0.06)**
Diff erence in femur length (standard deviation score)
Smoking in late pregnancy Model A Model B Model C
Non-smoking Reference Reference Reference
< 5 per day -0.16 (-0.26, -0.05)** -0.17 (-0.28, -0.06)** -0.17 (-0.29, -0.06)**
5 - 9 per day -0.28 (-0.41, -0.15)** -0.30 (-0.43, -0.17)** -0.29 (-0.42, -0.16)**
> 9 per day -0.41 (-0.58, -0.24)** -0.41 (-0.59, -0.24)** -0.40 (-0.57, -0.22)**
Values are regression coeffi  cients (95% confi dence interval) and refl ect the diff erence in growth characteristic 
(gestational age adjusted standard deviation score). 
Total number of subjects: n = 4,542; non-smoking: n = 3,864; less than fi ve per day: n = 322; fi ve to nine per day: n = 
225; more than nine per day: n = 131.
Model A: unadjusted.
Model B: adjusted for maternal body mass index and educational level.
Model B: adjusted for maternal body mass index, educational level, age, height, ethnicity and parity and fetal 
gender.
*p-value < 0.05, **p-value < 0.01 
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ing the associations of maternal smoking in pregnancy with fetal growth characteristics. 
Follow-up information at birth was available in 93% and information about a large num-
ber of potential confounders was available in this study. Information about smoking in 
pregnancy at enrolment was missing in 14% of all mothers. Birth weight was 41 (95% CI: 
6, 76) grams lower in the off spring of these mothers. The percentage of smoking moth-
ers may be higher among those not included than included in the present analysis. This 
would probably lead to loss of power and underestimation of the estimated eff ects of 
smoking on fetal growth characteristics. Categories of maternal smoking habits at base-
line were similarly distributed among those lost to follow-up and those with singleton 
live births as outcome. Non-response and loss to follow-up would lead to selection bias 
if the association of maternal smoking in pregnancy with fetal growth diff ers between 
those with and without complete data. This seems unlikely but can not be excluded. 
Information about maternal smoking in pregnancy was collected by questionnaires 
without reference to fetal growth characteristics. Although assessing smoking habits in 
pregnancy by questionnaires seems to be a valid method, misclassifi cation may occur 
[17]. Underreporting of maternal smoking across the various smoking categories may 
be present and would lead to misclassifi cation. The estimated diff erence in fetal growth 
between the off spring of non-smoking and low to moderate smoking mothers would 
be overestimated if this underreporting would be selectively present among heavy 
smoking mothers who report low to moderate smoking. To overcome these limitations, 
other studies used biomarkers of tobacco exposure, including cotinine, in maternal 
urine samples [18, 19]. However, low correlations between cotinine and self reported 
smoking habits have been demonstrated [20]. Possible explanations for these low cor-
relations include inaccurate maternal reporting of smoking habits in pregnancy, use of 
categories of number of cigarettes smoked in questionnaires and individual diff erences 
in inhalation, absorption and metabolism. Previous studies demonstrated that using 
cotinine levels is not superior to self-report in studying the eff ect of maternal smoking in 
pregnancy on birth weight [21]. We assessed smoking as categorical and not as continu-
ous variable since data collection and data cleaning are more easily conducted in such 
a large cohort. Inherently, this diminishes power to identify exposure eff ects because 
information within categories is lost. 
Smoking in pregnancy and fetal growth patterns
The associations of continued maternal smoking after pregnancy was known with 
growth of fetal head circumference, abdominal circumference and femur length were 
independent of potential confounders. No adverse eff ects on fetal growth were found in 
mothers who quitted smoking after their pregnancy was known. Unexpectedly, a higher 
fetal abdominal circumference growth was found in mothers who quitted smoking after 
pregnancy was known, compared to non-smokers. These fi ndings are in line with previ-
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ous studies demonstrating associations of continued maternal smoking in pregnancy 
with low birth weight in the off spring whereas quitting to smoke in early pregnancy is 
associated with a normal or even slightly increased birth weight [2, 22]. This second asso-
ciation seems not to be explained by an increase in body mass index [22]. The number of 
studies examining the eff ects of maternal smoking in pregnancy on fetal growth is limit-
ed [3-8]. Results from these studies are not conclusive and cannot easily be compared to 
our results because of the diff erences in study populations and growth measurements. 
More importantly, results from these studies were not appropriately adjusted for pos-
sible confounders. After full adjustment for life style and socio-economic status related 
variables, including maternal body mass index and educational level, and for known 
determinants of birth weight, including maternal age, height, ethnicity and parity and 
fetal gender, our study demonstrated strong associations of maternal smoking with 
femur length from mid-pregnancy onwards and of maternal smoking with head circum-
ference and abdominal circumference from late pregnancy. These fi ndings are in line 
with studies demonstrating that maternal smoking in the third trimester has the largest 
eff ect on birth weight in the off spring [23]. From the analyses with standard deviation 
scores as dependent variables, both the timing of the eff ect and the eff ect estimate sug-
gest that maternal smoking in pregnancy primarily aff ects femur length. This supports 
the previously described brain-sparing eff ects in mild fetal growth retardation. The rela-
tively stronger eff ect on femur length may indicate that maternal smoking in pregnancy 
or the fetal growth patterns associated with maternal smoking aff ect peripheral tissues 
and less so central tissues. Abdominal circumference was not more aff ected than head 
circumference. Further studies examining the eff ect of maternal smoking in pregnancy 
on fetal organ growth in especially late pregnancy are needed. 
Study implications
Our fi ndings suggest that maternal smoking in pregnancy leads to impaired growth of 
fetal head circumference, abdominal circumference and femur length. Maternal smok-
ing until pregnancy was known and quitting thereafter did not adversely aff ect fetal 
growth. The larger eff ects on femur length suggest that maternal smoking in pregnancy 
aff ects primarily peripheral tissues.
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Abstract
Background: The eff ect of low to moderate alcohol consumption in pregnancy on fetal 
growth is not clear. The aims of this study were to examine the associations of maternal 
alcohol consumption in diff erent periods of pregnancy with the risk of low birth weight 
and preterm birth. 
Methods: This study was embedded in the Generation R Study, a population-based 
prospective cohort study from fetal life until adulthood. Maternal alcohol consumption 
was assessed by questionnaires in early pregnancy, mid-pregnancy and late pregnancy. 
The present analysis was based on 7,141 subjects.
Results: Compared to no alcohol consumption, continued alcohol consumption after 
pregnancy was known, was not associated with low birth weight (adjusted odds ratio 
0.99 (95% confi dence interval: 0.79, 1.24)) or preterm birth (adjusted odds ratio 0.90 
(95% confi dence interval: 0.69, 1.16)). For both alcohol consumption until pregnancy 
was known and alcohol consumption in late pregnancy (gestational age ≥ 25 weeks), 
using less than one alcoholic drink per day was not associated with an increased risk of 
low birth weight and preterm birth. Alcohol consumption of one to three drinks per day 
until pregnancy was known, was associated with low birth weight (adjusted odds ratio 
2.28 (95% confi dence interval: 0.70, 7.36)) and preterm birth (adjusted odds ratio 2.46 
(95% confi dence interval: 0.82, 7.38)). Due to small numbers in these categories, these 
eff ect estimates were not statistically signifi cant. 
Conclusion: Maternal consumption of less than one alcoholic drink per day in early 
and late pregnancy is not associated with an increased risk of low birth weight and pre-
term birth. The eff ects of higher alcohol consumption need to be further studied.
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Introduction
Excessive alcohol consumption in pregnancy is associated with various pregnancy 
complications including low birth weight, preterm birth, congenital anomalies, fetal 
alcohol syndrome and perinatal death [1-3]. Recently, it was suggested that excessive 
alcohol consumption in pregnancy has adverse eff ects on postnatal neurodevelopment 
in children [4]. The eff ect of excessive alcohol consumption in pregnancy on prenatal 
and postnatal growth and development can not easily be extrapolated to lower levels of 
alcohol consumption. Previous studies examining the eff ect of low or moderate alcohol 
consumption in pregnancy (less than one alcoholic drink per day) on birth outcomes 
showed inconsistent results. Several studies found adverse eff ects, whereas others did 
not fi nd any eff ect or even reported benefi cial eff ects on weight and gestational age at 
birth [5-8]. These inconsistent results may be due to diff erences in study design and in 
the timing and methods of assessment of alcohol consumption. Several studies used 
dichotomized birth outcomes including low birth weight and preterm birth [7, 9]. How-
ever, the eff ect on birth weight may be present on the whole birth weight range and not 
only on low birth weight, mostly defi ned as a birth weight lower than 2500 grams. 
In a population-based cohort study among pregnant women and their children, 
we examined the associations of maternal alcohol consumption in diff erent periods 
of pregnancy with continuously measured birth weight and with the risk of low birth 
weight and preterm birth. 
Methods
Design
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life until young adulthood. This study is designed to identify early 
environmental and genetic determinants of growth, development and health in fetal life, 
childhood and adulthood and has been described previously in detail [10, 11]. Briefl y, 
the cohort includes 9,778 mothers and their children of diff erent ethnicities living in Rot-
terdam, the Netherlands. Enrolment was aimed in early pregnancy (gestational age < 18 
weeks) but was possible until birth of the child. Mothers were informed about the study 
by routine health care workers in pregnancy (midwives, obstetricians) and were enrolled 
in the study at their routine fetal ultrasound examination in pregnancy. Mothers who were 
missed in pregnancy, were approached and enrolled in the fi rst month after birth of their 
child at the routine child health centers. Assessments in pregnancy, including physical 
examinations, fetal ultrasound examinations and questionnaires, were planned in early 
pregnancy (gestational age < 18 weeks), mid-pregnancy (gestational age 18-25 weeks) 
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and late pregnancy (gestational age ≥ 25 weeks). Mothers enrolled in early pregnancy 
(69%) had three assessments planned (in early, mid- and late pregnancy) whereas those 
enrolled in mid-pregnancy (19%) had two assessments (in mid- and late pregnancy) and 
those enrolled in late pregnancy (3%) had one assessment (in late pregnancy) planned. 
The individual time scheme of these assessments depended on the specifi c gestational 
age at enrolment [11]. Mothers enrolled after birth of their off spring (9%) had no prena-
tal assessments. All children were born between April 2002 and January 2006 and form 
a prenatally enrolled birth-cohort that is currently followed until young adulthood. Of all 
eligible children in the study area, 61% participated at birth in the study [11]. The study 
has been approved by the Medical Ethical Committee of the Erasmus Medical Center, 
Rotterdam. Written informed consent was obtained from all participants.
Maternal alcohol consumption
Information about maternal alcohol consumption was obtained by postal questionnaires 
in early, mid- and late pregnancy [10]. In the fi rst questionnaire, the mothers were asked 
whether they used any alcoholic drinks in the fi rst three months of pregnancy (no, until 
pregnancy was known, continued after pregnancy was known). This questionnaire was 
sent to all mothers, also when they were enrolled after early pregnancy. In the second 
and third questionnaire, sent to the mothers in mid- and late pregnancy respectively, 
the mothers were asked whether they used alcoholic drinks in the past two months (no, 
yes). Mothers who reported in the fi rst questionnaire to have used alcoholic drinks until 
pregnancy was known (n = 2,061) but still reported to use alcoholic drinks in the second 
or third questionnaire (n = 1,106) were reclassifi ed into the ‘continued after pregnancy 
was known’ category. The same strategy was used for mothers who reported not to use 
alcoholic drinks in the fi rst questionnaire (n = 4,072), but used alcoholic drinks in the 
second or third questionnaire (n = 549). Among the mothers who reported to use any 
alcoholic drinks, the average number of drinks was assessed in the following six catego-
ries: less than one per week; one to three per week; four to six per week; one per day; two 
to three per day; and more than three per day. For each questionnaire, this information 
was combined and reclassifi ed into the following categories of maternal alcohol con-
sumption: 1) never; 2) less than one drink per week; 3) one to six drinks per week; and 
4) one to three drinks per day. Because of the small number of subjects using more than 
three alcoholic drinks per day (n = 12 in early pregnancy, n = 8 in mid-pregnancy and n 
= 6 in late pregnancy), this category was not included in the present analyses. 
Covariates 
Information about educational level, ethnicity and parity was obtained by the fi rst 
questionnaire at enrolment in the study. Maternal smoking habits were assessed in each 
questionnaire. Maternal anthropometrics, including height and weight, were measured 
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without shoes and heavy clothing and body mass index was calculated (weight/height2 
(kg/m2)) in early, mid- and late pregnancy during visits at the research center. 
Birth outcomes
Date of birth, birth weight and gender were obtained from midwife and hospital reg-
istries. Gestational age was established by fetal ultrasound examination because using 
last menstrual period has several limitations including the large number of women who 
do not know their exact last menstrual period date or have irregular cycles [12].
Population for analysis 
Of the total of 9,778 mothers, 91% (n = 8,880) was enrolled in pregnancy [11]. Those 
without information about alcohol consumption in pregnancy in the fi rst questionnaire 
were excluded from the analyses (14%, n = 1,204). Of the remaining 7,676 mothers, 
those with twin pregnancies (n = 81), fetal deaths (n = 100) or missing birth outcomes (n 
= 354) were excluded. The associations of maternal alcohol consumption in pregnancy 
with birth outcomes were analyzed in the remaining 7,141 mothers. Of these mothers, 
4% (n = 292) were second or third pregnancies in the study. Since there were no diff er-
ences in results after exclusion of these subjects, they were included in the analyses 
presented. Analyses focused on alcohol consumption in diff erent periods of pregnancy 
were restricted to mothers enrolled in early pregnancy to minimize misclassifi cation of 
alcohol consumption in pregnancy period. Alcohol consumption categories within indi-
viduals were correlated between early and mid-pregnancy (Spearman correlation coef-
fi cient r = 0.6, p < 0.01) and between mid- and late pregnancy (r = 0.7, p < 0.01). Since we 
did not have enough mothers to assess the separate eff ects of each pregnancy period, 
analyses were focused on early pregnancy (alcohol consumption until pregnancy was 
known) and late pregnancy. Among mothers enrolled in early pregnancy (n = 5,533), the 
associations of maternal alcohol consumption until pregnancy was known with birth 
outcomes were assessed in those in whom information about the number of alcoholic 
drinks was available and did not use alcoholic drinks after pregnancy was known (n = 
3,538). Among mothers enrolled in early pregnancy, information about the number of 
alcoholic drinks in late pregnancy was available in 83% (n = 4,589).
Data analysis
The associations of alcohol consumption habits at any time during pregnancy with con-
tinuously measured birth weight were assessed using multiple linear regression models 
and with low birth weight and preterm birth using multiple logistic regression models. 
Low birth weight was defi ned as birth weight below the 10th percentile in the study cohort 
(2850 grams) among infants born at a gestational age of 37 weeks or more. Preterm born 
children were excluded from the models with low birth weight as dependent variable. 
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Preterm birth was defi ned as a gestational age of less than 37 weeks at delivery. These 
linear and logistic regressions were adjusted for life style and socio-economic status 
related variables at enrolment (maternal body mass index, smoking, educational level) 
and additionally for known determinants of low birth weight and preterm birth (maternal 
ethnicity, parity and age and infant gender). In these models, smoking and body mass 
index were measured in the same period of pregnancy as maternal alcohol consumption. 
All models with low birth weight and continuously measured birth weight as dependent 
variable were additionally adjusted for gestational age. The same models were used 
to assess the associations of alcohol consumption categories in separate periods (until 
pregnancy was known, late pregnancy) with continuously measured birth weight, low 
birth weight and preterm birth. All measures of association are presented with their 95% 
confi dence intervals (CI). All statistical analyses were performed using the Statistical Pack-
age of Social Sciences version 11.0 for Windows (SPSS Inc, Chicago, IL, USA).
Results
Characteristics of the mothers are presented in Table 1. Of all mothers, 51% (n = 3,618) 
used alcoholic drinks in early pregnancy and 37% (n = 2,663) continued to use alcoholic 
drinks after pregnancy was known. In the total group, the age of mothers ranged from 
15.3 to 43.3 years with a mean age of 29.8 years. The percentage of mothers with a higher 
educational level was highest among those who continued to use alcoholic drinks after 
pregnancy was known. In the total cohort, the largest ethnic groups were the Dutch 
and other-European (57.8%), Surinamese (9.1%), Turkish (9.1%) and Moroccan (6.5%) 
mothers. Among the mothers who continued to use alcoholic drinks after pregnancy 
was known, the percentage of Dutch mothers was higher than among the mothers who 
did not use alcoholic drinks in pregnancy. Mean birth weight in the singleton live births 
was 3417 (range 670 - 5310) grams. Among the children born with a gestational age of 
more than 37 weeks (n = 6,727), 10.2% was defi ned as low birth weight. Gestational age 
at birth ranged from 25.4 until 43.1 weeks with a median of 40.0 weeks. Of all singleton 
live births, 5.8% was born before a gestational age of 37 weeks. 
Table 2 demonstrates that compared to never using alcohol in pregnancy, alco-
hol consumption until pregnancy was known, was not associated with a diff erence in 
continuously measured birth weight (diff erence -22 (95% CI: -54, 11) grams)), low birth 
weight (adjusted odds ratio (aOR) 1.20 (95% CI: 0.92, 1.57)) and preterm birth (aOR 0.87 
(95% CI: 0.63, 1.21)). Continued alcohol consumption after pregnancy was known, was 
associated with continuously measured birth weight in the model adjusted for gesta-
tional age, maternal body mass index, smoking and educational level (diff erence 47 
(95% CI: 22, 72) grams). This association disappeared after further adjustment for mater-
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nal ethnicity, parity, age and height and infant gender (diff erence 2 (95% CI: -23, 27) 
grams). Continued maternal alcohol consumption after pregnancy was known, was not 
associated with low birth weight (aOR 0.99 (95% CI: 0.79, 1.24)) or preterm birth (aOR 
0.90 (95% CI: 0.69, 1.16)). 
Among mothers who used alcoholic drinks until pregnancy was known, no diff er-
ences in continuously measured birth weight were found for all categories of number 
of alcoholic drinks compared to mothers who never used alcoholic drinks in pregnancy 
Table 1. Maternal characteristics according to their alcohol consumption habits in pregnancy
Alcohol consumption in pregnancy (n = 7,141)
Never in pregnancy
Until pregnancy 
was known
Continued after 
pregnancy was known
n = 3,523 n = 955 n = 2,663
Age (years) 28.4 (5.3) 29.5 (5.2) 31.6 (4.7)
Height (cm) 165.5 (7.3) 168.1 (7.1) 169.6 (6.9)
Weight (kg) 70.0 (14.4) 68.6 (12.9) 69.0 (11.8)
Body mass index (kg/m2) 25.5 (4.9) 24.3 (4.3) 24.0 (3.8)
Parity ≥ 1 (%) 47.8 31.4 44.1
Smoking in pregnancy (%)
 No 79.4 65.8 71.3
 Until pregnancy was known 4.3 17.0 10.4
 Continued 16.2 17.2 18.2
Education (%)
 Primary school 19.4 6.7 5.8
 Secondary school 55.0 47.6 31.5
 Higher education 25.5 45.7 62.8
Ethnicity (%)
 Dutch, other-European 41.1 68.4 76.0
 Surinamese 10.5 11.2 6.5
 Turkish 16.7 1.8 1.7
 Moroccan 12.8 0.3 0.6
 Cape Verdian 4.3 5.4 3.2
 Antillean 3.9 3.8 2.7
 Others 10.8 9.0 9.3
1st Child of the same mother in study (%) 95.6 95.0 96.5
Enrolment in study in early pregnancy (%) 72.2 85.4 81.7
Birth outcomes
 Birth weight (grams) 3395 (552) 3351 (573) 3470 (556)
 Gestational age (weeks)* 40.0 (36.7 – 42.0) 39.9 (36.4 – 41.9) 40.1 (37.0 – 42.0)
Values are means (standard deviation) or percentages. * Median (90% range). Data were missing on height (n = 11), 
weight (n = 27), body mass index (n = 38), parity (n = 419), smoking in pregnancy (n = 62), educational level (n = 
223) and ethnicity (n =61).
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(Table 3). No consistent associations of using less than one alcoholic drink per day with 
low birth weight and preterm birth were found. Associations were found between alco-
hol consumption of one to three drinks per day and low birth weight (aOR 2.28 (95% CI: 
0.70, 7.36)) and preterm birth (aOR 2.46 (95% CI: 0.82, 7.38)). Due to the small number of 
subjects in these categories (n = 27 for low birth weight, n = 31 for preterm birth), these 
eff ects were not statistically signifi cant.
Table 4 shows that alcohol consumption of less than one drink per week and one to 
six drinks per week in late pregnancy was not associated with a diff erence in continu-
ously measured birth weight. Although statistically not signifi cant, alcohol consumption 
Table 2. Associations of alcohol consumption habits in pregnancy with birth outcomes
Diff erence in birth weight (grams) a
Alcohol consumption 
n = 7,141
Model A Model B Model C
Never in pregnancy
n = 3,523
Reference Reference Reference
Until pregnancy was known 
n = 955
-16 (-49, 16) -11 (-44, 22) -22 (-54, 11)
Continued after pregnancy was known 
n = 2,663
46 (24, 69)** 47 (22, 72)** 2 (-23, 27)
Odds ratio for low birth weight b
Alcohol consumption 
n = 6,727 c
Model A Model B Model C
Never in pregnancy
n = 3,308
Reference Reference Reference
Until pregnancy was known 
n = 896
1.18 (0.94, 1.50) 1.16 (0.91, 1.48) 1.20 (0.92, 1.57)
Continued after pregnancy was known 
n = 2,523
0.86 (0.71, 1.03) 0.85 (0.69, 1.04) 0.99 (0.79, 1.24)
Odds ratio for preterm birth b
Alcohol consumption 
n = 7,141
Model A Model B Model C
Never in pregnancy
n = 3,523
Reference Reference Reference
Until pregnancy was known 
n = 955
1.01 (0.75, 1.36) 0.95 (0.69, 1.30) 0.87 (0.63, 1.21)
Continued after pregnancy was known 
n = 2,663
0.85 (0.69, 1.06) 0.82 (0.64, 1.05) 0.90 (0.69, 1.16)
a Values are regression coeffi  cients (95% confi dence interval) and number of subjects per alcohol consumption 
category. b Values are odds ratios (95% confi dence interval) and number of subjects per alcohol consumption 
category. c Preterm born children excluded. Model A: unadjusted; Model B: adjusted for maternal body mass index, 
smoking, educational level; Model C: adjusted for maternal body mass index, smoking, educational level, height, 
ethnicity, parity and age and infant gender. All models with birth weight and low birth weight as dependent 
variable are additionally adjusted for gestational age.
**p-value < 0.01
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of one to three drinks per day was associated with a decrease in birth weight (-118 (95% 
CI: -300, 65) grams). No associations were found for alcohol consumption of less than 
one drink per week with low birth weight and preterm birth. Using one to six alcoholic 
drinks per week was inversely associated with preterm birth but the estimate was not 
statistically signifi cant after adjustment (aOR 0.57 (95% CI: 0.30, 1.08)). No association 
was found for low birth weight. Using one to three alcoholic drinks per day was associ-
ated with an increased risk of low birth weight but the eff ect was not signifi cant. No 
association was present with preterm birth.
Table 3. Associations of alcohol consumption categories until pregnancy was known with birth outcomes
Diff erence in birth weight (grams) a
Alcohol consumption 
until pregnancy was known
n = 3,358
Model A Model B Model C
< 1 drink per week
n = 481
-23 (-67, 21) -23 (-67, 22) -23 (-66, 21)
1 - 6 drinks per week
n = 305
15 (-39, 68) 27 (-27, 82) 5 (-49, 59)
1 - 3 drinks per day 
n = 31
-50 (-210, 109) -79 (-241, 83) -126 (-279, 27)
Odds ratio for low birth weight b
Alcohol consumption 
until pregnancy was known
n = 3,138 c
Model A Model B Model C
< 1 drink per week
n = 454
0.97 (0.70, 1.35) 1.00 (0.71, 1.41) 1.00 (0.69, 1.45)
1 - 6 drinks per week
n = 287
0.96 (0.64, 1.44) 0.94 (0.61, 1.46) 0.99 (0.62, 1.60)
1 - 3 drinks per day 
n = 27
1.65 (0.53, 5.08) 1.88 (0.60, 5.92) 2.28 (0.70, 7.36)
Odds ratio for preterm birth b
Alcohol consumption 
until pregnancy was known
n = 3,358
Model A Model B Model C
< 1 drink per week
n = 481
0.92 (0.60, 1.39) 0.92 (0.61, 1.43) 0.81 (0.51, 1.28)
1 - 6 drinks per week
n = 305
0.97 (0.58, 1.60) 0.82 (0.48, 1.42) 0.82 (0.47, 1.43)
1 - 3 drinks per day 
n = 31
2.28 (0.79, 6.60) 2.31 (0.79, 6.80) 2.46 (0.82, 7.38)
a Values are regression coeffi  cients (95% confi dence interval) and number of subjects per alcohol consumption 
category. b Values are odds ratios (95% confi dence interval) and number of subjects per alcohol consumption 
category. c Preterm born children excluded. Reference groups are mothers who do not use alcoholic drinks. Model 
A: unadjusted; Model B: adjusted for maternal body mass index, smoking, educational level; Model C: adjusted 
for maternal body mass index, smoking, educational level, height, ethnicity, parity and age and infant gender. All 
models with birth weight and low birth weight as dependent variable are additionally adjusted for gestational age.
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Discussion
This population-based prospective cohort study showed that maternal alcohol con-
sumption of less than one drink per day is not associated with an increased risk of low 
birth weight and preterm birth. Adverse associations were found for alcohol consump-
tion of one to three drinks per day. 
Table 4. Associations of alcohol consumption categories in late pregnancy with birth outcomes
Diff erence in birth weight (grams) a
Alcohol consumption 
in late pregnancy
n = 4,589
Model A Model B Model C
< 1 drink per week
n = 1,229
53 (23, 83)** 42 (11, 73)** -6 (-36, 25)
1 - 6 drinks per week
n = 436
74 (28, 119)** 54 (7, 100)* 5 (-40, 49)
1 - 3 drinks per day 
n = 21
-72 (-266, 122) -87 (-276, 103) -118 (-300, 65)
Odds ratio for low birth weight b
Alcohol consumption 
in late pregnancy
n = 4,351c
Model A Model B Model C
< 1 drink per week
n = 1,165
0.80 (0.62, 1.03) 0.85 (0.65, 1.10) 1.07 (0.80, 1.43)
1 - 6 drinks per week
n = 425
0.67 (0.44, 1.03) 0.76 (0.49, 1.17) 0.90 (0.56, 1.45)
1 - 3 drinks per day 
n = 20
1.69 (0.46, 6.15) 1.80 (0.48, 6.78) 1.89 (0.38, 9.31)
Odds ratio for preterm birth b
Alcohol consumption 
in late pregnancy
n = 4,589
Model A Model B Model C
< 1 drink per week
n = 1,229
0.93 (0.69, 1.25) 0.99 (0.72, 1.36) 1.09 (0.78, 1.52)
1 - 6 drinks per week
n = 436
0.44 (0.24, 0.81)** 0.49 (0.26, 0.92)* 0.57 (0.30, 1.08)
1 - 3 drinks per day 
n = 21
0.85 (0.11, 6.34) 0.93 (0.12, 7.03) 1.20 (0.16, 9.17)
a Values are regression coeffi  cients (95% confi dence interval) and number of subjects per alcohol consumption 
category. b Values are odds ratios (95% confi dence interval) and number of subjects per alcohol consumption 
category. c Preterm born children excluded. Reference groups are mothers who do not use alcoholic drinks. Model 
A: unadjusted; Model B: adjusted for maternal body mass index, smoking, educational level; Model C: adjusted 
for maternal body mass index, smoking, educational level, height, ethnicity, parity and age and infant gender. All 
models with birth weight and low birth weight as dependent variable are additionally adjusted for gestational age.
*p-value < 0.05, **p-value < 0.01
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Methodological considerations
The strength of this study is the population-based cohort with a large number of subjects 
studied from early pregnancy and the availability of a large number of potential con-
founders. A potential limitation of this study is that information about maternal alcohol 
consumption was missing in 14% of all mothers that were enrolled in pregnancy in the 
cohort. Birth weight was slightly lower in the off spring of mothers without information 
about alcohol consumption in pregnancy (diff erence -35 (95% CI: -71, 1) grams). Of all 
mothers enrolled in pregnancy, information at birth was available for 93%. Categories of 
maternal alcohol consumption at baseline were similarly distributed among those with 
singleton live birth as pregnancy outcome and those lost to follow-up. Selection bias 
due to non-response or loss to follow-up would be present if the associations of mater-
nal alcohol consumption in pregnancy with the birth outcomes diff er between those 
with and without complete data. This seems unlikely but cannot be excluded. However, 
relatively more incomplete data among the mothers of infants with low birth weight 
may have introduced less power. 
Information about maternal alcohol consumption in pregnancy was collected by 
postal questionnaires. Using self-reported alcohol consumption may have introduced 
misclassifi cation mainly because of underreporting of alcohol consumption in preg-
nancy [13]. If this underreporting were present across all categories of alcohol consump-
tion, the eff ect estimates would be underestimated. However, if selectively mothers with 
heavy alcohol consumption underreport the number of drinks, the diff erences between 
no alcohol consumption and the lower categories of alcohol consumption may be 
overestimated. This misclassifi cation may be prevented by using objective measures of 
alcohol consumption. However, current available biomarkers of alcohol consumption, 
including carbohydrate-defi cient transferrin and gamma-glutamyl transferase, are not 
appropriate for assessment of light to moderate alcohol consumption [14]. 
Low birth weight and preterm birth 
We found no adverse eff ects of maternal alcohol consumption of less than one drink 
per day in pregnancy on weight and gestational age at birth. For alcohol consumption 
until pregnancy was known, using one to three drinks per day was associated with an 
increased risk of low birth weight and preterm birth. However, due to small numbers in 
this category in our study, no conclusions can be drawn.
Our results are in line with previous studies that demonstrated no adverse eff ects of 
light to moderate alcohol consumption in pregnancy on the risk of low birth weight and 
preterm birth in the off spring [3, 7-9, 15-17]. Although these studies measured maternal 
alcohol consumption in diff erent units including the number of drinks, milliliters and 
grams, tendencies of the relationships in these studies were similar [7-9, 15]. Lundsberg 
et al. demonstrated a benefi cial eff ect of low to moderate alcohol consumption on fetal 
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growth retardation [7]. They suggested a J-shaped relation between maternal alcohol 
consumption and fetal growth retardation. Other studies that demonstrated benefi cial 
eff ects of low to moderate alcohol consumption on birth weight, were not able to adjust 
appropriately for potential confounders [15]. Previous inconsistent results from studies 
assessing the associations of low to moderate maternal alcohol consumption in preg-
nancy with birth weight, may be explained by methodological issues including diff er-
ences in assessments of maternal alcohol consumption habits, the inability to examine 
the eff ect of alcohol consumption in diff erent periods of pregnancy and the inability 
to adjust for potential confounders. In our study, it turned out that continued alcohol 
consumption after pregnancy was known, was associated with determinants of higher 
birth weight (maternal height, higher educational level and Dutch ethnicity). Previous 
reported benefi cial eff ects may be partly explained by residual confounding due to 
unmeasured socio-economic factors and life style habits related to birth weight [18]. 
However, like maternal smoking habits, body mass index and ethnicity, moderate alco-
hol consumption may also be part of the biological pathways explaining the association 
between maternal socio-economic status and birth weight [19]. Studies identifying the 
biological pathways and their etiologic fractions underlying the association between 
maternal socio-economic status and birth weight and whether moderate alcohol con-
sumption in pregnancy is part of this pathway, are necessary.  
Main outcomes in our study were continuously measured birth weight, low birth 
weight and preterm birth. These outcomes are rather crude measures of fetal growth 
and development. Moreover, alcohol consumption may aff ect fetal organ development 
without any eff ect on birth weight. Therefore further studies examining the associations 
of low to moderate alcohol consumption with fetal and postnatal growth and develop-
ment are needed.
Study implications
Our fi ndings suggest that maternal consumption of less than one alcoholic drink per day 
in early and late pregnancy is not associated with an increased risk of low birth weight 
and preterm birth. Before developing new public health strategies focused on alcohol 
consumption in pregnancy, follow-up studies are needed to assess the associations of 
low to moderate alcohol consumption with postnatal growth and development.
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Abstract
Background: It has been suggested that left ventricular hypertrophy partly originates in 
early life. The aim of this study was to examine the associations of fetal growth charac-
teristics and characteristics at birth with left cardiac structure in early infancy.
Methods: This study was embedded in the Generation R Study, a population-based pro-
spective cohort study from fetal life until adulthood. Fetal growth (head circumference, 
abdominal circumference and femur length) was assessed by ultrasound examinations 
in mid-pregnancy (gestational age 18 - 25 weeks) and late pregnancy (gestational age 
≥ 25 weeks). Echocardiographic measurements were performed in a subgroup of 791 
infants aged 7 (95% range: 4.4 - 12.3) weeks.
Results: We did not fi nd associations of mid-pregnancy growth characteristics with 
postnatal left cardiac structures. In late pregnancy, fetal abdominal circumference was 
positively associated with left ventricular mass (0.33 (95% confi dence interval: 0.06, 
0.61) grams per standard deviation score) and aortic root diameter (0.13 (95% confi -
dence interval: 0.03, 0.22) mm per standard deviation score). Birth weight was positively 
associated with aortic root diameter (0.21 (95% confi dence interval: 0.07, 0.34) mm per 
standard deviation score). These eff ect estimates were adjusted for age, gender and 
infant weight and length. 
Conclusion: Our fi ndings suggest that smaller fetal size in late pregnancy is associated 
with smaller left ventricular mass and aortic root diameter in early infancy. Further stud-
ies should examine whether these changes persist with increasing age. 
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Introduction
The fetal origins hypothesis postulates that an adverse fetal environment leads to devel-
opmental adaptations that permanently program the fetus’ structure, physiology and 
metabolism [1]. This programming would be in favour of short-term survival and would 
lead to fetal growth retardation and low birth weight. Long-term eff ects of this pro-
gramming would be detrimental and lead to cardiovascular disease. This hypothesis is 
supported by epidemiological studies that have consistently demonstrated associations 
of low birth weight with coronary heart disease and its risk factors [2, 3]. The most com-
monly studied risk factors are blood pressure and total cholesterol levels [4, 5].
Left ventricular hypertrophy is a strong and independent risk factor of cardiovas-
cular morbidity and mortality [6]. An adverse environment in fetal or early postnatal 
life may aff ect left ventricular growth and development since the human heart has its 
highest growth rate in these periods [7]. Only few studies examined the associations of 
weight in early life with left ventricular mass in adulthood [8, 9]. These studies demon-
strated that low weight in infancy is associated with an increased left ventricular mass 
in adulthood and suggested that left ventricular hypertrophy originates at least partly 
in early life. To our knowledge, no previous studies have examined the associations of 
fetal growth characteristics with postnatal left ventricular mass in healthy children or 
adults. This information may be relevant for identifying critical periods in fetal life for left 
ventricular growth and development.
Therefore, we examined in a population-based prospective cohort study the asso-
ciations of fetal growth characteristics and characteristics at birth with left cardiac struc-
ture in early infancy.
Methods
Design
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life until young adulthood. This study is designed to identify 
early environmental and genetic determinants of growth, development and health in 
fetal life, childhood and adulthood and has been described previously in detail [10, 11]. 
Briefl y, the cohort includes 9,778 mothers and their children of diff erent ethnicities liv-
ing in Rotterdam, the Netherlands. Enrolment was aimed in early pregnancy (gestational 
age < 18 weeks) but was possible until birth of the child. Mothers were informed about 
the study by routine health care workers in pregnancy (midwives, obstetricians) and 
were enrolled at their routine fetal ultrasound examination in pregnancy. Mothers who 
were missed in pregnancy, were approached and enrolled in the fi rst month after birth 
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of their child at the routine child health centers. Assessments in pregnancy, including 
physical examinations, fetal ultrasound examinations and questionnaires, were planned 
in early pregnancy (gestational age < 18 weeks), mid-pregnancy (gestational age 18 - 
25 weeks) and late pregnancy (gestational age ≥ 25 weeks). Mothers enrolled in early 
pregnancy (69%) had three assessments planned (in early, mid- and late pregnancy) 
whereas those enrolled in mid-pregnancy (19%) had two assessments (in mid- and 
late pregnancy) and those enrolled in late pregnancy (3%) had one assessment (in late 
pregnancy) planned [11]. Mothers enrolled after birth of their off spring (9%) had no 
prenatal assessments. All children were born between April 2002 and January 2006 and 
form a prenatally enrolled birth-cohort that is currently followed until young adulthood. 
Additional detailed assessments are conducted in a subgroup study, comprising 1,232 
Dutch pregnant women and their children, referred to as the Generation R Focus Study. 
The subgroup is ethnic homogeneous to exclude confounding or eff ect modifi cation 
by ethnicity. Of all approached women, 80% was enrolled in this subgroup study in late 
pregnancy. Postnatal echocardiograms were planned in infants aged 6 weeks in this sub-
group. The study was approved by the Medical Ethics Committee of the Erasmus Medical 
Center, Rotterdam. Written informed consent was obtained from all participants. 
Fetal growth and birth characteristics
Fetal ultrasound examinations were carried out at the visits in one of the research cen-
ters in early, mid- and late pregnancy. These fetal ultrasound examinations were used for 
both establishing gestational age and assessing fetal growth characteristics [12]. Preg-
nancy dating curves were constructed on subjects in the study with complete data on 
gestational age measured by ultrasound and last menstrual period. Crown-rump length 
was used for pregnancy dating until a gestational age of 12 weeks (crown-rump length 
smaller than 80 mm) and biparietal diameter was used for pregnancy dating thereafter 
(gestational age from 12 weeks onwards, biparietal diameter larger than 20 mm) [13, 
14]. Fetal growth measurements used for the present study included head circumfer-
ence, abdominal circumference and femur length in mid- and late pregnancy, measured 
to the nearest mm using standardized ultrasound procedures [15]. Early pregnancy 
was not included since these fetal ultrasound examinations were primarily performed 
to establish gestational age. Gestational age adjusted standard deviation scores were 
constructed for all fetal growth measurements. These were based on reference growth 
curves from the whole study population. The median (95% range) gestational age for 
the fetal ultrasound examinations in early, mid- and late pregnancy was 13.1 (9.3 - 17.5) 
weeks, 20.5 (18.4 - 23.3) weeks and 30.4 (27.9 - 33.0) weeks, respectively. Date of birth, 
birth weight and gender were obtained from midwife and hospital registries.
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Left cardiac structure 
Two-dimensional M-mode and Doppler echocardiograms were performed using Kretz 
Voluson 530D equipment in the infants. The examination was carried out in a quiet room 
with the baby quietly awake in supine position. One echocardiographer performed the 
vast majority (86%) of these measurements. Two other echocardiographers performed 
the other measurements. In a parasternal long-axis view, left ventricular end diastolic 
diameter (LVEDD), interventricular septal thickness (IVST), left ventricular posterior wall 
thickness (LVPWT), aortic root diameter (AO) and left atrial diameter (LAD) were mea-
sured using methods recommended by the American Society of Echocardiography [16]. 
Left ventricular mass was computed by use of the formula derived by Devereux et al.: 
Left ventricular mass = 0.80 * 1.04 ((IVST + LVEDD +LVPWT)3 – (LVEDD)3)+ 0.6 [17].
Covariates
Postnatal anthropometrics were measured without clothes at the same visit as the echo-
cardiograms. Weight (grams) was measured using an electronic scale and length (cm) 
was measured in supine position using a neonatometer. 
Population for analysis 
In total 1,232 mothers were enrolled in the Generation R Focus Study in the prenatal 
period. The present analysis was limited to singleton live births (n = 1,208). Of these 
singleton live births, 77% (n = 927) participated in the postnatal assessments. Echocar-
diograms were performed in 86% (n = 801) of these infants. Missing echocardiograms 
in the others infants were mainly due to crying or unavailability of the equipment or 
echocardiographer. Infants who had a postnatal echocardiogram did not diff er from the 
singleton live births who did not have a postnatal echocardiogram (n = 407) in mean birth 
weight (diff erence 18 (95% confi dence interval: –48, 83) grams). Infants with congenital 
heart disease were excluded (n = 10) from the present analysis, leaving 791 subjects. 
Data analysis
Associations of fetal growth characteristics with left cardiac structures (left ventricular 
mass, left atrium diameter, aortic root diameter) were assessed using multiple linear 
regression models. These fetal growth characteristics included standard deviation 
scores for head circumference, abdominal circumference and femur length measured in 
mid- and late pregnancy and birth weight. These models were fi rst adjusted for gender 
and age (Model A) and additionally for current weight and current length (Model B). All 
models with birth weight as independent variable were also adjusted for gestational 
age. The simultaneous eff ects of fetal and postnatal growth were examined by observed 
mean values of left ventricular mass and aortic root diameter in tables with tertiles of 
abdominal circumference in late pregnancy, birth weight and current weight. Multiple 
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linear regression models adjusted for gender and age were considered to be tests for 
trends within these tertile strata. All measures of association are presented with their 
95% confi dence intervals (CI). All statistical analyses were performed using the Statisti-
cal Package of Social Sciences version 11.0 for Windows (SPSS Inc, Chicago, IL, USA). 
Results
Characteristics of infants and their mothers are presented in Table 1. The percentage 
of boys was 52%. Fetal head circumference and birth weight were larger in boys than 
in girls. Femur length was larger in girls. The median age in infants at their visit was 7.0 
(95% range: 4.4 – 12.3) weeks. Weight, length and left cardiac dimensions were lower in 
girls than in boys. 
Table 1. Subject characteristics 
Boys
(n = 413)
Girls
(n = 378)
Pregnancy and birth characteristics
Maternal age (years) 31.7 (3.9) 31.8 (3.8)
Mid-pregnancy growth (standard deviation score)
 Head circumference 0.24 (1.22) -0.20 (1.23)
 Abdominal circumference 0.16 (0.97) 0.11 (0.96)
 Femur length -0.16 (1.17) 0.02 (1.22)
Late pregnancy growth (standard deviation score)
 Head circumference 0.37 (1.23) -0.05 (1.13)
 Abdominal circumference 0.18 (1.03) 0.16 (0.98)
 Femur length -0.25 (1.19) 0.02 (1.22)
Birth weight (grams) 3528 (541) 3476 (517)
Gestational age (weeks) 40.3 (35.6 – 42.6) 40.3 (36.1 – 42.4)
Postnatal characteristics
Age at visit (weeks) 7.0 (4.4 – 12.8) 6.9 (4.4 – 11.6)
Weight (grams) 5094 (754) 4747 (631)
Length (cm) 58 (3) 56 (3)
Left cardiac structure
 Left ventricular mass (grams) 16.1 (3.1) 14.6 (2.9)
 Left atrium diameter (mm) 16.9 (1.9) 16.6 (1.9)
 Aortic root diameter (mm) 12.0 (1.2) 11.5 (1.0)
Values are means (standard deviation) or medians (95% range). 
Of the total group, data were missing on mid-pregnancy head circumference (n = 11), mid-pregnancy abdominal 
circumference (n = 15), mid-pregnancy femur length (n = 15), late pregnancy head circumference (n = 15), late 
pregnancy abdominal circumference (n = 18), late pregnancy femur length (n = 14), weight (n =3), length (n = 12), 
left ventricular mass (n = 102), left atrium diameter (n = 31) and aortic root diameter (n = 39).
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Table 2 presents the regression coeffi  cients of mid-pregnancy growth character-
istics with left cardiac structures. All eff ect estimates were small and not statistically 
signifi cant. No consistent tendencies were found. Table 3 presents the associations of 
late pregnancy growth characteristics and birth weight with left cardiac structures. All 
fetal growth characteristics were positively associated with left ventricular mass after 
adjustment for age and gender. After additional adjustment for current weight and 
length, only abdominal circumference was positively associated with left ventricular 
mass (0.33 (95% CI: 0.06, 0.61) grams per standard deviation score). Although not sta-
tistically signifi cant in the fully adjusted model, birth weight was positively associated 
with left ventricular mass (0.28 (95% CI: -0.12, 0.69) grams per standard deviation score). 
Of all growth characteristics in late pregnancy, only femur length was associated with 
left atrium diameter (-0.16 (95% CI: -0.30, -0.02) mm per standard deviation score). In the 
full adjusted model, the association between birth weight and left atrium diameter was 
inverse but not signifi cant (-0.11 (95% CI: -0.35, 0.14) mm per standard deviation score). 
All growth characteristics in late pregnancy were positively associated with aortic root 
diameter. After adjustment for length and current weight, only statistically signifi cant 
associations were found for abdominal circumference (0.13 (95% CI: 0.03, 0.22) mm per 
standard deviation score) and birth weight (0.21 (95% CI: 0.07, 0.34) mm per standard 
deviation score). 
Table 2. Fetal growth characteristics in mid-pregnancy and left cardiac structures
Left ventricular mass (grams)
Mid-pregnancy growth characteristic Model A Model B
Head circumference 0.09 (-0.13, 0.31) 0.08 (-0.12, 0.29)
Abdominal circumference 0.15 (-0.15, 0.44) 0.03 (-0.24, 0.31)
Femur length 0.04 (-0.19, 0.26) -0.03 (-0.24, 0.19)
Left atrium diameter (mm)
Mid-pregnancy growth characteristic Model A Model B
Head circumference -0.01 (-0.02, 0.01) -0.01 (-0.02, 0.01)
Abdominal circumference 0.01 (0, 0.03) 0.01 (-0.01, 0.03)
Femur length 0.01 (0, 0.02) 0.01 (-0.01, 0.02)
Aortic root diameter (mm)
Mid-pregnancy growth characteristic Model A Model B
Head circumference 0 (-0.01, 0.01) 0 (-0.01, 0.01)
Abdominal circumference 0.01 (0, 0.02) 0 (-0.01, 0.01)
Femur length 0 (-0.01, 0.01) 0 (-0.01, 0.01)
Values are regression coeffi  cients (95% confi dence interval) and refl ect the diff erence in left cardiac structure 
per standard deviation score increase in growth characteristic. Model A: adjusted for age and gender; Model B: 
adjusted for age, gender, current weight and current length. 
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Table 4 presents the simultaneous eff ects of late pregnancy abdominal circumfer-
ence, birth weight and current weight on left ventricular mass. Current weight was posi-
tively associated with left ventricular mass in all tertiles of late pregnancy abdominal 
circumference and birth weight. Within the lowest and middle tertiles of current weight, 
positive associations of late pregnancy abdominal circumference with left ventricular 
mass were found (both tests for trend: p < 0.05). Birth weight was only associated with 
left ventricular mass in the highest tertile of current weight (test for trend: p < 0.01). 
The simultaneous eff ects of late pregnancy abdominal circumference, birth weight 
and current weight on aortic root diameter are given in Table 5. Positive associations 
were found between late pregnancy abdominal circumference and aortic root diameter 
among subjects in the lowest and middle tertiles of current weight (tests for trend p < 
0.01 for lowest tertile, p < 0.05 for middle tertile). In all tertiles of current weight, birth 
weight was associated with aortic root diameter.
Table 3. Fetal growth characteristics in late pregnancy and at birth and left cardiac structures
Left ventricular mass (grams)
Late pregnancy growth characteristic Model A Model B
Head circumference 0.41 (0.17, 0.64)** 0.12 (-0.07, 0.39)
Abdominal circumference 0.65 (0.38, 0.92)** 0.33 (0.06, 0.61)*
Femur length 0.26 (0.03, 0.49)* 0 (-0.23, 0.23)
Birth weight 1.00 (0.73, 1.27)** 0.28 (-0.12, 0.69)
Left atrium diameter (mm)
Late pregnancy growth characteristic Model A Model B
Head circumference -0.01 (-0.15, 0.12) -0.07 (-0.21, 0.07)
Abdominal circumference 0.04 (-0.12, 0.20) -0.05 (-0.22, 0.11)
Femur length -0.08 (-0.21, 0.05) -0.16 (-0.30, -0.02)*
Birth weight 0.17 (0, 0.33)* -0.11 (-0.35, 0.14)
Aortic root diameter (mm)
Late pregnancy growth characteristic Model A Model B
Head circumference 0.12 (0.04, 0.20)** 0.06 (-0.02, 0.14)
Abdominal circumference 0.20 (0.11, 0.29)** 0.13 (0.03, 0.22)**
Femur length 0.09 (0.01, 0.17)* 0.03 (-0.05, 0.11)
Birth weight 0.32 (0.23, 0.41)** 0.21 (0.07, 0.34)**
Values are regression coeffi  cients (95% confi dence interval) and refl ect the diff erence in left cardiac structure 
per standard deviation score increase in growth characteristic. Model A: adjusted for age and gender; Model B: 
adjusted for age, gender, current weight and current length. Models with birth weight as independent variable are 
additionally adjusted for gestational age.
*p-value < 0.05, **p-value < 0.01
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Table 4. Left ventricular mass (grams) in tertiles of late pregnancy abdominal circumference and birth weight, 
stratifi ed by current weight
Current weight tertile
Lowest Middle Highest Total
Late pregnancy 
abdominal circumference tertile
Lowest 13.4 (106) 15.0 (64) 16.5 (56) 14.6 (226) P
trend
 < 0.01
Middle 14.1 (71) 15.7 (82) 16.8 (64) 15.5 (217) P
trend
 < 0.01
Highest 14.4 (51) 15.8 (70) 16.8 (106) 16.0 (227) P
trend
 < 0.01
Total 13.9 (228) 15.6 (216) 16.7 (226) 15.4 (670)
P
trend
 < 0.05 P
trend
 < 0.05 P
trend
 = 0.2
Current weight tertile
Lowest Middle Highest Total
Birth weight tertile
Lowest 13.7 (143) 15.6 (56) 16.2 (30) 14.5 (229) P
trend
 < 0.01
Middle 13.9 (76) 15.4 (90) 16.3 (60) 15.5 (226) P
trend
 < 0.01
Highest 15.4 (15) 15.8 (75) 17.1 (138) 16.5 (228) P
trend
 < 0.05
Total 13.9 (234) 15.6 (221) 16.8 (228) 15.4 (683)
P
trend
 = 0.11 P
trend
 = 0.24 P
trend
 < 0.01
Values are observed means of left ventricular mass (number of subjects). Test for trends are based on multiple 
linear regression models within tertiles adjusted for gender and age. Models with birth weight as independent 
variable are additionally adjusted for gestational age.
Table 5. Aortic root diameter (mm) in tertiles of late pregnancy abdominal circumference and birth weight, 
stratifi ed by current weight
Current weight tertile
Lowest Middle Highest Total
Late pregnancy 
abdominal circumference tertile
Lowest 11.1 (116) 11.6 (67) 12.2 (60) 11.5 (243) P
trend
 < 0.01
Middle 11.4 (80) 11.8 (90) 12.2 (69) 11.8 (239) P
trend
 < 0.01
Highest 11.3 (51) 11.9 (76) 12.1(123) 11.8 (250) P
trend
 < 0.01
Total 11.3 (247) 11.7 (233) 12.2 (252) 11.7 (732)
P
trend
 < 0.01 P
trend
 = 0.05 P
trend
 = 0.6
Current weight tertile
Lowest Middle Highest Total
Birth weight tertile
Lowest 11.2 (154) 11.6 (60) 12.0 (36) 11.4 (250) P
trend
 < 0.01
Middle 11.4 (83) 11.7 (99) 12.2 (67) 11.7 (249) P
trend
 < 0.01
Highest 11.3 (16) 11.9 (76) 12.2(152) 12.1 (247) P
trend
 < 0.01
Total 11.3 (253) 11.7 (238) 12.2 (255) 11.7 (746)
P
trend
 < 0.01 P
trend
 < 0.05 P
trend
 < 0.01
Values are observed means of aortic root diameter (number of subjects). Test for trends are based on multiple 
linear regression models within tertiles adjusted for gender and age. Models with birth weight as independent 
variable are additionally adjusted for gestational age.
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Discussion
Our population-based prospective cohort study showed positive associations of late 
pregnancy abdominal circumference and birth weight with left ventricular mass and 
aortic root diameter in early infancy. These associations were independent of current 
weight and length. 
Methodological considerations
To our knowledge, this is the largest prospective cohort study examining the asso-
ciations of fetal growth characteristics with left cardiac structures. Postnatal follow-up 
echocardiograms were successfully obtained in 65% of all singleton live births of moth-
ers enrolled in pregnancy in the Generation R Focus Study. Birth weight was similar 
between infants with and without a postnatal echocardiogram The eff ect estimates 
would be biased if the associations of fetal growth characteristics with left cardiac 
structures diff er between those included and not included in the present analyses. This 
seems unlikely. The missing values of left cardiac structure among infants who did par-
ticipate in the other postnatal (anthropometric) assessments were mainly due to cry-
ing or unavailability of equipment or echocardiographer. These missing values are not 
expected to lead to biased results. 
Fetal growth and cardiac structure
Our fi ndings indicate that subjects who are smaller in late pregnancy or at birth have 
smaller left ventricular mass and aortic root diameter in early infancy. These associations 
were still present after adjustment for weight and length in infancy. However, adjustment 
for weight and length in infancy did aff ect almost all eff ect estimates towards smaller or 
even inverse associations. Confounding may be the case, but we cannot exclude overad-
justment due to strong positive associations between growth characteristics in fetal life, 
at birth and in infancy. Therefore, the eff ect estimates were given both unadjusted and 
adjusted for weight and length in infancy. An inverse association was found between 
late pregnancy femur length and left atrium diameter. We cannot explain this fi nding 
since it was not consistent with the other results. 
We did not fi nd any associations between mid-pregnancy growth characteristics or 
late pregnancy head circumference with postnatal cardiac structures. Relatively small 
abdominal circumference in late pregnancy is a measure of fetal growth retardation in 
the second half of pregnancy. Therefore, an adverse fetal environment in the second 
half of pregnancy may aff ect growth and development of the left cardiac and aortic 
structures. 
Several biological pathways may explain the associations between fetal growth 
retardation and cardiac changes. Fetal growth retardation is associated with fetal blood 
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fl ow redistribution to the brain at expense of the abdomen and lower limbs [18, 19]. 
This redistribution is associated with an increase in fetal left ventricular blood fl ow and 
increased peripheral arterial resistance [18]. These fetal changes in haemodynamic 
stimuli may lead to persistent structural left ventricular changes. Previous studies dem-
onstrated that fetal growth retardation is associated with changes in left ventricular 
diastolic fi lling patterns, which may be attributed to increased ventricular stiff ness [20]. 
Another biological pathway may include hormonal changes associated with fetal growth 
retardation that directly aff ect heart growth. Growth hormone, insulin like growth fac-
tor-1 and insulin stimulate ventricular growth and are decreased in fetal growth retarda-
tion [21]. An adverse fetal environment may also directly aff ect cardiac growth. Recently, 
it was suggested that maternal smoking in pregnancy is associated with adaptations in 
fetal cardiac dimensions and volumes [22]. Further studies are needed to identify these 
pathways.
From our study, it is not known whether and to what extend the cardiac changes 
we demonstrated in early infancy persist in later life. However, previous studies suggest 
that these cardiac changes have consequences for later life. A relatively smaller left ven-
tricle and aortic root may lead to insuffi  cient cardiac functioning for increasing meta-
bolic demands in postnatal life. The heart may respond to these increased demands by 
growth and remodelling. Since the number of heart cells is established largely in fetal 
life, this remodelling would lead to adaptation and growth of existing cells. This process 
may be in favour of short-term cardiac functioning but may eventually lead to increased 
left ventricular mass or even left ventricular hypertrophy. Our hypothesis is supported 
by studies in children and adults [23-25]. Recently, it was demonstrated that low birth 
weight was, independently of current weight and height associated with persistent 
smaller total coronary heart diameter, aortic root diameter and left ventricular outfl ow 
tract diameter in children aged 9 years [23]. Increased growth rate and weight change 
in childhood, which is present in most low birth weight children, are associated with 
increased left ventricular mass [24, 25]. Studies in adults demonstrated that low weight 
in infancy was associated with increased left ventricular mass in adults [8, 9]. Follow-up 
studies in our children or in other studies examining the eff ect of growth in diff erent 
periods of life on left cardiac structure, are needed to confi rm these fi ndings.
Study implications
Our fi ndings suggest that smaller fetal size in late pregnancy is associated with smaller 
left ventricular mass and aortic root diameter in early infancy. Further studies are needed 
to examine the biological pathways leading to these cardiac changes and to examine 
whether these cardiac changes persist with increasing age.
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Abstract
Background: Maternal smoking in pregnancy seems to be associated with increased 
blood pressure in the off spring in childhood. The aim of this study was to examine the 
eff ect of maternal smoking in pregnancy on the longitudinal blood pressure develop-
ment from childhood into adulthood.
Methods: Blood pressure was annually measured from 1975 to 1993 and in 2002 in a 
cohort of 350 subjects, aged 5-19 years at baseline. Pregnancy and birth data were 
obtained through questionnaires sent to the parents. 
Results: The median follow-up period was 23.6 (95% range 3.1 - 26.9) years. Children 
of mothers who smoked in pregnancy showed a higher annual change of 0.27 (95% 
confi dence interval: 0.10, 0.44) mmHg per year for systolic blood pressure and 0.17 
(95% confi dence interval: 0.04, 0.30) mmHg per year for diastolic blood pressure com-
pared to the off spring of mothers who did not smoke in pregnancy. This diff erence in 
annual change led to a higher systolic and diastolic blood pressure from early adulthood 
onwards. Adjustment for adult risk factors including current weight, current smoking 
and current alcohol consumption, did not materially change the eff ect estimates and 
their confi dence intervals. After adjustment for socio-economic status, the association 
showed the same direction but was only signifi cant in men. Additional adjustment for 
birth weight did not change the eff ect estimates. 
Conclusion: Maternal smoking in pregnancy is associated with a steeper increase in 
systolic and diastolic blood pressure in the off spring leading to a higher blood pres-
sure from early adulthood onwards. The underlying causal pathway may involve other 
mechanisms than low birth weight.
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Introduction
Recent studies suggested that maternal smoking in pregnancy is associated with 
increased blood pressure in the off spring [1-3]. These studies were conducted in chil-
dren until the age of 9 years. Since blood pressure under the age of 10 years tends to 
track from childhood into adulthood, these fi ndings suggest that maternal smoking in 
pregnancy may have lifelong consequences for the risk of high blood pressure and the 
development of cardiovascular disease [4-6]. To our knowledge, no studies have been 
conducted examining the eff ect of maternal smoking in pregnancy on longitudinal 
blood pressure development in the off spring from early childhood until adulthood. 
Furthermore, current studies are not conclusive about the causal pathway leading from 
maternal smoking in pregnancy to increased blood pressure in the off spring in child-
hood [1-3]. Maternal smoking in pregnancy is an important determinant of low birth 
weight in Western countries. Low birth weight is associated with an increased blood 
pressure in adulthood and may explain at least part of the proposed association of 
maternal smoking in pregnancy with increased blood pressure in the off spring [7].
The aim of the present study was to examine the association of maternal smok-
ing in pregnancy with the longitudinal blood pressure development in the off spring 
from childhood until adulthood. We also examined whether the causal pathway from 
maternal smoking in pregnancy to increased blood pressure in the off spring includes 
low birth weight.
Methods
Design and study population
All subjects aged 5 years and older living in two districts in Zoetermeer, a suburban 
town in the Netherlands, were invited to participate in the Epidemiological Preventive 
Organization Zoetermeer (EPOZ) Study between 1975 and 1978 [8]. This is a popula-
tion-based study on risk indicators for chronic disease. Of the 5,670 eligible children 
aged 5-19 years, 4,649 (response 82%) were included. From this group, a random sample 
of 596 children was selected for an annual follow-up study on the natural history of 
cardiovascular risk factors and their determinants. Complete data were available for 425 
fathers and 454 mothers at baseline. The children visited the research center annually in 
the same month of the year, preferably at the same time of the day, between 1975 and 
1993 and again in 2002. The response for these annual visits gradually declined to 81% 
(n = 483) in 1993 and 61% (n = 362) in 2002. The median number of visits for the present 
analysis is 15 (range 2 - 19) and the median follow-up time is 23.6 (95% range 3.1 - 26.9) 
years. 
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Measurements
Blood pressure was measured using a Hawksley random-zero sphygmomanometer 
(Lancing, Sussex) according to a standardized protocol on the left brachial artery of a 
sitting subject after a resting period of 15 minutes [9]. A cuff  of 23 by 10 or 14 cm was 
used depending on the arm circumference. The largest cuff  was used in children over 
10 years of age. Diastolic blood pressure was taken at the 5th Korotkoff  phase. The mean 
of two consecutive measurements was used in the analyses. Body height and weight 
were measured without shoes and heavy clothing and body mass index was calculated 
(weight/height2 (kg/m2). Information on life style factors including smoking habits and 
alcohol consumption was obtained through questionnaires at each visit. The same 
methods were used in both parents at baseline. 
Pregnancy and birth data
A questionnaire to obtain pregnancy and birth data was sent to the parents of the chil-
dren in 1993. This questionnaire included questions about birth weight (grams), birth 
length (cm), gestational age (weeks) and maternal smoking in pregnancy (no, yes). Of 
the 483 subjects in the study in 1993, the addresses of 33 parents could not be found 
and 2 children had died during follow-up. Of the 448 questionnaires sent, 353 were com-
pleted and returned to the investigators (response 79%). In 2002, missing pregnancy 
and birth data were completed. Information on maternal smoking in pregnancy was 
known in 350 subjects.
Data analysis
The main outcome of the present study was repeatedly measured blood pressure in the 
off spring. Since repeated blood pressure measurements within children are dependent 
observations, unbalanced repeated measurement analysis was used. First, the associa-
tion between age and blood pressure was modeled using fractional polynomials result-
ing in a best fi tting model including both age and age-0.5 [10]. The intercept and slope 
were used as random eff ects. Second, since the eff ect of maternal smoking in pregnancy 
on blood pressure depended on age (p-value for interaction < 0.05), the interaction 
term maternal smoking*age was added to this model. The basic model for the infl uence 
of maternal smoking in pregnancy on systolic and diastolic blood pressure development 
over time in the off spring, adjusted for gender, can be written as: 
blood pressure = β
0
 + β
1
*smoking in pregnancy + β
2
* gender + β
3
*age + β
4
*age-0.5 + 
β
5
*smoking in pregnancy*age.
In this model ‘β
0
 + β
1
*smoking in pregnancy + β
2
* gender’ refl ects the intercept and 
‘β
3
*age + β
4
*age-0. 5 + β
5
*smoking in pregnancy*age’ refl ects the slope of the change in 
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blood pressure over time. The term β
5 
refl ects the diff erence in annual blood pressure 
change between the off spring of mothers who smoked in pregnancy and of mothers 
who did not smoke in pregnancy. This basic model was subsequently adjusted for cur-
rent risk factors in childhood and adulthood (height, weight, body mass index, current 
smoking habits and current alcohol consumption, socio-economic status) and covari-
ates related to birth (birth weight, gestational age). In an additional analysis, birth 
weight, current weight and their interaction were added to the basic model as proposed 
by Lucas et al [11]. These models were proposed to identify the diff erent associations of 
birth weight, current weight and their interaction with blood pressure. All measures of 
association are presented with their 95% confi dence interval (CI). All statistical analyses 
were performed using the Statistical Analysis System (SAS), including the Proc Mixed 
module for unbalanced repeated measurements [12].
Results
Characteristics of the subjects at baseline and at their latest visit are presented in Table 
1. Data on maternal smoking in pregnancy were available for 192 men and 158 women. 
The mean age at baseline was 13 years. The number of off spring of mothers who smoked 
in pregnancy was 71 (20.2%). 
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Figure 1. Maternal smoking in pregnancy and systolic blood pressure development in the off spring
Values are based on the following repeated measurements regression model: 
Systolic blood pressure = β
0
 + β
1
*smoking in pregnancy + β
2
* gender + β
3
*age + β
4
*age-0,5 + β
5
*smoking in 
pregnancy*age.
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Figures 1 and 2 show the systolic and diastolic blood pressure development in the 
off spring from mothers who smoked and who did not smoke in pregnancy. Systolic 
and diastolic blood pressure of off spring of mothers who smoked in pregnancy were 
somewhat lower in early childhood but showed a higher annual blood pressure change 
leading to an increased absolute systolic and diastolic pressure from early adulthood. 
The increase in annual change was 0.27 (95% CI: 0.10, 0.44) mmHg per year for systolic 
blood pressure and 0.17 (95% CI: 0.04, 0.30) mmHg per year for diastolic blood pressure 
compared to the off spring of mothers who did not smoke in pregnancy. 
Adjustment for risk factors in current and early life
Table 2 presents the eff ect of diff erent potential confounders on the association of 
maternal smoking in pregnancy with the annual change in systolic and diastolic blood 
pressure. Maternal smoking in pregnancy was associated with a steeper increase in 
annual blood pressure change leading to an increased absolute systolic and diastolic 
blood pressure from early adulthood in all models. Current body mass index and height 
had similar eff ects on the estimated diff erence in annual change for both systolic and for 
diastolic blood pressure as current weight and the results are therefore not presented 
separately. Current smoking habits, including the number of cigarettes, and alcohol con-
sumption did not materially change the eff ect estimates. Highest followed educational 
level was the only current factor that infl uenced the association. After adjustment for 
highest followed educational level the association of maternal smoking in pregnancy 
with systolic blood pressure had the same direction in men and women and was signifi -
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Figure 2. Maternal smoking in pregnancy and diastolic blood pressure development in the off spring
Values are based on the following repeated measurements regression model: 
Diastolic blood pressure = β
0
 + β
1
*smoking in pregnancy + β
2
* gender + β
3
*age + β
4
*age-0.5 + β
5
*smoking in 
pregnancy*age
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cant for men (0.33 (95% CI: 0.09, 0.57) mmHg per year) but not for women (0.11 (95% 
CI: -0.13, 0.35) mmHg per year). After adjustment for highest educational level the esti-
mated diff erences for annual change in diastolic blood pressure were 0.16 (95% CI: -0.02, 
0.34) mmHg per year in men and 0.14 (95% CI: -0.07, 0.35) mmHg per year in women. 
These diff erences between men and women are not shown in Table 2. Adjustment for 
factors in early life did not change the estimated diff erence in slope to a large extent. 
Table 1. General characteristics of men and women at their fi rst and last visit
Men (n = 192) Women (n = 158)
Baseline (1975-1978)
Age (years) 13.3 (4.2) 12.9 (4.0)
Height (cm) 157.4 (21.9) 152.3 (17.1)
Weight (kg) 47.1 (17.8) 44.2 (14.7)
Body mass index (kg/m2) 18.1 (2.7) 18.4 (3.1)
Systolic blood pressure (mmHg) 116.0 (16.0) 112.3 (13.9)
Diastolic blood pressure (mmHg) 68.0 (10.6) 66.7 (9.7)
Birth weight (grams) 3520 (643) 3335 (551)
Gestational age (weeks) 39.1 (1.6) 39.1 (1.5)
Maternal smoking in pregnancy (%) 19.3 22.2
Maternal systolic blood pressure (mmHg) 125.8 (16.5) 124.4 (16.7)
Maternal diastolic blood pressure (mmHg) 79.5 (11.2) 78.2 (11.1)
Last visit 
Age (years) 34.5 (6.8) 33.8 (6.9)
Height (cm) 181.8 (6.8) 168.7 (7.4)
Weight (kg) 83.0 (13.7) 71.2 (14.8)
Body mass index (kg/m2) 25.1 (3.6) 25.0 (4.6)
Systolic blood pressure (mmHg) 125.1 (13.1) 115.6 (11.8)
Diastolic blood pressure (mmHg) 80.1 (9.4) 74.7 (9.7)
Smoking (%) 42.7 30.1
Alcohol use (%) 86.5 81.7
Highest followed education level (%)
 Elementary / secondary school 20.9 26.4
 Lower / intermediate vocational training 54.0 51.8
 Higher vocational training / university 25.1 21.8
Follow-up (years)* 23.7 (6.0 – 26.5) 23.4 (3.1 - 26.9)
Values are expressed as mean (standard deviation) in case of continuous variables and as percentage in case of 
categorical variables.
* Median (95% range)
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Birth weight as mediating factor
The mean birth weight was 3298 (SD 521) grams in the off spring of mothers who smoked 
in pregnancy and 3470 (SD 626) grams in the off spring of mothers who did not smoke 
in pregnancy. Table 3 presents the diff erence in annual change in systolic and diastolic 
blood pressure in the off spring of mothers who smoked in pregnancy compared to the 
off spring of mothers who did not smoke in pregnancy after adjustment for birth weight, 
current weight and their interaction according to the models proposed by Lucas et al 
[11]. Maternal smoking in pregnancy was signifi cantly associated with an increased 
Table 2. Diff erence in annual blood pressure change in the off spring of mothers who smoked in pregnancy 
compared to those of mothers who did not smoke in pregnancy
Model adjustment
Systolic blood pressure
(mmHg / year)
Diastolic blood pressure
(mmHg / year)
Maternal smoking, age, gender 0.27 (0.10, 0.44)** 0.17 (0.04, 0.30)*
Adjustment for current risk factors
+ current weight 0.21 (0.06, 0.36)** 0.14 (0.03, 0.26)*
+ current smoking (no, yes) 0.26 (0.09, 0.43)** 0.16 (0.03, 0.29)*
+ current number of cigarettes 0.20 (0, 0.39)* 0.17 (0.04, 0.34)*
+ current alcohol consumption (no, yes) 0.26 (0.09, 0.43)** 0.16 (0.03, 0.29)*
+ educational level 0.16 (-0.03, 0.36) 0.11 (-0.03, 0.25)
Adjustment for early life factors 
+ birth weight 0.28 (0.10, 0.45)** 0.18 (0.05, 0.31)**
+ gestational age 0.27 (0.09, 0.45)** 0.17 (0.04, 0.31)*
+ maternal blood pressure 0.25 (0.07, 0.42)** 0.17 (0.04, 0.30)*
Values are regression coeffi  cients (95% confi dence interval) based on repeated measurements analysis and refl ect 
the diff erence in annual blood pressure change between the off spring of mothers who smoked in pregnancy and 
the off spring of mothers who did not smoke in pregnancy. 
*p-value < 0.05
**p-value < 0.01
Table 3. Diff erence in annual blood pressure change in the off spring of mothers who smoked in pregnancy 
compared to those of mothers who did not smoke in pregnancy adjusted for birth weight and current weight
Model adjustment
Systolic blood pressure
(mmHg / year) 
Diastolic blood pressure
(mmHg / year)
Maternal smoking, age, gender, birth weight 0.28 (0.10, 0.45)** 0.18 (0.05, 0.31)**
+ current weight 0.21 (0.07, 0.36)** 0.14 (0.03, 0.26)*
+ current weight and interaction between birth 
weight and current weight 
0.20 (0.06, 0.35)** 0.15 (0.03, 0.27)*
Values are regression coeffi  cients (95% confi dence interval) based on repeated measurements analysis and refl ect 
the diff erence in annual blood pressure change between the off spring of mothers who smoked in pregnancy and 
the off spring of mothers who did not smoke in pregnancy. 
*p-value < 0.05
**p-value < 0.01
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annual change in systolic and diastolic blood pressure development in the off spring 
in all models. Birth weight was negatively and current weight was positively associ-
ated with systolic and diastolic blood pressure development in all models. However, 
the association between birth weight and systolic blood pressure was only signifi cant 
in the model including current weight (increase of 2.85 (95% CI: 1.34, 4.35) mmHg per 
kilogram decrease in birth weight). The association between birth weight and diastolic 
blood pressure was inverse but non-signifi cant in all models.
Discussion
This 27-year follow-up study showed an association between maternal smoking in preg-
nancy and a higher annual change in systolic and diastolic blood pressure in the off spring 
leading to increased blood pressure levels from early adulthood. The association was not 
explained by low birth weight, suggesting that other causal pathways may be involved.
Strengths and limitations
The strength of this study is the long-term prospective follow-up with a large number of 
measurements performed in each subject. This large number increases the accuracy of 
the estimation of the true underlying blood pressure of each subject. A potential limita-
tion of this study is that it is based on 62% of the subjects of the original cohort. Blood 
pressure at baseline was similar in those lost to follow-up and those not lost to follow-up 
(113.6 (SD 14.9) and 114.6 (SD 15.1) for systolic blood pressure, respectively). This loss to 
follow-up would only lead to selection bias if the association between maternal smoking 
in pregnancy and blood pressure development diff ers between those lost to follow-up 
and those not lost to follow-up. This seems unlikely. Information about maternal smok-
ing in pregnancy was retrospectively obtained by questionnaires sent to the mothers. 
Of the 353 completed and returned questionnaires 99% (n = 350) had information about 
maternal smoking in pregnancy. Although questionnaires seem to be a valid method for 
retrospective information collection on maternal smoking in pregnancy, misclassifi ca-
tion and information bias may occur [13]. The mothers were not aware of this specifi c 
research question at the moment of completing the questionnaires. The pregnancy data 
were obtained without reference to the blood pressure data and a large number of the 
blood pressure measurements have been conducted after returning the questionnaire 
about maternal smoking in pregnancy. Therefore, any misclassifi cation is most likely to 
be random and would tend to underestimate the eff ect size. 
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Maternal smoking in pregnancy and blood pressure in the off spring
The most important fi nding of this study is the association between maternal smok-
ing in pregnancy and a higher annual change in systolic and diastolic blood pressure 
development in the off spring. This fi nding was independent of most potential con-
founding variables. Socio-economic status, measured as highest followed educational 
level, was the only confounder that changed the estimated eff ect size. However, even 
after adjusting for socio-economic status, the association showed the same trend and 
was still signifi cant in men. In adults, socio-economic status is associated with hyperten-
sion and cardiovascular diseases [14]. Intermediate variables in the association between 
socio-economic status and cardiovascular disease seem to include body mass index, 
alcohol consumption and smoking habits [14, 15]. Since adjusting for these variables 
separately did not change the estimated eff ect size in our subjects, other mechanisms 
may be important. Residual confounding by other life-style habits associated with socio-
economic status including diet may be the case. However, since socio-economic status 
was associated with maternal smoking in pregnancy and may be a correlate of maternal 
smoking, over-adjustment cannot be excluded (Table 4). 
The fi nding of the association between maternal smoking in pregnancy with blood 
pressure development in the off spring is in line with other studies [1-3]. These studies 
showed associations between maternal smoking in pregnancy and blood pressure in 
children aged till 9 years. However, in contrast to these studies, in our study absolute sys-
tolic and diastolic blood pressure were increased only from young adulthood onwards in 
the off spring of mothers who smoked in pregnancy compared to the off spring of moth-
ers who did not smoke in pregnancy. Another diff erence is that in these other studies 
maternal smoking in pregnancy was also associated with an increased body mass index 
in young children. Adjustment for body mass index did not change the eff ect estimates 
in our study. Diff erences in other risk factors or life style habits between populations 
may explain the diff erences between these study results. 
Table 4. Distribution of educational level in the off spring of mothers who smoked in pregnancy and in those of 
mothers who did not smoke in pregnancy 
Educational level
No maternal smoking 
in pregnancy 
Maternal smoking
in pregnancy
Elementary / secondary school (%) 20.3 35.6
Lower / intermediate vocational training (%) 52.8 53.3
Higher vocational training / university (%) 26.9 11.1
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Underlying mechanisms 
In adults, the biological mechanisms underlying the associations between smoking 
and blood pressure have not been clarifi ed yet. Although smoking is associated with an 
acute rise in blood pressure, some epidemiological studies have suggested that smok-
ing is associated with a lower blood pressure in adults [16, 17]. Furthermore, smoking 
cessation is associated with an increase in blood pressure in adults [18, 19]. These eff ects 
seem to be independent of current weight and body mass index. However, smoking is 
associated with hypertension, atherosclerosis and coronary heart disease in the longer 
term [20]. Suggested mechanisms leading from smoking to hypertension and athero-
sclerosis in the long run include platelet aggregation, impaired lipoprotein metabolism, 
infl ammatory responses and arterial stiff ness [21-24]. Although maternal smoking 
in pregnancy may not lead to an increased blood pressure at younger age in the off -
spring, the cumulative eff ects of these separate sub-clinical mechanisms may lead to an 
increased blood pressure in adolescence and eventually hypertension. Studies examin-
ing the associations between maternal smoking in pregnancy and these potential sub-
clinical mechanisms have not been conducted yet.
Based on the association between low birth weight and cardiovascular disease in 
adulthood, it has been hypothesized that an adverse fetal environment leads to fetal 
adaptation mechanisms in growth and development [25]. These adaptation mechanisms 
would lead to fetal growth retardation and low birth weight in short term and to cardio-
vascular disease in later life. Maternal smoking in pregnancy may lead to an adverse 
fetal environment both by direct fetal exposure to nicotine and by fetal undernutrition 
or placental dysfunction due to associated dietary habits in women who smoke in preg-
nancy. According to this hypothesis, fetal growth retardation and low birth weight could 
be intermediates in the association between maternal smoking in pregnancy and blood 
pressure in the off spring. Although maternal smoking in pregnancy was associated with 
low birth weight in our study, the association between maternal smoking in pregnancy 
and blood pressure development in the off spring did not disappear in models adjust-
ing for low birth weight. This fi nding suggests that the causal pathway from maternal 
smoking in pregnancy to increased blood pressure in the off spring does not include 
birth weight per se. However, since fetal growth retardation due to maternal smoking in 
pregnancy does not have to lead to low birth weight if the fetus was supposed to grow 
on the upper percentiles, misclassifi cation cannot be excluded. A small study in humans 
has demonstrated that fetal exposure to nicotine is associated with smaller kidneys [26]. 
It has been suggested that small kidneys are associated with increased blood pressure 
in later life [27]. Therefore, fetal organ development may be permanently changed due 
to fetal exposure to nicotine despite only small changes in birth weight. Further studies 
examining the eff ect of maternal smoking in pregnancy on fetal and early postnatal 
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renal growth and vascular development and subsequent blood pressure could identify 
part of the underlying mechanisms. 
Study implications
Although the additional annual increase in blood pressure change between the off spring 
of mothers who smoked in pregnancy and of mothers who did not smoke in pregnancy 
seems to be small, the life-course change will be larger. The additional annual change 
would lead to an additional 4 – 6 mmHg increase in systolic blood pressure between the 
ages of 10 and 30 years, and even larger in later years. This eff ect size suggests important 
implications for public health. Therefore other studies, especially focused on the under-
lying mechanisms are necessary.
References 
1. Morley R, Leeson Payne C, Lister G, Lucas A. Maternal smoking and blood pressure in 7.5 to 8 year 
old off spring. Arch Dis Child 1995;72:120-4.
2. Blake KV, Gurrin LC, Evans SF, Beilin LJ, Landau LI, Stanley FJ, et al. Maternal cigarette smoking during 
pregnancy, low birth weight and subsequent blood pressure in early childhood. Early Hum Dev 
2000;57:137-47.
3. Lawlor DA, Najman JM, Sterne J, Williams GM, Ebrahim S, Davey Smith G. Associations of parental, 
birth, and early life characteristics with systolic blood pressure at 5 years of age: fi ndings from the 
Mater-University study of pregnancy and its outcomes. Circulation 2004;110:2417-23.
4. Labarthe DR, Eissa M, Varas C. Childhood precursors of high blood pressure and elevated choles-
terol. Annu Rev Public Health 1991;12:519-41.
5. Nelson MJ, Ragland DR, Syme SL. Longitudinal prediction of adult blood pressure from juvenile 
blood pressure levels. Am J Epidemiol 1992;136:633-45.
6. Berenson GS, Srinivasan SR, Bao W, Newman WP, 3rd, Tracy RE, Wattigney WA. Association between 
multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa 
Heart Study. N Engl J Med 1998;338:1650-6.
7. Uiterwaal CS, Anthony S, Launer LJ, Witteman JC, Trouwborst AM, Hofman A, et al. Birth weight, 
growth, and blood pressure: an annual follow-up study of children aged 5 through 21 years. Hyper-
tension 1997;30:267-71.
8. Valkenburg HA, Hofman A, Klein F, Groustra FN. An epidemiological study of risk indicators for car-
diovascular diseases (EPOZ). I. Blood pressure, serum cholesterol level, Quetelet-index and smoking 
habits in an open population aged 5 years and older. Ned Tijdschr Geneeskd 1980;124:183-9.
9. Hofman A, Valkenburg HA. Determinants of change in blood pressure during childhood. Am J Epi-
demiol 1983;117:735-43.
10. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk vari-
ables in epidemiology. Int J Epidemiol 1999;28:964-74.
11. SAS/STAT User’s Guide. Cary NSII eds.; 1998.
12. Tomeo CA, Rich-Edwards JW, Michels KB, Berkey CS, Hunter DJ, Frazier AL, et al. Reproducibility and 
validity of maternal recall of pregnancy-related events. Epidemiology 1999;10:774-7.
13. Colhoun HM, Hemingway H, Poulter NR. Socio-economic status and blood pressure: an overview 
analysis. J Hum Hypertens 1998;12:91-110.
Maternal smoking and blood pressure in off spring 147
14. Bell AC, Adair LS, Popkin BM. Understanding the role of mediating risk factors and proxy eff ects 
in the association between socio-economic status and untreated hypertension. Soc Sci Med 
2004;59:275-83.
15. Green MS, Jucha E, Luz Y. Blood pressure in smokers and nonsmokers: epidemiologic fi ndings. Am 
Heart J 1986;111:932-40.
16. Omvik P. How smoking aff ects blood pressure. Blood Press 1996;5:71-7.
17. Janzon E, Hedblad B, Berglund G, Engstrom G. Changes in blood pressure and body weight follow-
ing smoking cessation in women. J Intern Med 2004;255:266-72.
18. Lee DH, Ha MH, Kim JR, Jacobs DR, Jr. Eff ects of smoking cessation on changes in blood pressure and 
incidence of hypertension: a 4-year follow-up study. Hypertension 2001;37:194-8.
19. Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke: a statement for health-
care professionals from the American Heart Association. American Heart Association Task Force on 
Risk Reduction. Circulation 1997;96:3243-7.
20. Fusegawa Y, Goto S, Handa S, Kawada T, Ando Y. Platelet spontaneous aggregation in platelet-rich 
plasma is increased in habitual smokers. Thromb Res 1999;93:271-8.
21. Muscat JE, Harris RE, Haley NJ, Wynder EL. Cigarette smoking and plasma cholesterol. Am Heart J 
1991;121:141-7.
22. Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK. Relationship between cigarette smoking and 
novel risk factors for cardiovascular disease in the United States. Ann Intern Med 2003;138:891-7.
23. Stefanadis C, Tsiamis E, Vlachopoulos C, Stratos C, Toutouzas K, Pitsavos C, et al. Unfavorable eff ect 
of smoking on the elastic properties of the human aorta. Circulation 1997;95:31-8.
24. Lampl M, Kuzawa CW, Jeanty P. Growth patterns of the heart and kidney suggest inter-organ col-
laboration in facultative fetal growth. Am J Hum Biol 2005;17:178-94.
25. Brenner BM, Chertow GM. Congenital oligonephropathy and the etiology of adult hypertension and 
progressive renal injury. Am J Kidney Dis 1994;23:171-5.

Maternal smoking in pregnancy and 
cholesterol development in the off spring
5.3
150
C
ha
p
te
r 5
.3
Abstract
Background: Maternal smoking in pregnancy is associated with overweight and increased 
blood pressure in the off spring and may thereby increase the risk for cardiovascular 
disease in adulthood. The aim of the present study was to examine whether maternal 
smoking in pregnancy is also associated with development of cholesterol levels from 
childhood into adulthood. 
Methods: Total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipo-
protein (LDL) cholesterol, weight and height were measured annually from 1975 to 1993 
and in 2002 in a cohort of 350 subjects, aged 5 - 19 years at baseline. Pregnancy and 
birth data were obtained through questionnaires sent to the parents. 
Results: The median follow-up period was 23.6 (95% range 3.1 - 26.9) years. Children of 
mothers who smoked in pregnancy showed a higher annual change in total cholesterol 
of 0.01 mmol/l per year (95% confi dence interval: 0, 0.02) compared to children whose 
mothers did not smoke in pregnancy. The association between maternal smoking in 
pregnancy and cholesterol development was restricted to children with moderate over-
weight. HDL-cholesterol and LDL-cholesterol showed trends towards a decrease and 
increase, respectively, in children of mothers who smoked in pregnancy compared to 
children whose mothers did not smoke in pregnancy. Adjustment for potential con-
founders including current smoking habits, alcohol consumption, socio-economic sta-
tus and birth weight did not materially change these eff ect estimates.
Conclusion: This study demonstrates for the fi rst time that maternal smoking in preg-
nancy is associated with an increased childhood rise in total cholesterol levels and a 
trend towards an adverse lipoprotein profi le in the off spring. The eff ect of maternal 
smoking in pregnancy on total cholesterol development was restricted to the off spring 
with moderate overweight.
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Introduction
The fetal origins hypothesis postulates that an adverse fetal environment, especially 
fetal undernutrition, leads to developmental adaptations that permanently program the 
fetus’ structure, physiology and metabolism [1]. This programming would be in favour 
of short-term survival and would lead to fetal growth retardation and low birth weight. 
Long-term eff ects of this programming would be detrimental and lead to cardiovascular 
diseases and their risk factors. This hypothesis has gradually been modifi ed into a more 
general developmental plasticity model in which various fetal and postnatal exposures 
would lead to programming responses [2].
Recent systematic reviews of epidemiological studies suggested only small eff ects 
of low birth weight on both blood pressure and blood cholesterol in later life [3, 4]. An 
explanation for these small eff ect sizes and the discrepancy with fi ndings from animal 
studies may be that low birth weight is not an appropriate measure of an adverse fetal 
environment. Studies examining the eff ect of directly measured adverse fetal exposures 
instead of only birth weight on diseases in later life may reveal stronger associations. 
Maternal smoking in pregnancy is the most important determinant of low birth weight 
in Western countries and may lead to persistent adverse developmental changes due 
to direct fetal exposure to nicotine and the associated maternal life style and dietary 
habits. It has been demonstrated previously that maternal smoking in pregnancy is 
associated with obesity and higher blood pressure in childhood [5, 6]. These eff ects were 
independent of birth weight and may predispose the individual to the development of 
cardiovascular disease. To our best knowledge, it is currently unknown whether mater-
nal smoking in pregnancy is associated with cholesterol levels in the off spring. 
Therefore, we studied the associations between maternal smoking in pregnancy 
with development of total cholesterol, HDL-cholesterol and LDL-cholesterol levels from 
childhood into adulthood. 
Methods
Design and study population
All subjects aged 5 years and older living in two districts in Zoetermeer, a suburban 
town in the Netherlands, were invited to participate in the Epidemiological Preventive 
Organization Zoetermeer (EPOZ) Study between 1975 and 1978 [7]. This is a popula-
tion-based study on risk indicators for chronic disease. Of the 5,670 eligible children 
aged 5-19 years, 4,649 (response 81%) were included. From this group, a random sample 
of 596 children was selected for an annual follow-up study on the natural history of 
cardiovascular risk factors and their determinants. Complete data were available for 425 
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fathers and 454 mothers at baseline. The children visited the research center annually in 
the same month of the year, preferably at the same time of the day, between 1975 and 
1993 and again in 2002. The response for these annual visits gradually declined to 81% 
(n = 483) in 1993 and 61% (n = 362) in 2002. The median number of visits for the present 
analysis is 15 (range 2 - 19) and the median follow-up time is 23.6 (95% range 3.1 - 26.9) 
years. 
Measurements
The annual measurements were performed in the same month of the year for each 
individual. Blood samples were drawn by antecubital venipuncture for cholesterol mea-
surements from the start of the study. Measurements of high-density lipoprotein (HDL)-
cholesterol were started in 1979 and of low-density lipoprotein (LDL)-cholesterol were 
started in 1984. Height and weight were measured without shoes and heavy clothing 
and body mass index was calculated (weight/height2 (kg/m2)). Information on life style 
factors including smoking habits and alcohol consumption was obtained through ques-
tionnaires at each visit. The same methods were used in both parents at baseline. 
Laboratory analysis
The laboratory analysis of lipoprotein-cholesterol concentrations for this study is 
described in detail elsewhere [8]. Briefl y, serum total cholesterol was measured with 
an automated enzymatic method at baseline and from 1983 to 1993 with a modifi ed 
reagent (CHOD/PAP High Performance, Boehringer Mannheim, FRG) [9]. The standard 
deviation of duplicate serum cholesterol measurements stored at –20oC for up to 4 years 
did not exceed 3.0% and did not show a signifi cant drift. Measurements of HDL-choles-
terol (from 1979) and LDL-cholesterol (from 1984) were performed by the same method 
after precipitation. A phosphotungstate method with a minor modifi cation was used for 
HDL-cholesterol measurements and polyvinylsulphate (Boehringer Mannheim, FRG) was 
used for LDL-cholesterol [10, 11]. All measurements were carried out at the Department 
of Epidemiology & Biostatistics at the Erasmus Medical Center, Rotterdam, the Nether-
lands. This department participated in the Dutch National Cholesterol standardization 
program (KCA foundation) from 1977 and in the lipid standardization program of the 
World Health Organization (WHO) Regional Lipid Reference Center in Prague, Czecho-
slovakia from 1978. During the baseline period, quality control was indirectly checked 
on the CDC protocol by monthly comparison with cholesterol determination using the 
Abell-Kendall method [12]. Accuracy and precision of total cholesterol and HDL-cho-
lesterol measurement were within acceptable limits (CDC/WHO) over the entire period. 
From 1989, automated analyses were carried out on a Technicon Auto Analyser-II system 
(Technicon Instruments, Tarrytown, NY, USA) initially and on a Kone Specifi c Analyzer 
(Kone Instruments, Espoo, Finland) using frozen (–20oC) serum samples. In 2002, serum 
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total cholesterol was measured by an automated enzymatic procedure using Roche 
CHOD-PAP reagent kit. HDL-cholesterol was measured with the Roche CHOD-PAP direct 
HDL-cholesterol assay using PEG-modifi ed enzymes and dextran sulphate.
Pregnancy and birth data
A questionnaire to obtain pregnancy and birth data was sent to the parents of the chil-
dren in 1993. This questionnaire included questions about birth weight (grams) and 
maternal smoking in pregnancy (no, yes). Of the 483 subjects in the study in 1993, the 
addresses of 33 parents could not be found and 2 children had died during follow-up. 
Of the 448 questionnaires sent, 353 were completed and returned to the investigators 
(response 79%). Information about maternal smoking in pregnancy was known in 350 
subjects.
Data analysis
The main outcomes of the present study were repeatedly measured total cholesterol, 
HDL-cholesterol and LDL-cholesterol levels. Since these measurements within chil-
dren are dependent observations, unbalanced repeated measured analysis was used. 
The associations between age and the main outcomes were modelled using fractional 
polynomials resulting in the best fi tting model including both age and age-0.5 [13]. The 
intercept and slope were used as random eff ects in all models. Since the eff ect of mater-
nal smoking in pregnancy on total cholesterol depended on age (p-value for interac-
tion 0.04), the interaction term maternal smoking*age was added to the model with 
total cholesterol as outcome. This interaction was also tested but not signifi cant in the 
models with HDL-cholesterol and LDL-cholesterol as outcome. The basic model for the 
infl uence of maternal smoking in pregnancy on total cholesterol development over time 
in the off spring, adjusted for gender, can be written as: 
Total cholesterol = β
0 
+ β
1
*smoking in pregnancy + β
2
*gender + β
3
*age + β
4
*age-0.5 + 
β
5
*smoking in pregnancy*age.
In this model ‘β
0 
+ β
1
*smoking in pregnancy + β
2
*gender’ refl ects the level of total cho-
lesterol and ‘β
3
*age + β
4
*age-0.5 + β
5
*smoking in pregnancy*age’ refl ects the slope of 
the change in total cholesterol over time. The term β
5 
refl ects the diff erence in overall 
annual change of total cholesterol between the off spring of mothers who smoked in 
pregnancy and of mothers who did not smoke in pregnancy. The similar models without 
the interaction term ‘β
5
*smoking in pregnancy*age’ were used for HDL-cholesterol and 
LDL-cholesterol as outcomes. Main interest in these models was in β
1
, which refl ects 
the diff erence in HDL-cholesterol and LDL-cholesterol between the off spring of moth-
ers who smoked in pregnancy and of mothers who did not smoke in pregnancy and 
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which is assumed to be constant over time. All models were subsequently adjusted for 
potential confounders in childhood and adulthood (current height, weight, body mass 
index, current smoking habits, current alcohol consumption, socio-economic status and 
birth weight). Since there was a signifi cant interaction between smoking in pregnancy 
and body mass index (p-value for interaction 0.03), the modifying eff ect of body mass 
index on the association of maternal smoking in pregnancy with the annual change in 
cholesterol development was examined in an additional stratifi ed analysis within three 
body mass index standard deviation score groups (< -1, -1 to 1, > 1). These scores  were 
based on national reference curves and were standardized by age and gender. Moderate 
overweight was defi ned as body mass index standard deviation score > 1. All measures 
of association are presented with their 95% confi dence intervals (CI). All statistical analy-
ses were performed using the Statistical Analysis System (SAS), including the Proc Mixed 
module for unbalanced repeated measurements [14].
Results
Table 1 demonstrates the characteristics of the subjects at baseline and at their latest 
visit. Data on maternal smoking in pregnancy were available for 192 men and 158 wom-
en. The number of off spring of mothers who smoked in pregnancy was 71 (20.2%). 
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Figure 1. Maternal smoking in pregnancy and total blood cholesterol development in the off spring
Values are based on the following repeated measurements regression model: 
Total cholesterol = β
0 
+ β
1
*smoking in pregnancy + β
2
*gender + β
3
*age + β
4
*age-0.5 + β
5
*smoking in pregnancy*age.
Maternal smoking and cholesterol in off spring 155
Figure 1 shows the development of total cholesterol levels in the off spring from 
mothers who smoked and who did not smoke in pregnancy. Total cholesterol showed a 
higher annual rise (0.01 (95% CI: 0, 0.02) mmol/l per year) leading to increased total cho-
lesterol levels from early adulthood onwards in the off spring of mothers who smoked 
in pregnancy compared to the off spring of mothers who did not smoke in pregnancy. 
Figure 2 shows that HDL-cholesterol and LDL-cholesterol tended towards a lower level 
(-0.05 (95% CI: -0.11, 0) mmol/l) and higher level (0.19 (95% CI: -0.05, 0.43) mmol/l), 
respectively, in the off spring of mothers who smoked in pregnancy than in the off spring 
of mothers who did not smoke in pregnancy.
Table 2 demonstrates the eff ects of potential confounders on the associations of 
maternal smoking in pregnancy with development of total cholesterol, HDL-cholesterol 
Table 1. General characteristics of men and women at their fi rst and last visit
Men (n = 192) Women (n = 158)
Baseline (1975-1978)
Age (years) 13.3 (4.2) 12.9 (4.0)
Height (cm) 157.6 (21.7) 152.3 (17.0)
Weight (kg) 47.2 (17.7) 44.2 (14.7)
Body mass index (kg/m2) 18.2 (2.7) 18.4 (3.1)
Total blood cholesterol (mmol/l) 4.6 (0.8) 4.7 (0.7)
Birth weight (grams) 3520 (643) 3335 (551)
Gestational age (weeks) 39.1 (1.6) 39.1 (1.5)
Maternal smoking in pregnancy (%) 19.3 22.2
Last visit 
Age (years) 34.5 (7.0) 33.8 (7.0)
Height (cm) 181.6 (7.3) 168.6 (7.5)
Weight (kg) 82.8 (14.2) 71.1(15.0)
Body mass index (kg/m2) 25.0 (3.7) 24.9 (4.7)
Total blood cholesterol (mmol/l) 5.2 (1.2) 5.0 (0.9)
LDL-cholesterol (mmol/l) 3.6 (1.1) 3.4 (1.0)
HDL-cholesterol (mmol/l) 1.1 (0.3) 1.4 (0.3)
Smoking (%) 42.7 30.9
Alcohol use (%) 86.5 81.0
Educational level (%)
 Elementary / secondary school 20.9 26.4
 Lower / intermediate vocational training 54.0 51.8
 Higher vocational training / university 25.1 21.8
Follow-up (years)* 23.7 (6.0 – 26.5) 23.4 (3.1 - 26.9)
Values are expressed as mean (standard deviation) in case of continuous variables and as percentages in case of 
categorical variables.
* Median (95% range)
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and LDL-cholesterol levels in the off spring. The eff ect estimate of maternal smoking in 
pregnancy on total cholesterol was of borderline signifi cance in the basic model includ-
ing only age and gender as covariates. Adjustment for all covariates, except current 
weight and body mass index, revealed signifi cant associations. The estimated eff ect of 
Table 2. Total cholesterol, HDL-cholesterol and LDL-cholesterol levels in the off spring of mothers who smoked in 
pregnancy compared to the off spring of mothers who did not smoke in pregnancy
Diff erence in annual 
change in
total cholesterol
(mmol/l/year)
Diff erence in
HDL-cholesterol
(mmol/l)
Diff erence in
LDL-cholesterol
(mmol/l)
Basic model
Maternal smoking, age, gender 0.01 (0, 0.02) -0.05 (-0.11, 0) 0.19 (-0.05, 0.43)
Adjustment for potential confounders
Basic model
+ current height 0.01 (0, 0.03)* -0.06 (-0.12, -0.01)* 0.19 (-0.05, 0.43)
+ current weight 0.01 (0, 0.02) -0.06 (-0.11, 0)* 0.16 (-0.08, 0.40)
+ current body mass index 0.01 (0, 0.02) -0.05 (-0.10, 0) 0.12 (-0.12, 0.36)
+ current smoking 0.01 (0, 0.03)* -0.05 (-0,10, 0) 0.18 (-0,07 0.43)
+ current number of cigarettes 0.02 (0, 0.03)* -0.07 (-0.14, -0.01)* 0.17 (-0.10, 0.43)
+ current alcohol consumption 0.01 (0, 0.03)* -0.06 (-0.11, 0)* 0.20 (-0.04, 0.44)
+ educational level 0.01 (0, 0.03)* -0.06 (-0.12, 0) 0.09 (-0,20 0.38)
+ birth weight 0.01 (0, 0.02)* -0.05 (-0.11, 0) 0.20 (-0.03, 0.44)
Values are regression coeffi  cients (95% confi dence interval) based on repeated measurements models refl ecting 
the diff erence between cholesterol levels between the off spring of mothers who smoked in pregnancy and who 
did not smoke in pregnancy. 
*p-value < 0.05
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Figure 2. Maternal smoking in pregnancy and LDL and HDL-cholesterol development in the off spring
Values are based on the following repeated measurements regression model: 
HDL (LDL)-cholesterol = β
0 
+ β
1
*smoking in pregnancy + β
2
*gender + β
3
*age + β
4
*age-0.5
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maternal smoking in pregnancy on the longitudinal development of HDL-cholesterol 
and LDL-cholesterol was not materially aff ected by adjustment for potential confound-
ers. Similar as for the total cholesterol models, the basic model, including age and gen-
der, was of borderline signifi cance for HDL-cholesterol. A statistically signifi cant associa-
tion appeared after adjustment for current height, current smoking habits and current 
alcohol consumption. In all models, LDL-cholesterol demonstrated tendencies towards 
higher levels in the off spring of mothers who smoked in pregnancy compared to the 
off spring of mothers who did not smoke in pregnancy. Birth weight did not materially 
change the eff ect estimates and was itself not associated with total cholesterol, HDL-
cholesterol and LDL-cholesterol levels.
Figure 3 shows the results of a stratifi ed analysis within three body mass index 
groups, which revealed a stronger association within the highest group (body mass 
index standard deviation score > 1) There were no associations within the other body 
mass index standard deviation scores groups.
Discussion
This 27-year follow-up study demonstrates for the fi rst time that maternal smoking in 
pregnancy is associated with an increased annual rise in total cholesterol levels from 
childhood into adulthood and trends towards an adverse lipoprotein profi le in the off -
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Figure 3. Diff erence in annual change in total blood cholesterol in the off spring of mothers who smoked in 
pregnancy compared to off spring of mothers who did not smoke in pregnancy within body mass index standard 
deviation score groups
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spring. The eff ect of maternal smoking in pregnancy on total cholesterol development 
was restricted to the off spring in the highest body mass index. 
Strengths and limitations
The strength of this study is the long-term prospective follow-up with a large number 
of measurements performed in each subject. This large number increases the accuracy 
of the estimation of the true underlying cholesterol levels of each subject. A potential 
limitation of this study is that it was based on 61% of the subjects of the original cohort. 
Total cholesterol and body mass index at baseline were similar in those with and with-
out information about maternal smoking in pregnancy. Loss to follow-up would lead to 
selection bias if the associations between maternal smoking in pregnancy and choles-
terol level development diff ers between those lost to follow-up and those not lost to 
follow-up. This seems unlikely. Information about maternal smoking in pregnancy was 
retrospectively obtained by questionnaires sent to the mothers. Of the 353 completed 
and returned questionnaires, 99% (n = 350) contained information about maternal smok-
ing in pregnancy. Although questionnaires seem to be a valid method for retrospective 
information collection on maternal smoking in pregnancy, misclassifi cation may occur 
[15]. The mothers were not aware of the specifi c research question of this study at the 
moment of completing the questionnaires. Furthermore, the pregnancy data were 
obtained without reference to the cholesterol data and a large number of cholesterol 
measurements were conducted after returning the questionnaire about maternal smok-
ing in pregnancy. Therefore, any misclassifi cation is most likely to be non-diff erential 
and would tend to underestimate the eff ect size. 
Maternal smoking and cholesterol development in the off spring
Maternal smoking in pregnancy was associated with an increased annual change in 
total cholesterol and trends towards adverse lipoprotein profi les in the off spring. These 
fi ndings were independent of most potential confounding variables. Current body 
mass index was the only covariate that modifi ed the estimated eff ect size. The eff ect of 
maternal smoking in pregnancy on total cholesterol development was restricted to the 
children with moderate overweight. Our fi ndings are in line with studies that presented 
associations between low birth weight and subsequent increased cholesterol levels 
in childhood and adulthood. A recent systematic review of these studies suggested a 
decrease in total cholesterol of -0.04 (95% CI: -0.05, -0.03) mmol/l per kilogram increase 
in birth weight [4]. From a public health perspective, the authors concluded that low 
birth weight does not have a material impact on vascular risk in adulthood. However, 
the small eff ect sizes may be explained by misclassifi cation due to measuring adverse 
fetal environment by only low birth weight. According to the fetal origins hypothesis, 
low birth weight is just a proxy for an adverse fetal environment. Direct measures of 
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an adverse fetal environment, including maternal smoking or maternal undernutrition, 
may reveal stronger associations with development of cardiovascular disease and its risk 
factors in the off spring. 
Maternal smoking in pregnancy, which is the most important determinant of low 
birth weight in Western countries, may lead to an adverse fetal environment both by 
direct fetal exposure to nicotine and by fetal undernutrition due to associated dietary 
habits or placental dysfunction. Maternal smoking leads to a disproportional fetal 
growth retardation aff ecting primarily abdominal growth [20]. A small abdominal cir-
cumference may be a proxy for impaired hepatic growth, development and function 
including impaired lipid metabolism [21]. Maternal undernutrition or smoking in preg-
nancy may even induce developmental adaptations in organ development and function 
that are not accompanied by changes in growth characteristics. Experimental studies 
in rats suggested that protein restriction directly aff ects lipid metabolism and hepatic 
enzymes activity in the off spring without aff ecting growth [22, 23]. These results cannot 
easily be extrapolated to humans yet. 
In our study, the associations of maternal smoking in pregnancy with cholesterol 
levels were not materially changed after adjustment for birth weight. This is in line with 
previous studies examining associations between maternal smoking in pregnancy and 
both obesity and increased blood pressure in the off spring [5, 6]. These fi ndings suggest 
that the causal pathway from maternal smoking in pregnancy to development of car-
diovascular risk factors in the off spring does not include birth weight per se. Fetal organ 
development may be permanently changed due to fetal exposure to nicotine despite 
only small changes in birth weight. Further studies examining the eff ect of maternal 
smoking in pregnancy on fetal and early postnatal organ growth and function could 
identify part of the underlying mechanisms.
Our fi ndings are also in line with studies focused on maternal undernutrition instead 
of maternal smoking as measure of an adverse fetal environment. The Dutch Famine 
study found that individuals who were exposed in utero to maternal undernutrition had 
an increased risk of developing obesity and impaired glucose tolerance [16, 17]. These 
associations were independent of birth weight. In utero exposure to maternal undernu-
trition was not associated with total cholesterol, HDL-cholesterol and LDL-cholesterol 
[18]. These fi ndings were not be replicated in the Leningrad Siege study, which also 
studied subjects who were exposed to a famine in utero [19]. 
Body mass index 
We demonstrated in a stratifi ed analysis that the eff ect of maternal smoking in preg-
nancy on total cholesterol development was restricted to the off spring with moderate 
overweight (body mass index standard deviation score > 1). Thus, children of mothers 
who smoked in pregnancy and who develop overweight themselves are especially at 
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risk of developing higher cholesterol levels. Cumulative and synergistic eff ects of mater-
nal smoking and current obesity per se may explain these fi ndings. However, current 
obesity may also represent other current life style habits including diet, which may be 
more important. Further studies are necessary to assess these cumulative or synergistic 
eff ects and the underlying biological mechanisms.
Study implications
Our fi ndings may be important with regard to the early etiology of increased cholesterol 
levels and the subsequent risk of cardiovascular disease. The estimated additional annual 
change in off spring of mothers who smoked in pregnancy would lead to an increase in 
total cholesterol level of 0.30 mmol/l over a period of 30 years. This eff ect size suggests 
potential implications for public health on a population level. Therefore other studies, 
especially focused on the underlying mechanisms, are necessary.
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stiff ness in adulthood
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Abstract
Background: The associations of maternal smoking in pregnancy, low birth weight and 
preterm birth with blood pressure in later life may be explained by increased arterial 
stiff ness. The aim of this study was to examine whether these early life factors are associ-
ated with measures of general and local arterial stiff ness in adulthood.
Methods: Aortic pulse wave velocity and carotid distensibility were measured in 362 sub-
jects aged 37.5 (SD 4.5) years participating in a cohort study with a 27-year follow-up. 
Information about maternal smoking in pregnancy, birth weight and gestational age 
was obtained through questionnaires sent to the parents. 
Results: Maternal smoking in pregnancy and birth weight were, after adjustment for 
age, gender, mean arterial pressure and heart rate not associated with aortic pulse wave 
velocity and carotid distensibility. Gestational age was positively associated with aortic 
pulse wave velocity (0.12 (95% confi dence interval: 0.01, 0.23) per week) but was not 
associated with carotid distensibility. Additional adjustment for potential confounders 
did not materially change the eff ect estimates and their confi dence intervals.
Conclusion: Maternal smoking in pregnancy and birth weight were not associated with 
arterial stiff ness in adulthood. We found a weak positive association between gesta-
tional age and arterial stiff ness. The causal pathway underlying the associations of early 
life characteristics with blood pressure in later life probably includes other mechanisms 
than arterial stiff ness.
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Introduction
High blood pressure has at least part of its origins in early life. It is known that blood 
pressure tracks to some extent from childhood into adulthood [1]. More recent studies 
suggested that not only childhood characteristics but also fetal and birth characteristics 
are associated with blood pressure levels in childhood and adulthood. These character-
istics include maternal smoking in pregnancy, low birth weight and preterm birth [2-4]. 
Increased arterial stiff ness has been identifi ed as a factor contributing to the devel-
opment of hypertension and may be one of the mechanisms underlying the associations 
of early life characteristics with blood pressure in later life [5]. Martyn and Greenwald 
hypothesized that an adverse fetal environment leads to both fetal growth retardation 
and reduced elastin synthesis in the large arteries and subsequently to permanent stiff er 
arteries and increased blood pressure in later life [6]. This hypothesis was tested in a 
limited number of studies examining the associations of birth weight and gestational 
age with arterial stiff ness in children and adults [7-17]. Results from these studies are 
not conclusive. To our knowledge, no studies have been conducted examining the asso-
ciations between maternal smoking in pregnancy and arterial stiff ness in the off spring. 
Maternal smoking in pregnancy is the most important determinant of low birth weight 
in Western countries and may be a direct measure of an adverse fetal environment. Fetal 
exposure to maternal smoking may lead to an adverse fetal environment and subse-
quently vascular developmental changes due to the direct eff ect of nicotine and the 
eff ect of associated maternal dietary and life style habits. 
The aim of the present study was to examine the associations of maternal smok-
ing in pregnancy, birth weight and gestational age with measures of arterial stiff ness in 
adulthood.
Methods
Design and study population
All subjects aged 5 years and older living in two districts in Zoetermeer, a suburban 
town in the Netherlands, were invited to participate in the Epidemiological Preventive 
Organization Zoetermeer (EPOZ) Study between 1975 and 1978 [18]. This is a popula-
tion-based study on risk indicators for chronic disease. Of the 5,670 eligible children 
aged 5-19 years, 4,649 (response 82%) were included. From this group, a random sample 
of 596 children was selected for an annual follow-up study on the natural history of 
cardiovascular risk factors and their determinants. Complete data were available for 425 
fathers and 454 mothers at baseline. The children visited the research center annually in 
the same month of the year, preferably at the same time of the day, between 1975 and 
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1993. The response for these annual visits gradually declined to 81% (n = 483) in 1993. 
In 2002, all subjects were invited again for additional data collection, including arterial 
stiff ness measurements. The response for this visit was 61% (n = 362).
Blood pressure and anthropometric measurements
Blood pressure was measured using a Hawksley random-zero sphygmomanometer 
(Lancing, Sussex) according to a standardized protocol on the left brachial artery of a 
sitting subject after a resting period of 15 minutes [19]. A cuff  of 23 by 10 or 14 cm was 
used depending on the arm circumference. The mean of two consecutive measurements 
was used in the analyses. Height and weight were measured without shoes and heavy 
clothing and body mass index was calculated (weight/height2 (kg/m2)). Information 
on life style factors including smoking habits and alcohol consumption was obtained 
through questionnaires.
Pregnancy and birth data
A questionnaire to obtain pregnancy and birth data was sent to the parents of the chil-
dren in 1993. This questionnaire included questions about maternal smoking in preg-
nancy (no, yes), birth weight (grams) and gestational age (weeks). Of the 483 subjects 
in the study in 1993, the addresses of 33 parents could not be found and 2 children 
had died during follow-up. Of the 448 questionnaires sent, 353 were completed and 
returned (response 79%). In 2002, missing pregnancy and birth data were completed in 
subjects participating in the measurements at the research center. 
Arterial stiff ness measurements
Aortic pulse wave velocity and carotid distensibility were used to measure general and 
local arterial stiff ness respectively. Participants were instructed to refrain from smoking, 
drinking coff ee and tea and taking pain-medication on the same day of the measure-
ments, and from drinking alcohol on the day before the measurements.
Aortic pulse wave velocity, a measure of aortic stiff ness, was assessed using an auto-
mated device (Complior, Colson, Garges-lès-Gonesse Cx, France) that computed the time 
delay between the rapid upstroke of the feet of simultaneously recorded pulse waves in 
the carotid and femoral artery [20, 21]. Distances from the carotid artery sampling site to 
the suprasternal notch and from the suprasternal notch to the femoral artery sampling 
site were measured using a pair of compasses. Pulse wave velocity was calculated as 
the ratio between the distance travelled by the pulse wave and the foot-to foot time 
delay and expressed as meters per second (m/s). The average of ten successive mea-
surements was used in the analysis to cover a complete respiratory cycle. Pulse wave 
velocity increases with increasing arterial stiff ness. Before measurement of pulse wave 
velocity, blood pressure measurement was measured twice with a sphygmomanometer 
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after fi ve minutes of rest and the mean was used in the analyses. Mean arterial pressure 
was calculated by the following formula: diastolic blood pressure + 1/3 *(systolic blood 
pressure-diastolic blood pressure).
Carotid distensibility measures the change in arterial diameter due to change in 
arterial pressure over the cardiac cycle at one specifi c point in the arterial tree and 
decreases with increasing arterial stiff ness [22, 23]. The vessel wall motion of the right 
common carotid artery was measured by means of a Duplex scanner (Ultramark IV, ATL, 
Bethel, Washington, USA) connected to a vessel wall movement detector system with 
the subject in supine position. After fi ve minutes of rest, a region at 1,5 cm proximal to 
the origin of the bulb of the carotid artery was identifi ed using B-mode ultrasonography. 
The displacement of the arterial walls was obtained by processing the radio frequency 
signals originating from two-selected sample volumes positioned over the anterior and 
posterior walls. The end-diastolic diameter (D), the absolute stroke change in diameter 
(∆D) during systole and the relative stroke change in diameter (∆D/D) were computed as 
the mean of four cardiac cycles of three successive recordings. During the carotid disten-
sibility measurement, blood pressure was measured at the brachial artery twice with a 
Dinamap automated blood pressure recorder (Critikon, Tampa, Florida, USA). Pulse pres-
sure (∆P) was calculated as the diff erence between systolic and diastolic blood pressure. 
The cross-sectional arterial wall distensibility coeffi  cient (DC) was calculated according 
to the following equation DC = (2∆D/D)/ ∆P (10-3 /kPa) [24].
Data analysis
Associations of early life characteristics with aortic pulse wave velocity and carotid dis-
tensibility were assessed using multiple linear regression models. Early life characteris-
tics include maternal smoking in pregnancy, birth weight and gestational age. The asso-
ciations of early life characteristics with arterial stiff ness measures were fi rst adjusted for 
age and gender (Model A). This model was extended with major determinants of arterial 
stiff ness including mean arterial pressure and heart rate (Model B). Subsequently, model 
B was adjusted for body mass index, current smoking and current alcohol consumption 
(Model C). Selection of these confounders was based on previous studies examining 
the associations of early life factors and arterial stiff ness [7-17]. Further adjustment for 
weight, height and total cholesterol did not materially change the eff ect estimates and 
their confi dence intervals. These models are therefore not presented separately. All 
measures of association are presented with their 95% confi dence interval (CI). Statistical 
analyses were performed using the Statistical Package of Social Sciences version 11.0 for 
Windows (SPSS Inc, Chicago, IL, USA). 
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Results
General characteristics of the subjects participating in 2002 are presented in Table 1. The 
mean age was 37.5 (SD 4.49) years. Table 2 demonstrates the age and gender adjusted 
regression coeffi  cients for all main exposures and covariates on both aortic pulse wave 
velocity and carotid distensibility. Table 3 and 4 present the eff ect estimates of the main 
determinants for aortic pulse wave velocity and carotid distensibility, respectively. After 
full adjustment, maternal smoking in pregnancy and birth weight were not associated 
with aortic pulse wave velocity and carotid distensibility. Gestational age was weakly 
positively associated with aortic pulse wave velocity (0.12 (95% CI: 0, 0.23) m/s per week) 
but not with carotid distensibility.
Table 1. General characteristics of men and women
Men (n = 194) Women (n = 168)
Characteristics in adulthood
Age (years) 38.0 (4.4) 36.9 (4.5)
Height (cm) 182.2 (6.8) 168.9 (7.5)
Weight (kg) 85.2 (13.7) 72.8 (15.1)
Body mass index (kg/m2) 25.6 (3.6) 25.5 (4.7)
Systolic blood pressure (mmHg) 123.0 (12.8) 115.6 (12.0)
Diastolic blood pressure (mmHg) 82.5 (9.3) 76.5 (9.1)
Mean arterial pressure (mmHg) 96.0 (9.8) 89.5 (9.4)
Pulse pressure (mmHg) 40.5 (8.6) 39.1(8.0)
Heart rate (beats/min) 65.6 (11.2) 69.2 (10.9)
Aortic pulse wave velocity (m/s) 10.0 (1.5) 8.6 (1.2)
Carotid distensibility coeffi  cient (10-3/kPa) 23.3 (5.8) 27.0 (7.6)
Current smoking (%) 38.7 29.3
Current alcohol consumption (%) 86.4 77.4
Early life characteristics
Maternal smoking in pregnancy (%) 14.2 21.9
Gestational age (weeks) 39.1 (1.5) 39.1 (1.5)
Birth weight (grams) 3491 (619) 3312 (533)
Values are expressed as mean (standard deviation) in case of continuous variables and as percentages in case of 
categorical variables.
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Table 2. Univariate regression coeffi  cients of subject characteristics on arterial stiff ness measures
Change per standard deviation or category increase
Aortic pulse wave velocity 
(m/s)
Carotid distensibility
(10-3/kPa)
Characteristics in adulthood
Age (1 SD = 4.4 years) 0.41 (0.26, 0.56)** -1.52 (-2.23, -0.81)**
Height (1 SD = 9.8 cm) 0.59 (0.44, 0.74)** -1.40 (-2.12, -0.67)**
Weight (1SD = 15.6 kg) 0.38 (0.23, 0.54)** -2.65 (-3.32, -1.98)**
Body mass index (1 SD = 4.2 kg/m2) 0.06 (-0.11, 0.22) -2.30 (-2.98, -1.62)**
Systolic blood pressure (1 SD = 13.0 mmHg) 0.53 (0.38, 0.69)** -2.94 (-3.57, -2.30)**
Diastolic blood pressure (1 SD = 9.7 mmHg) 0.52 (0.37, 0.69)**  -2.68 (-3.33, -2.03)**
Mean arterial pressure (1SD = 10.1 mmHg) 0.56 (0.41, 071)** -2.94 (-3.57, -2.30)**
Heart rate (1 SD= 11.2 beats/min) 0.24 (0.08, 0.39)** -1.90 (-2.61, -1.20)**
Current smoking (diff erence yes / no) -0.01 (-0.05, 0.04) 0.42 (-1.14, 1.98)
Current alcohol consumption (diff erence yes / no) -0.07 (-0.16, 0.01) -0.29 (-2.19, 1.62)
Early life characteristics
Maternal smoking in pregnancy (diff erence yes / no) -0.24 (-0.73 0.26) 0.94 (-1.29, 3.18)
Gestational age (1 SD = 1.49 weeks) 0.18 (-0.01, 0.37) 0.26 (-0.61, 1.12)
Birth weight (1SD = 585 grams) 0.20 (0.04, 0.37)** -0.27 (-1.05, 0.51)
**p-value < 0.01
Table 3. Associations of early life characteristics with aortic pulse wave velocity
Change in aortic pulse wave velocity (m/s) per 1 unit increase
Model A Model B Model C
Maternal smoking in pregnancy 
(diff erence yes / no)
-0.10 (-0.54, 0.33) -0.29 (-0.74, 0.16) -0.33 (-0.79, 0.14)
Gestational age (weeks) 0.13 (0.16, 0.24)* 0.12 (0.01, 0.23)* 0.12 (0.01, 0.23)*
Birth weight (kg) 0.19 (-0.07, 0.44) 0.17 (-0.09, 0.42) 0.16 (-0.10, 0.42)
Values are regression coeffi  cients (95% confi dence interval) 
Model A: adjusted for age and gender.
Model B: adjusted for age, gender, mean arterial pressure and heart rate.
Model C: adjusted for age, gender, mean arterial pressure, heart rate, body mass index, smoking and alcohol 
consumption.
* p-value < 0.05
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Table 4. Associations of early life characteristics with carotid distensibility
Change in carotid distensibility (10-3/kPa) per 1 unit increase
Model A Model B Model C
Maternal smoking in pregnancy (diff erence 
yes / no)
0.60 (-1.55, 2.76) -0.05 (-2.08, 1.99) -0.49 (-2.53, 1.55)
Gestational age (week) 0.17 (-0.39, 0.74) 0.21 (-0.30, 0.72) 0.20 (-0.30, 0.70)
Birth weight (kg) -0.03 (-1.32, 1.26) -0.26 (-1.41, 0.90) -0.16 (-1.31, 0.99)
Values are regression coeffi  cients (95% confi dence interval) 
Model A: adjusted for age and gender.
Model B: adjusted for age, gender, mean arterial pressure and heart rate.
Model C: adjusted for age, gender, mean arterial pressure, heart rate, body mass index, smoking and alcohol 
consumption.
Discussion
In this cohort study, we did not fi nd associations of maternal smoking in pregnancy and 
birth weight with arterial stiff ness in adulthood. We found a weak positive association 
between gestational age and aortic pulse wave velocity.
Methodological issues 
A potential limitation of this study is that measurements of arterial stiff ness were avail-
able in 61% of the subjects of the original cohort. Lost to follow-up would lead to selec-
tion bias if the associations of parental and early life characteristics with arterial stiff -
ness diff er between those lost to follow-up and those not lost to follow-up. This seems 
unlikely. Blood pressure and body mass index at baseline were similar in those lost to fol-
low-up and those not lost to follow-up. Information on maternal smoking in pregnancy, 
birth weight and gestational age was retrospectively obtained by questionnaires sent to 
the mothers. Of all subjects participating in 2002 with arterial stiff ness measurements, 
birth weight was known in 91% and gestational age and whether mother smoked in 
pregnancy was known in 70%. Although questionnaires seem to be a valid method 
for retrospective information collection on maternal smoking in pregnancy and birth 
outcomes, misclassifi cation may be present [25]. However, the mothers were not aware 
of the specifi c research question at the moment of completing the questionnaires. Fur-
thermore, the pregnancy and birth data were obtained without reference to the arterial 
stiff ness measurements. Therefore, misclassifi cation is most likely to be random and, if 
anything, would tend to underestimate the eff ect size. 
Measurement of arterial stiff ness
The main elastic materials in the arterial wall are collagen and elastin. The distribution of 
elastin and collagen in the arterial wall diff ers between the central and peripheral arter-
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ies [6]. In the proximal aorta, elastin is the dominant component, in the distal aorta the 
content reverses and in the peripheral arteries collagen dominates. Since elastin is much 
more elastic than collagen, the arteries become stiff er with increasing distance from the 
heart. We used two methods for measuring arterial stiff ness.  Before interpreting our 
results, several methodological aspects of these methods need to be discussed.
Aortic pulse wave velocity measures arterial stiff ness over a large part of the arterial 
tree thereby providing a measure of general arterial stiff ness [20]. It combines proper-
ties of elastic arteries (proximal aorta) with more muscular arteries (distal aorta, iliac and 
femoral artery). This makes it diffi  cult to evaluate diff erences in determinants of arterial 
stiff ness between elastic and more muscular arteries. Using the distance between the 
carotid and femoral arteries leads to an overestimation of the real distance travelled 
by the pulse wave, resulting in higher mean values of aortic pulse wave velocity. Since 
variations in the anatomy are limited and this error may be considered similar for all 
subjects examined, it is unlikely that this limitation has seriously biased our results.
Carotid distensibility measures arterial stiff ness at one site in the common carotid 
artery. An important limitation of measurements at one site is that this site may be not 
representative of a larger area of that artery and may be biased due to local vascular 
changes including atherosclerotic lesions. In computing the carotid distensibility coef-
fi cient we used the brachial artery pulse pressure and not the carotid pulse pressure. 
Information on comparisons between carotid and brachial artery pulse pressure indi-
cates that the diff erence between these pressures is 8 mmHg in a presumed healthy 
population and 2.6 mmHg in patients with severe coronary heart disease [26]. Using 
brachial artery pulse pressure may have led to an underestimation of the distensibility 
coeffi  cient. Since our study population was relatively young and healthy, the diff erences 
between brachial and carotid artery pulse pressure are expected to be relatively stable 
among subjects and are not likely to bias our results. The main advantage of the pres-
ent study is that we used both aortic pulse wave velocity and carotid distensibility as 
measures of arterial stiff ness. 
The eff ect of early life factors on arterial stiff ness
The main hypothesis for this study is that an adverse fetal environment leads to fetal 
growth retardation and a reduced elastin synthesis in the large arteries and subsequent-
ly to permanent stiff er arteries [6]. In our study, maternal smoking, low birth weight and 
preterm birth were used as measures of an adverse early environment and develop-
ment. 
Recent studies have suggested that maternal smoking in pregnancy is associ-
ated with increased blood pressure in the off spring in childhood [2]. Fetal exposure to 
maternal smoking may lead to an adverse fetal environment and subsequently vascular 
developmental changes due to the direct eff ect of nicotine and the eff ect of associ-
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ated maternal dietary and life style habits. In adults, both active and passive smoking 
were associated with increased arterial stiff ness, independent of blood pressure [27]. 
To our knowledge, the present study is the fi rst exploring the association between 
maternal smoking in pregnancy and arterial stiff ness in the off spring. Since we did not 
fi nd associations of maternal smoking in pregnancy with aortic pulse wave velocity and 
carotid distensibility, the mechanisms underlying the associations of maternal smoking 
in pregnancy with increased blood pressure in the off spring may be others than arterial 
stiff ness.
Birth weight was not associated with aortic pulse wave velocity and carotid dis-
tensibility. Other studies used only aortic pulse wave velocity or carotid distensibility 
measurements and demonstrated confl icting results but do not suggest systematic 
diff erences between results from studies with aortic pulse wave velocity or carotid dis-
tensibility as outcome [10-17]. These studies are diffi  cult to compare with each other 
and with the present study because of the diff erences in methods used to assess arterial 
stiff ness and diff erences in statistical adjustment. A potential explanation for previously 
demonstrated associations between small size at birth and increased arterial stiff ness 
may, especially in middle-aged and older subjects, refl ect other vascular processes 
including atherosclerosis. We found a weak positive association of gestational age with 
aortic pulse wave velocity but not with carotid distensibility. Recently, it has been sug-
gested that also preterm birth is associated with arterial stiff ness [14]. We are not aware 
of any previous studies demonstrating positive associations between gestational age 
and arterial stiff ness and cannot explain this association. Further studies are necessary 
to elucidate the associations between gestational age and birth weight and arterial stiff -
ness.
Conclusion
Maternal smoking in pregnancy and birth weight were not associated with arterial stiff -
ness in adulthood. We found a weak positive association between gestational age and 
arterial stiff ness. The causal pathway underlying the previously suggested associations 
of early life characteristics with increased blood pressure in later life probably includes 
other mechanisms than arterial stiff ness.
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Background
In the past two decades, epidemiological studies demonstrated associations of low 
birth weight with cardiovascular disease and its risk factors in later life [1-3]. The fetal 
origins hypothesis proposes that an adverse fetal environment leads to developmental 
adaptations which permanently program the fetus’ structure, physiology and metabo-
lism [4]. This programming would lead to fetal growth retardation and low birth weight 
and would be in favour of short-term survival. Long-term eff ects of this programming 
would be detrimental and lead to cardiovascular disease. Several alternative hypotheses 
focused on environmental and genetic mechanisms that may underlie these associa-
tions, have been proposed [5-8]. Based on these hypotheses, the search for the origins 
of cardiovascular disease has recently been extended from epidemiological studies in 
adults and children into new studies focused on fetal and early postnatal life. 
Although birth weight is easily measured and available from obstetric records, it 
is not the best marker for an adverse fetal environment or exposure. The same birth 
weight may be the result of various fetal exposures and growth patterns. Therefore, 
birth weight is not likely to be the causal factor per se. Studies that directly examine the 
eff ects of fetal exposures on cardiovascular disease and its risk factors, irrespective of 
birth weight, are necessary. Maternal life style habits, including smoking in pregnancy, 
are the most important determinants of low birth weight in Western countries [9]. An 
adverse fetal environment due to maternal smoking may lead to developmental chang-
es by the direct eff ects of nicotine and the associated maternal life style and dietary 
habits. Therefore, maternal smoking in pregnancy may be a better marker of an adverse 
fetal environment than low birth weight.
The general aim of studies presented in this thesis, was to identify pathways leading 
from adverse fetal exposures, including smoking and alcohol consumption, to subop-
timal fetal growth patterns and subsequently risk factors for cardiovascular disease in 
later life. The main merits and shortcomings of these studies have been discussed in the 
previous chapters. This chapter provides a more general discussion of the main fi ndings, 
considers general methodological issues and gives suggestions for further research. 
Main fi ndings
Determinants of fetal growth retardation and low birth weight
Studies examining determinants of fetal growth retardation and low birth weight were 
conducted in the Generation R Study, a population-based prospective cohort study 
from fetal life until young adulthood among 9,778 mothers and their children [10]. Our 
studies were focused on maternal smoking and alcohol consumption in pregnancy.
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Active maternal smoking in pregnancy seems to be the most important modifi able 
risk factor for low birth weight in Western countries [11, 12]. Smoking in pregnancy 
leads to low birth weight by decreased fetal supplies of both nutrients and oxygen and 
subsequently fetal growth retardation [11, 12]. Recently, it was suggested that passive 
maternal smoking in pregnancy, defi ned as exposure to environmental tobacco smoke, 
is also associated with low birth weight [13]. We found that active and passive maternal 
smoking in pregnancy were associated with a lower birth weight in the off spring (chap-
ter 4.1). Continued active maternal smoking after pregnancy was known was associated 
with an increased risk of low birth weight and preterm birth. The eff ect of smoking on 
birth weight was already present in the lowest smoking categories. Maternal smoking 
until pregnancy was known, was not adversely associated with weight or gestational 
age at birth. Completely quitting to smoke in early pregnancy, rather than reducing the 
number of actively smoked cigarettes during pregnancy, was associated with benefi cial 
eff ects on birth weight.
Since low birth weight is only a proxy for fetal growth retardation, it is not the best 
marker for assessing the adverse eff ects of smoking in pregnancy on fetal growth and 
development. Fetal growth retardation may lead to normal birth weight if the fetus was 
actually supposed to grow on the upper percentiles based on the genetic growth poten-
tial. Previous studies suggested that maternal smoking in pregnancy is associated with 
impaired fetal growth from a gestational age of 20 weeks onwards [14-19]. However, 
these studies were conducted in small groups or in hospital-based populations and 
were not able adjust for all potential confounders. We found that that continued active 
maternal smoking in pregnancy was associated with reduced growth of fetal head cir-
cumference, abdominal circumference and femur length (chapter 4.2). These impaired 
fetal growth rates led to smaller femur length from mid-pregnancy onwards and smaller 
head circumference and abdominal circumference from late pregnancy. The earlier and 
larger eff ects on femur length suggest that maternal smoking in pregnancy aff ects pri-
marily peripheral tissues. Maternal smoking until pregnancy was known and quitting 
thereafter, did not adversely aff ect fetal growth patterns. 
Excessive alcohol consumption in pregnancy is associated with various pregnancy 
complications including low birth weight, preterm birth and congenital anomalies [20-
22]. The eff ects of heavy alcohol consumption in pregnancy can not easily be extrapolat-
ed to lower levels of alcohol consumption. Previous studies examining the eff ects of low 
or moderate alcohol consumption in pregnancy on birth outcomes were inconsistent. 
Several studies found adverse eff ects, whereas others did not fi nd any eff ect or even 
reported protective eff ects on weight and gestational age at birth [23-26]. These incon-
sistent results may be due to diff erences in study design and assessment of maternal 
alcohol consumption habits. Our study showed that maternal alcohol consumption of 
less than one drink per day was not associated with an increased risk of delivering a low 
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birth weight or preterm born infant. For alcohol consumption of one to three drinks per 
day, tendencies for an increased risk of low birth weight and preterm birth were found 
(chapter 4.3). 
Development of risk factors for cardiovascular disease 
Left ventricular hypertrophy is a strong and independent risk factor of cardiovascular 
morbidity and mortality [28]. Since the human heart has its highest growth rates in 
fetal and early postnatal life, an adverse environment in this period may aff ect left ven-
tricular growth [29]. Previous studies did not examine the associations of fetal growth 
characteristics with postnatal left ventricular mass in healthy children. In a subgroup of 
the Generation R Study, we found positive associations of abdominal circumference in 
late pregnancy and birth weight with left ventricular mass and aortic root diameter in 
early infancy (chapter 5.1). These associations were independent of current weight and 
length and suggest that smaller fetal size in late pregnancy is associated with persistent 
smaller left ventricular mass and aortic root diameter in early infancy. From our study, 
it is not known whether and to what extend these cardiac changes persist in later life. 
We hypothesize that a relatively smaller left ventricle and aortic root diameter may lead 
to insuffi  cient cardiac functioning for increasing metabolic demands in postnatal life. 
The heart may respond to these increased demands by growth and remodelling. Since 
the number of heart cells is largely established in fetal life, this remodelling would lead 
to adaptation and growth of existing cells. This process may be in favour of short-term 
cardiac functioning but may eventually lead to relative left ventricular dysfunction, 
increased left ventricular mass or even left ventricular hypertrophy. This hypothesis is 
supported by studies in children and adults. Recently, it was demonstrated that low 
birth weight was, independently of current weight and height, associated with per-
sistent smaller total coronary heart diameter, aortic root diameter and left ventricular 
outfl ow tract diameter in children aged 9 years [30]. Increased growth rate and weight 
change, as occur in most low birth weight children, are associated with increased left 
ventricular mass [31, 32]. Studies in adults demonstrated that low weight in infancy was 
associated with increased left ventricular mass in adults [33, 34]. Follow-up studies are 
needed to test this hypothesis. 
Long-term follow-up studies were performed in the Epidemiological Prevention 
Organization Zoetermeer (EPOZ) Study. The EPOZ Study is a population-based prospec-
tive cohort study in 596 children, initially aged 5 to 19 years. Current follow-up is 27 
years. Recent studies suggested that maternal smoking in pregnancy is associated with 
increased blood pressure in the off spring [35-37]. These studies were conducted in chil-
dren until the age of 9 years. We demonstrated in the EPOZ study, which comprises a 
27-year follow-up, associations between maternal smoking in pregnancy and increased 
annual changes of systolic and diastolic blood pressure in the off spring (chapter 5.2). 
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This increase leads to higher systolic and diastolic blood pressure levels from early 
adulthood onwards. The associations were not explained by low birth weight, suggest-
ing that other causal pathways may be involved. Mechanisms leading from smoking 
to higher blood pressure and atherosclerosis in adults include platelet aggregation, 
impaired lipoprotein metabolism, infl ammatory responses and arterial stiff ness [38-41]. 
These mechanisms may also be involved in the associations between maternal smoking 
in pregnancy and higher blood pressure in the off spring. 
In the same study, we examined the associations of maternal smoking in pregnancy 
with total cholesterol, HDL-cholesterol and LDL-cholesterol development from child-
hood into adulthood. Our study demonstrated for the fi rst time that maternal smoking 
in pregnancy is associated with an increased annual rise in total cholesterol levels from 
childhood into adulthood and tendencies towards an adverse lipoprotein profi le in the 
off spring (chapter 5.3). The eff ect of maternal smoking in pregnancy on total cholesterol 
development was restricted to the off spring in the highest body mass index group. The 
associations between maternal smoking and cholesterol may be explained by the eff ects 
of maternal smoking in pregnancy on fetal abdominal growth. Smoking in pregnancy 
leads to disproportional fetal growth retardation [42]. A small abdominal circumfer-
ence may be a proxy for impaired hepatic growth, development and function including 
impaired lipids metabolism [43]. Maternal undernutrition or smoking in pregnancy may 
even induce developmental adaptations in organ development and function that are 
not accompanied by changes in growth characteristics. Experimental studies in rats sug-
gested direct persistent eff ects of protein restriction on lipid metabolism and hepatic 
enzymes activity in the off spring [44, 45]. These results cannot easily be extrapolated to 
humans yet. 
Increased arterial stiff ness has been identifi ed as a factor contributing to the devel-
opment of hypertension and may be one of the mechanisms underlying the associations 
of early life characteristics with blood pressure in later life [46]. Martyn and Greenwald 
hypothesized that an adverse fetal environment leads to both fetal growth retardation 
and reduced elastin synthesis in the large arteries and subsequently to permanent stiff er 
arteries and increased blood pressure in later life [47]. This hypothesis has been tested 
in a limited number of studies examining the associations of birth weight and gesta-
tional age with arterial stiff ness in children and adults [48-58]. Results from these studies 
are not conclusive. In our study, we did not fi nd associations of maternal smoking in 
pregnancy and birth weight with arterial stiff ness in adulthood (chapter 5.4). We found 
a weak positive association between gestational age and arterial stiff ness, measured 
by aortic pulse wave velocity. Our fi ndings suggest that the causal pathway underlying 
the previously found associations of maternal smoking in pregnancy, low birth weight 
and preterm birth with increased blood pressure in later life, includes other mechanisms 
than arterial stiff ness.
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Methodological considerations
The methodological considerations of the studies presented in this thesis have been 
discussed in the separate chapters. In this paragraph, methodological issued regarding 
selection bias, information bias and confounding are discussed.
Selection bias
Our studies with fetal growth and birth weight as outcome were embedded in the Gen-
eration R Study. Of all eligible children at birth, 61% participate in this study. Among 
the participating mothers, information about smoking in pregnancy and alcohol con-
sumption at enrolment was missing in 14%. Non-response due to non-participation and 
missing values at baseline among the participants is not likely to be random. National 
and regional registries do not have subject characteristics in all children and their par-
ents that enable detailed non-response analyses. However, the percentages of moth-
ers from ethnic minorities and lower socio-economic status and of mothers or children 
with medical complications are lower among the participants than expected from the 
population fi gures in Rotterdam [59]. Among the participating children, birth weight 
was 41 (95% confi dence interval: 6, 76) grams lower when maternal information about 
smoking in pregnancy was missing. This selection towards a more affl  uent and healthy 
study population would lead to bias in our etiological association studies if the selec-
tion mechanisms are related to both the determinant and outcome and the associa-
tions diff er between the study population and the eligible population. Although we do 
not expect that this is generally the case, the potential for selection bias is discussed 
in each chapter. The selection towards a more affl  uent and healthy study population 
aff ects probably the frequency rates and, as a consequence, the statistical power in our 
studies.
Selection bias in our studies embedded in the Generation R Study may not only be 
introduced due to selective non-response but also due to selective loss to follow-up. 
Major birth outcomes were available in 93% of all enrolled mothers and categories of 
maternal smoking habits at enrolment were similarly distributed among those lost to 
follow-up and those with singleton live birth as outcome. Lost to follow-up would lead 
to selection bias if the association of maternal smoking in pregnancy with fetal growth 
diff ers between those lost and those not lost to follow-up. This seems unlikely in our 
study. 
In the EPOZ Study, the response at baseline was 82%. The population selected for 
follow-up in the EPOZ Study was a random sample of children, initially aged 5 to 19 
years who participated in the baseline study. We do not believe that selection bias due 
to non-response has occurred since it is unlikely that children and their parents based 
their participation in the EPOZ Study on awareness of relations between early determi-
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nants and later disease. To introduce selection bias, the association between early life 
characteristics and cardiovascular risk factors in adult life should diff er between those 
participating and not participating.
A potential problem in this 27-year follow-up study is selective loss to follow-up 
leading to selection bias. However, our data do not indicate selective loss to follow-up. 
Baseline subject characteristics, including body mass index, blood pressure and total 
cholesterol were similar among those who were and who were not lost to follow-up. 
Furthermore, since the EPOZ Study comprises young adults, massive selective lost to 
follow-up due to manifest cardiovascular disease or other diseases, is not likely. 
Information bias 
Information about maternal smoking and alcohol consumption in pregnancy was 
obtained prospectively in the Generation R Study and retrospectively in the EPOZ Study 
by questionnaires sent to the mothers. This information was obtained without reference 
to fetal growth characteristics and cardiovascular risk factors. The mothers were not 
aware of the specifi c research questions addressed in this thesis. Although assessing life 
style habits in pregnancy by questionnaires seems to be a valid method, misclassifi ca-
tion may occur [60]. This is especially the case for retrospective data collection as was 
conducted in the EPOZ Study. 
Assessment of adverse life style habits by questionnaires may lead to underreport-
ing. Random misclassifi cation of the smoking and alcohol consumption categories 
would lead to bias towards the null. Alternatively, the estimated diff erences in fetal 
growth characteristics between the off spring of non-smoking and smoking mothers 
would be overestimated if underreporting would be selectively present among heavy 
smoking mothers who report low- to moderate smoking. 
To overcome these limitations, other studies used biomarkers for smoking and 
alcohol consumption. Cotinine in maternal urine samples is used as biomarker for mea-
suring tobacco exposure [61, 62]. However, low correlations between cotinine and self 
reported smoking habits have been demonstrated [63]. Possible explanations for these 
low correlations include inaccurate maternal reporting of smoking habits in pregnancy, 
use of categories of number of cigarettes smoked in questionnaires and individual 
diff erences in inhalation, absorption and metabolism. Previous studies demonstrated 
that using cotinine levels is not superior to self-report in studying the eff ect of mater-
nal smoking in pregnancy on birth weight [64, 65]. Biomarkers of alcohol consumption 
including carbohydrate-defi cient transferrin and gamma-glutamyl transferase, are not 
appropriate for assessment of light to moderate alcohol consumption because of their 
low sensitivity [66].
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Confounding
Our main interest was in the eff ect of maternal smoking and alcohol consumption in 
pregnancy on fetal growth, birth weight and development of postnatal cardiovascular 
risk factors. Adjustment for demographic characteristics including maternal ethnicity, 
parity, educational level and age weakened the strengths of the associations. We used 
educational level as measure of socio-economic status in our models. Socio-economic 
status is strongly associated with birth weight [11]. Suggested biological pathways 
explaining associations between maternal socio-economic status and birth weight in 
the off spring include maternal smoking habits, body mass index, ethnicity and parity 
[67]. Studies identifying the biological mechanisms and their etiologic fractions explain-
ing the associations of maternal socio-economic status and educational level in preg-
nancy with birth weight are necessary. 
Future research
Our studies suggest that maternal smoking in pregnancy and reduced fetal growth 
aff ect postnatal development of cardiovascular risk factors. These fi ndings underline 
the importance of focusing on exposures and growth patterns in fetal life rather than on 
birth weight in studying the fetal origins of cardiovascular disease. 
Maternal smoking in pregnancy was related to reduced fetal growth, lower birth 
weight and postnatal development of cardiovascular risk factors. These results suggest 
that fetal exposure to smoking leads to adaptation mechanisms that predispose the indi-
vidual to development of cardiovascular disease in adulthood. Further studies are need-
ed to examine the direct eff ects of maternal smoking in pregnancy on these adaptation 
mechanisms, including changes in fetal organ development and to explore the causal 
pathways leading from maternal smoking in pregnancy to postnatal cardiovascular risk 
factors. Our fi nding of eff ect modifi cation by postnatal body mass index of the associa-
tion of maternal smoking in pregnancy with total cholesterol development, indicates the 
importance of including postnatal life style habits and growth patterns in future studies. 
Well-designed epidemiological studies are necessary to overcome the existing 
methodological limitations, to identify the causal pathways and to quantify the eff ect 
sizes for public health. Such studies have recently been started or are currently planned 
[68-72]. The general approach of these studies is to assess prospectively environmental 
and genetic determinants of fetal and postnatal growth patterns and subsequently the 
development of risk factors for common diseases in childhood and adulthood. Informa-
tion from these studies is needed to develop strategies for identifying groups at risk and 
prevention focused on the earliest phase of life. Obviously, in the meanwhile, public 
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health strategies for pregnant women should be aimed at non-smoking at all or quitting 
completely to smoke in early pregnancy.
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In the past two decades, epidemiological studies demonstrated associations of low 
birth weight with cardiovascular disease and its risk factors in later life. The fetal origins 
hypothesis proposes that an adverse fetal environment leads to developmental adapta-
tions that permanently program the fetus’ structure, physiology and metabolism. This 
programming would lead to fetal growth retardation and low birth weight and would 
be in favour of short-term survival. Long-term eff ects of this programming would be 
detrimental and lead to cardiovascular disease. Based on this hypothesis, the search for 
the origins of cardiovascular disease has recently been extended from epidemiological 
studies in adults and children into new studies focused on fetal and early postnatal life. 
Although birth weight is easily measured and available from obstetric records, it 
is not likely to be the best marker for an adverse fetal environment or exposure. The 
same birth weight may be the result of various fetal exposures and growth patterns. 
Maternal smoking in pregnancy is the most important determinant of low birth weight 
in Western countries. An adverse fetal environment due to maternal smoking may lead 
to developmental changes by the direct eff ects of nicotine and the associated maternal 
life style and dietary habits. Therefore, maternal smoking in pregnancy may be a better 
marker of an adverse fetal environment than low birth weight.
The fetal origins hypothesis was the main point of departure for studies presented 
in this thesis. The general aim of these studies was to identify pathways leading from 
adverse fetal exposures to suboptimal fetal growth patterns and subsequently risk 
factors for cardiovascular disease in later life. The fetal exposure of main interest was 
maternal smoking in pregnancy.
Several hypotheses focused on mechanisms underlying the associations of low birth 
weight with diseases in adulthood have been proposed. These hypotheses proposed 
central roles for 1) fetal undernutrition; 2) increased fetal cortisol exposure; 3) genetic 
susceptibility to both low birth weight and diseases in adulthood; and 4) accelerated 
postnatal growth in low birth weight children. In chapter 2, epidemiological studies 
designed to explore these hypotheses, are reviewed. Thus far, it is not known which 
mechanisms underlie the associations of low birth weight with adult diseases. The 
causal pathways linking low birth weight to diseases in adulthood seem to be complex 
and may include combined environmental and genetic mechanisms in various periods 
of life. Well-designed epidemiological studies are necessary to identify the underlying 
mechanisms and to estimate the population eff ect size. 
In chapter 3, the Generation R Study is presented. The Generation R Study is a popula-
tion-based prospective cohort study from fetal life until young adulthood. The study is 
designed to identify early environmental and genetic causes of normal and abnormal 
growth, development and health from fetal life until young adulthood. The study focuses 
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on four primary areas of research: 1) growth and physical development; 2) behavioural 
and cognitive development; 3) diseases in childhood; and 4) health and healthcare for 
pregnant women and children. In total, 9,778 mothers with a delivery date from April 
2002 until January 2006 were enrolled in the study. Of all eligible children at birth, 61% 
participate in the study. Data collection in the prenatal phase was planned in early preg-
nancy (gestational age < 18 weeks), mid-pregnancy (18 - 25 weeks) and late pregnancy 
(gestational age ≥ 25 weeks) and included physical examinations, questionnaires, fetal 
ultrasound examinations and biological samples. The children form a prenatally recruit-
ed birth-cohort that is currently followed until young adulthood. 
Studies in chapter 4 deal with the eff ect of maternal smoking and alcohol consumption 
in pregnancy on fetal growth and birth weight and were conducted in the Generation 
R Study. 
Smoking in pregnancy leads to low birth weight by decreased fetal supplies of 
both nutrients and oxygen and subsequently fetal growth retardation. Recently, it was 
suggested that passive maternal smoking in pregnancy, defi ned as exposure to envi-
ronmental tobacco smoke, is also associated with low birth weight. In the study pre-
sented in chapter 4.1, we found that active and passive maternal smoking in pregnancy 
were associated with a lower birth weight in the off spring. Continued active maternal 
smoking after pregnancy was known, was associated with an increased risk of low birth 
weight and preterm birth. The eff ect of smoking on birth weight was already present 
in the lowest smoking categories. Maternal smoking until pregnancy was known, was 
not adversely associated with weight or gestational age at birth. Completely quitting 
to smoke in early pregnancy, rather than reducing the number of actively smoked ciga-
rettes during pregnancy, was associated with benefi cial eff ects on birth weight in the 
off spring.
Since low birth weight is only a proxy for fetal growth retardation, it is not the best 
marker for assessing the adverse eff ects of smoking in pregnancy on fetal growth and 
development. Fetal growth retardation may lead to normal birth weight if the fetus 
was actually supposed to grow on the upper percentiles based on the genetic growth 
potential. We demonstrated in chapter 4.2 that continued active maternal smoking in 
pregnancy was associated with reduced growth of fetal head circumference, abdominal 
circumference and femur length. These impaired fetal growth rates led to smaller femur 
length from mid-pregnancy onwards and smaller head circumference and abdominal 
circumference from late pregnancy. The earlier and larger eff ects on femur length sug-
gest that maternal smoking in pregnancy aff ects primarily peripheral tissues. Maternal 
smoking until pregnancy was known and quitting thereafter did not adversely aff ect 
fetal growth patterns. 
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Excessive alcohol consumption in pregnancy is associated with various pregnancy 
complications including low birth weight, preterm birth and congenital anomalies. The 
eff ects of heavy alcohol consumption in pregnancy can not easily be extrapolated to 
lower levels of alcohol consumption. Our study, presented in chapter 4.3 showed that 
maternal alcohol consumption of less than one drink per day was not associated with 
an increased risk of delivering a low birth weight or preterm born infant. For alcohol 
consumption of one to three drinks per day, tendencies for an increased risk of low birth 
weight and preterm birth were found. 
Studies in chapter 5 deal with the eff ects of fetal growth retardation and maternal smok-
ing in pregnancy on the postnatal development of cardiovascular risk factors. 
Left ventricular hypertrophy is a strong and independent risk factor of cardiovas-
cular morbidity and mortality. Since the human heart has its highest growth rates in 
fetal and early postnatal life, an adverse environment in this period may aff ect left ven-
tricular growth. The study presented in chapter 5.1 was performed in a subgroup of 
the Generation R Study and showed positive associations of abdominal circumference 
in late pregnancy and birth weight with left ventricular mass and aortic root diameter 
in early infancy. These associations were independent of current weight and length and 
suggest that smaller fetal size in late pregnancy is associated with persistent smaller left 
ventricular mass and aortic root diameter in early infancy. Further studies are needed to 
assess whether and to what extend these cardiac changes persist in later life. 
Long-term follow-up studies were performed in the Epidemiological Prevention 
Organization Zoetermeer (EPOZ) Study. The EPOZ Study is a population-based prospec-
tive cohort study in 596 children, initially aged 5 to 19 years. Current follow-up is 27 
years. 
Previous studies suggested that maternal smoking in pregnancy is associated with 
increased blood pressure in the off spring. These studies were conducted in children 
until the age of 9 years. The study presented in chapter 5.2 was conducted in the EPOZ 
Study and showed that maternal smoking in pregnancy was associated with increased 
annual changes of systolic and diastolic blood pressure in the off spring. This increase led 
to higher systolic and diastolic blood pressure levels from early adulthood. The associa-
tions were not explained by low birth weight, suggesting that other causal pathways 
may be involved. 
In the same study, we examined the associations of maternal smoking in pregnancy 
with total cholesterol, HDL-cholesterol and LDL-cholesterol development from child-
hood into adulthood. Our study, presented in chapter 5.3, demonstrated for the fi rst 
time that maternal smoking in pregnancy was associated with an increased annual rise 
in total cholesterol levels from childhood into adulthood and tendencies towards an 
adverse lipoprotein profi le in the off spring. The eff ect of maternal smoking in pregnancy 
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on total cholesterol development was restricted to the off spring in the highest body 
mass index group. 
Increased arterial stiff ness has been identifi ed as a factor contributing to the develop-
ment of hypertension and may be one of the mechanisms underlying the associations of 
early life characteristics with blood pressure in later life. Previously, it was hypothesized 
that an adverse fetal environment leads to both fetal growth retardation and reduced 
elastin synthesis in the large arteries and subsequently to permanent stiff er arteries and 
increased blood pressure in later life. This hypothesis was tested in the study presented 
in chapter 5.4. Results from this study suggest that the causal pathway underlying the 
previously found associations of maternal smoking in pregnancy, low birth weight and 
preterm birth with increased blood pressure in later life, includes other mechanisms 
than arterial stiff ness.
In chapter 6 the general discussion, the results described in this thesis are considered 
in a broader context. In addition, relevant methodological issues are discussed and sug-
gestions for future research are given.
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Samenvatting 
In de afgelopen twintig jaar zijn in epidemiologisch onderzoek associaties aangetoond 
tussen een laag geboortegewicht en de ontwikkeling van hart en vaatziekten en de risi-
cofactoren daarvoor op latere leeftijd. De ‘foetale origine van volwassen aandoeningen’ 
hypothese veronderstelt dat een ongunstige foetale omgeving leidt tot aanpassingen 
in de ontwikkeling die permanent de structuur, fysiologie en het metabolisme van de 
foetus beïnvloeden. Dit leidt tot foetale groeivertraging en een laag geboortegewicht 
en zou ten gunste zijn voor de overleving op korte termijn. Lange termijn eff ecten 
zouden echter schadelijk zijn en leiden tot hart en vaatziekten. Door deze hypothese is 
recent de zoektocht naar de oorsprong van hart en vaatziekten uitgebreid van epidemi-
ologisch onderzoek bij volwassenen en kinderen naar onderzoek gericht op het foetale 
en vroege postnatale leven. 
Hoewel het geboortegewicht makkelijk te meten is en beschikbaar is uit obstetri-
sche dossiers, is het waarschijnlijk niet de beste afspiegeling van een ongunstige foe-
tale omgeving of blootstelling. Hetzelfde geboortegewicht kan het resultaat zijn van 
verschillende foetale blootstellingen en groeipatronen. Roken van moeder tijdens de 
zwangerschap is de belangrijkste determinant van laag geboortegewicht in westerse 
landen. Een ongunstige foetale omgeving als gevolg van roken van moeder kan door 
de directe eff ecten van nicotine en de geassocieerde maternale levensstijl en voedings-
gewoonten leiden tot veranderingen in de ontwikkeling. Om die reden zou roken van 
moeder tijdens de zwangerschap een betere afspiegeling kunnen zijn van een nadelige 
foetale omgeving dan het geboortegewicht. 
De ‘foetale origine van volwassen aandoeningen’ hypothese was de belangrijkste 
aanleiding tot het doen van het onderzoek dat beschreven wordt in dit proefschrift. Het 
doel van dit onderzoek was om mechanismen te identifi ceren die leiden van ongunstige 
foetale blootstellingen, tot suboptimale foetale groeipatronen en vervolgens tot de ont-
wikkeling van risicofactoren voor hart en vaatziekten. Hierbij hebben we ons gericht op 
roken van moeder tijdens de zwangerschap als ongunstige foetale blootstelling.
Er zijn verschillende hypothesen voorgesteld voor mechanismen die de associaties 
tussen een laag geboortegewicht en ziekten op de volwassen leeftijd zouden kunnen 
verklaren. Deze hypothesen stellen een centrale rol voor voor 1) foetale ondervoeding; 
2) toegenomen foetale blootstelling aan cortisol; 3) genetische aanleg voor zowel 
laag geboortegewicht als ziekten op de volwassen leeftijd; en 4) versnelde postnatale 
groei van kinderen met een laag geboortegewicht. In hoofdstuk 2 worden resultaten 
beschreven van eerder verricht epidemiologisch onderzoek, dat opgezet was om deze 
hypothesen te testen. Het is nog niet bekend welke mechanismen de associaties tussen 
laag geboortegewicht en ziekten op de volwassen leeftijd verklaren. De mechanismen 
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die leiden van een laag geboortegewicht tot ziekten op latere leeftijd lijken complex te 
zijn en gecombineerde omgevings- en genetische factoren in verschillende perioden 
van het leven te omvatten. Goed opgezet epidemiologisch onderzoek is nodig om de 
verklarende mechanismen te identifi ceren en om de grote van het eff ect op populatie-
niveau te schatten. 
In hoofdstuk 3 wordt het Generation R onderzoek gepresenteerd. Het Generation R 
onderzoek, is een populatiegebaseerd prospectief cohort onderzoek vanaf het vroe-
ge foetale leven tot de jongvolwassenheid. Het onderzoek is opgezet om de vroege 
omgevings- en genetische oorzaken van normale en abnormale groei, ontwikkeling en 
gezondheid van het foetale leven tot aan de jongvolwassenheid te identifi ceren. Het 
onderzoek is gericht op vier primaire onderzoeksgebieden: 1) groei en ontwikkeling; 2) 
gedrag en cognitieve ontwikkeling; 3) ziekten op de kinderleeftijd en 4) zorg en zorg-
gebruik voor zwangere vrouwen en kinderen. In totaal zijn 9.778 moeders geïncludeerd 
met een bevallingsdatum tussen april 2002 en januari 2006. Van alle kinderen die bij de 
geboorte in aanmerking kwamen, doet 61% mee aan het onderzoek. Data verzameling 
in de prenatale fase was gepland in de vroege zwangerschap (zwangerschapsduur < 
18 weken), halverwege de zwangerschap (zwangerschapsduur 18-25 weken) en laat in 
de zwangerschap (zwangerschapsduur ≥ 25 weken) en omvatte lichamelijk onderzoek, 
vragenlijsten, foetaal echo-onderzoek en biologische monsters. De kinderen vormen 
een prenataal geïncludeerd geboortecohort dat gevolgd wordt tot aan de jongvolwas-
senheid. 
Onderzoek beschreven in hoofdstuk 4 is gericht op het eff ect van roken en alcoholge-
bruik van moeder tijdens de zwangerschap op de foetale groei en het geboortegewicht. 
Dit onderzoek werd uitgevoerd in het Generation R onderzoek. 
Roken tijdens de zwangerschap leidt tot een laag geboortegewicht door vermin-
derde foetale voorraden van zowel voedingsstoff en als zuurstof en de daaruitvolgende 
groeivertraging. Recent werd gesuggereerd dat ook passief roken van moeder tijdens 
de zwangerschap, gedefi nieerd als blootstelling aan tabaksrook in de omgeving, geas-
socieerd is met een laag geboortegewicht. In het onderzoek gepresenteerd in hoofd-
stuk 4.1 vonden we dat actief en passief roken van moeder geassocieerd waren met 
een laag geboortegewicht. Actief roken van moeder nadat de zwangerschap bekend 
was, was ook geassocieerd met een toegenomen risico op vroeggeboorte. De eff ecten 
van roken op het geboortegewicht waren al te zien in de minst blootgestelde groepen. 
Roken van moeder tot de zwangerschap bekend was, was niet nadelig geassocieerd 
met het gewicht of de zwangerschapsduur bij de geboorte. Volledig stoppen met 
roken vroeg in de zwangerschap was, meer dan het verminderen van het aantal actief 
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gerookte sigaretten tijdens de zwangerschap, geassocieerd met gunstige eff ecten op 
het geboortegewicht. 
Omdat een laag geboortegewicht slechts een afgeleide is van foetale groeivertra-
ging, is het niet de beste maat om de nadelige eff ecten van roken tijdens de zwanger-
schap op de foetale groei te onderzoeken. Foetale groeivertraging kan leiden tot een 
normaal geboortegewicht bij een foetus die, gezien het genetische groei potentieel, 
eigenlijk volgens de bovenste percentielen had moeten groeien. In hoofdstuk 4.2 
toonden we aan dat actief blijven roken van moeder tijdens de zwangerschap geas-
socieerd was met een verminderde groei van de foetale hoofdomtrek, buikomtrek en 
femurlengte. Deze verminderde foetale groei leidde tot een kleinere femurlengte vanaf 
halverwege de zwangerschap en een kleinere hoofdomtrek en buikomtrek vanaf laat in 
de zwangerschap. De eerder optredende en grotere eff ecten op de femurlengte sug-
gereren dat roken van moeder tijdens de zwangerschap primair de perifere weefsels 
beïnvloed. Roken van moeder totdat de zwangerschap bekend was, had geen nadelige 
invloed op de foetale groeipatronen.
Overmatig alcoholgebruik tijdens de zwangerschap is geassocieerd met verschil-
lende zwangerschapscomplicaties zoals laag geboortegewicht, vroeggeboorte en 
congenitale afwijkingen. De eff ecten van overmatig alcoholgebruik tijdens de zwanger-
schap kunnen niet makkelijk geëxtrapoleerd worden naar het eff ect van gebruik van 
alcoholische dranken in mindere mate. Onze bevindingen, gepresenteerd in hoofdstuk 
4.3, lieten zien dat alcoholgebruik van moeder van minder dan één consumptie per 
dag niet geassocieerd was met een toegenomen risico op een laag geboortegewicht en 
vroeggeboorte. Voor alcoholgebruik van één of drie drankjes per dag werd een tendens 
naar een toegenomen risico op laag geboortegewicht en vroeggeboorte gevonden.
Onderzoek in hoofdstuk 5 bestudeert de eff ecten van foetale groeivertraging en roken 
van moeder tijdens de zwangerschap op de postnatale ontwikkeling van risicofactoren 
voor hart en vaatziekten. 
Linker ventrikelhypertrofi e is een sterke en onafhankelijke risicofactor van morbi-
diteit en mortaliteit. Aangezien het hart zijn grootste groeisnelheid heeft in de foetale 
en vroeg postnatale fase, zou een ongunstige omgeving in deze periode de groei en 
ontwikkeling van de linker ventrikel kunnen beïnvloeden. Het onderzoek gepresenteerd 
in hoofdstuk 5.1 werd uitgevoerd in een subgroep van het Generation R cohort en liet 
positieve associaties zien van de buikomtrek laat in de zwangerschap en het geboorte-
gewicht met de linker ventrikelmassa en de diameter van de aortabasis op de vroege 
zuigelingenleeftijd. Deze associaties waren onafhankelijk van het huidige gewicht en 
lengte en suggereren dat een kleinere foetusgrootte laat in de zwangerschap geassoci-
eerd is met een persisterende kleinere linker ventrikelmassa en diameter van de aorta-
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basis op de vroege zuigelingenleeftijd. Verder onderzoek is nodig om na te gaan of en in 
welke mate deze cardiale veranderingen persisteren op latere leeftijd.
Lange termijn follow-up onderzoek werd uitgevoerd in het Epidemiologisch Pre-
ventief Onderzoek Zoetermeer (EPOZ), een populatiegebaseerd prospectief cohort 
onderzoek in 596 kinderen, oorspronkelijk in de leeftijd van 5 tot 19 jaar. De huidige 
follow-up in dit onderzoek is 27 jaar.
Eerder onderzoek suggereerde dat roken van moeder in de zwangerschap geas-
socieerd is met een toegenomen bloeddruk bij de kinderen. Dit onderzoek werd verricht 
bij kinderen tot de leeftijd van 9 jaar. Het onderzoek gepresenteerd in hoofdstuk 5.2 
liet zien dat roken van moeder in de zwangerschap geassocieerd was met toegenomen 
jaarlijkse veranderingen in systolische en diastolische bloeddruk bij de kinderen. Deze 
toename leidde tot een hogere systolische en diastolische bloeddruk vanaf de jong vol-
wassenheid. De associaties werden niet verklaard door een laag geboortegewicht. Dit 
suggereert dat een andere onderliggend mechanisme van invloed is.
In hetzelfde onderzoek onderzochten we de associaties van roken van moeder tij-
dens de zwangerschap met de ontwikkeling van het totale cholesterol, HDL-cholesterol 
en LDL-cholesterol vanaf de kinderjaren tot in de volwassenheid. In hoofdstuk 5.3, 
toonden we voor het eerst aan dat roken van moeder tijdens de zwangerschap geas-
socieerd was met een toegenomen jaarlijkse stijging van het totaal cholesterol vanaf 
de kinderjaren tot in de volwassenheid en een neiging naar een ongunstig lipoproteine 
profi el bij het nageslacht. Het eff ect van roken van moeder tijdens de zwangerschap op 
de totale cholesterol ontwikkeling was beperkt tot kinderen in de hoogste body mass 
index groep. 
Toegenomen arteriële vaatwandstijfheid draagt bij aan de ontwikkeling van hyper-
tensie en zou één van de mechanismen kunnen zijn die de associatie tussen karakteristie-
ken in het vroege leven en bloeddruk op latere leeftijd verklaren. Eerder is de hypothese 
geformuleerd dat een ongunstige foetale omgeving leidt tot zowel groeivertraging als 
afgenomen elastine synthese in de grote arteriën en vervolgens tot permanente stijvere 
arteriën en een toegenomen bloeddruk later in het leven. Deze hypothese werd getest 
in het onderzoek gepresenteerd in hoofdstuk 5.4. Resultaten van dit onderzoek sug-
gereren dat het causale verband voor de eerder gevonden associaties van roken van 
moeder tijdens de zwangerschap, laag geboortegewicht en vroeggeboorte met een 
toegenomen bloeddruk op latere leeftijd in het leven andere mechanismen omvat dan 
arteriële stijfheid. 
In hoofdstuk 6, de algemene discussie, worden de resultaten van dit proefschrift 
beschreven en in een bredere context geplaatst. Bovendien worden relevante methodo-
logische kwesties bediscussieerd en suggesties gegeven voor toekomstig onderzoek.
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